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Abstract
Fbw7 belongs to the family of F-box proteins, which function as 
substrate recognition subunits of SCF complexes. Fbw7 controls the stability of 
several proteins including cyclin E, the Notch intracellular domain and c-Myc. 
In 2004 our lab additionally identified phospho-c-Jun as an Fbw7 substrate, c- 
Jun is part of the AP-1 transcription complex, whose activity is strongly 
induced in response to numerous signals such as growth factors, cytokines and 
extracellular stresses. Furthermore elevated phospho-c-Jun levels induce 
neuronal apoptosis. To investigate the significance of c-Jun regulation by Fbw7 
in the nervous system, I generated mice harbouring a floxed fbw7 allele, fb w 7^. 
j b w f ,f mice were bred to various Cre transgenic lines that express the Cre 
recombinase under nervous system specific promoters to obtain mice with a 
tissue specific deletion of Fbw7.
I confirmed published results that ubiquitous deletion of Fbw7 mediated 
by PGK-Cre is lethal. To delete Fbw7 at the stage of neuronal precursors, 
j b w f /f mice were crossed to the Nestin-cre line (fbw?**4). These mice die 
perinatally and show an increase in apoptosis at E l6. As the lethality of the 
fb w 7 ^  mice does not allow the investigation of Fbw7 in the adult nervous 
system, further crosses, using other cre-transgenic lines, were set up. Fbw7 
deletion in postmitotic neurons {fbw7^N) causes a Parkinson's disease like 
phenotype with a severe hindlimb tremor and a reduced cortical cellularity. 
Fbw7 deletion in the cerebellar vermis (fbw7ACb) resulted in cerebella that are 
characterised by a reduced size, foliation defects accompanied by an astrocytic 
gliosis and a phospho-c-Jun dependent Purkinje cell loss. Concomitant deletion 
of c-Jun in in the cerebellum (fbw7ACb:c-junACb) partially rescues the cerebellar 
phenotype caused by Fbw7 deletion.
Thus the data in this thesis demonstrate a role for Fbw7 in cerebellar 
development and the central nervous system and identify c-Jun as an essential 
Fbw7 substrate in the nervous system.
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Chapter 1
1 INTRODUCTION
1.1 JNK signalling and the transcription factor c- 
Jun
The Mitogen Activated Protein Kinase (MAPK) pathway mediates the 
response to numerous extracellular signals by regulating the activation of 
transcription factors, which in turn control cell growth, differentiation or 
apoptosis depending on the cellular context. The MAPK cascade is initiated 
upon stimulation of various receptors such as hormone and growth factor 
receptors, cytokine receptors or in response to environmental stresses such as 
UV-irradiation or osmotic shock (reviewed in (K. J. Cowan and K. B. Storey, 
2003)). Activation of these receptors leads to the recruitment of adaptor 
molecules to the relevant receptors, which then activate small GTP-binding 
proteins. These in turn activate a cascade consisting of multiple tiers of 
serine/threonine kinases such as the MAPKinase Kinase Kinase (MAPKKK), 
MAPKinase Kinase (MAPKK) and MAPKinases (MAPKs). There are three 
subclasses of MAPKs: the extracellular signal regulated kinases (ERK), the 
stress activated MAPKs including the 38 kD protein kinases (p38), and the c- 
Jun-N-terminal kinases (JNKs) (T. S. Lewis et al., 1998).
With regards to the JNK pathway MKK4 (SEK1) and MKK7 (SEK2) 
are the two MAPKKs that activate JNKs through the dual phosphorylation of a 
Thr-Xaa-Tyr motif (Figure 1.1 A) (B. Derijard et al., 1994). MKK4 is primarily 
activated by environmental stress and can additionally activate p38 (reviewed
19
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in (R. J. Davis, 2000)). In contrast MKK7, is specific for JNKs and is activated 
by generic stimuli such as anisomycin and UV irradiation and additionally by 
specific stimuli like tumour necrosis factor (TNF) and interleukin-1 (IL-1) (C. 
W. Chow et al., 1997; C. Toumier et al., 2001). Studies using mice and mouse 
embryonic fibroblasts (MEFs) deficient for MKK4, MKK7 or both have 
demonstrated that the JNK signalling pathway regulates not only apoptosis but 
is also essential for survival and organogenesis. Whilst mkk4'f' and mkkTA 
MEFs are resistant to anisomycin or heat shock induced JNK activation, mkk4~f~ 
embryos exhibit severe defects in liver formation and the liver cells undergo 
massive apoptosis (D. Yang et al., 1997; H. Nishina et al., 1999; C. Toumier et 
al., 2001). This apparent ambiguity of the resistance against UV induced 
apoptosis in MEFs and an increase in apoptosis during organogenesis shows 
that the effects of MAPK signalling are strongly dependent on the cellular 
context and that MKK4 and MKK7 are important mediators of MAPK 
signalling.
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Figure 1.1 The JNK signalling cascade and the transcription factor 
c-Jun. A) JNK signalling is activated upon extracellular stimuli and is 
relayed via small G-Proteins and adaptor molecules to a kinase cascade. 
Upstream kinases such as MEKK and MLKs activate their downstream 
kinase which are in case of JNK signalling MKK4 and MKK7. This causes 
activation of c-Jun N-terminal kinases (JNKs) which then phosphorylate 
various cytoplasmic and nuclear substrates as indicated. The JNK- 
interacting protein JIP acts as a scaffold for the signalling cascade. 
B) Domain structure of c-Jun. JNK binds within the 6 domain and activates 
c-Jun by phosphorylation at S63/73 and Thr91/93 in the transactivation 
domain. c-Jun dimerises with other AP-1 components via its c-terminal 
leucine zipper (L-Zip). Binding to target genes occurs via the DNA binding 
domain (DBD).
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1.1.1 The physiological role of JNKs
The JNKs JNK1, JNK2 and JNK3 are encoded by 3 different genes and 
and are also known as the Stress Activated Protein Kinases (SAPKs): SAPK-y, 
SAPK-a and SAPK-(3 respectively. They show a distinct expression pattern 
and while JNK1 and JNK2 are expressed ubiquitously, JNK3 is found 
predominantly in the brain and testis (S. Gupta et al., 1996; C. Y. Kuan et al., 
1999). Additionally, the different JNKs appear to have an at least partially 
redundant function in the organism as mice bearing a single deletion for either 
JNK1 or JNK2 are viable whereas concomitant deletion of JNK1 and JNK2 
results in embryonic lethality (C. Dong et al., 1998; C. D. Yang DD, 
Whitmarsh AJ, Barrett T, Davis RJ, Rincon M, Flavell RA., 1998; K. 
Sabapathy et al., 1999). Although JNKs were named after their major target c- 
Jun, it became apparent over the last years that JNKs can additionally 
phosphorylate and activate JunB, JunD, Elk-1 and ATF-2, (reviewed in (M. A. 
Bogoyevitch and B. Kobe, 2006)). Furthermore the Nuclear-Factor-of- 
Activated-T-cells (NFAT-4)(C. W. Chow et al., 1997), p53 (S. S. Shklyaev et 
al., 2001), c-Myc and a number of non-nuclear substrates including the 
microtubule associated protein Tau (H. Yoshida et al., 2004) and the ubiquitin 
E3 ligase Itch (M. Gao et al., 2004) have been identified as JNK substrates. 
Thus JNK signalling is not only a part of the cellular stress response and 
mediates apoptosis, it also regulates mechanisms such as cytoskeletal 
rearrangements, the immune response and protein degradation (see also 1.2.3).
22
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With regards to the role of JNKs in the nervous system it was shown 
that the response to apoptotic stimuli also varies in different JNK knockout 
mice. While deletion of JNK1 or JNK2 does not alter the response to kainate 
induced neuronal apoptosis, mice lacking the brain specific JNK3 are resistant 
to kainate induced excitotoxicity (D. D. Yang et al., 1997). Kainate receptors 
are found throughout the brain and are activated by the primary excitatory 
amino acid glutamate and their specific agonist kainate, which mimics the 
effect of glutamate. Administration of kainate causes an increase in the 
intracellular Ca2+ levels and the calcium dependent release of the excitatory 
neurotransmitter glutamate. This excess of glutamate leads to neuronal 
apoptosis and this mechanism is also known as excitotoxicity (J. W. Ferkany 
and J. T. Coyle, 1983; S. F. Giardina et al., 1998). Kainate receptors are located 
presynaptically where the presence of nanomolar kainate concentrations 
increases the glutamate release into the synapse and postsynaptic kainate 
receptors participate in the mediation of synaptic currents (reviewed in (J. 
Lerma, 2003)). Brain regions that are sensitive to kainate express high levels of 
the GluR6 and K2 kainate receptor genes and Savinainen et al have shown that 
after GluR6 receptor activation the PSD-95 protein anchors the JNK upstream 
kinases MLK2 and MLK3 to the glutamate receptor complex, which 
subsequently results in JNK activation (W. Wisden and P. H. Seeburg, 1993; A. 
Savinainen et al., 2001). In 1999 Behrens et al demonstrated that the excitotoxic 
effect in hippocampal neurons is dependent on c-Jun phosphorylation at the N- 
terminal S63/73 residues as junAA mice that harbour mutations of these residues 
to alanines are resistant to kainate induced excitotoxicity (A. Behrens et al., 
1999). The fact that JNK signalling is an essential mechanism in the regulation
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of survival signals in neurons is further supported by the fact that jnk3~A mice 
but also neurons are partially protected from apoptosis upon
administration of MPTP, a neurotoxic drug that induces loss of dopaminergic 
neurons (S. Hunot et al., 2004). However jnkl~l~ neurons are not protected in 
this system indicating that there are distinct roles of the different JNK isoforms 
in the brain (reviewed in (S. Brecht et al., 2005)).
1.1.2 The transcription factor c-Jun
One of the downstream targets of the JNK cascade is the transcription 
factor c-Jun, which is the cellular counterpart to the transforming protein v-Jun 
of the chicken retrovirus ASV17. To activate c-Jun, JNK first binds to the N- 
terminal 6 domain in c-Jun and phosphorylates residues Ser63/Ser73 and 
Thr91/Thr93 located within the transactivation domain of c-Jun (Figure 1.1 B) 
c-Jun forms homo- or heterodimeric complexes with proteins such as JunB, 
JunD, members of the Fos protein family or ATF-2 to generate the activator- 
protein-1 (AP-1) transcription complex. The AP-1 complex binds to a 
consensus sequence (AP-1 sites) found in promoters and enhancers of a great 
variety of genes and is involved in the regulation of cell growth, transformation 
and in the response to stress (E. Shaulian and M. Karin, 2002).
Regarding c-Jun in the nervous system, Herdegen et al. observed that 
c-Jun is upregulated in response to injury, while the other components of the 
AP-1 complex were not induced to the same extent (T. Herdegen et al., 1997) 
(T. Herdegen et al., 1998). In 2004 the role of c-Jun in the nervous system was 
further clarified in a study that used mice that lack c-Jun specifically in cells of 
the neuronal lineage (c -ju n ^  mice) (G. Raivich et al., 2004). c-juri^ mice
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develop normally but display defects in the axonal regeneration after injury 
while at the same time apoptosis in response to the injury was reduced.
The importance of c-Jun phosphorylation in neuronal apoptosis was 
underlined in a study that characterised junAA mice, where the N-terminal 
phosphorylation sites S63/S73 in the transactivation domain were mutated to 
alanines (A. Behrens et al., 1999). As the jn k3 _/' mice the ju n AA mice are 
resistant to kainate-induced apoptosis, which demonstrates a requirement for c- 
Jun phosphorylation in the initiation of neuronal cell death. Also cultured 
sympathetic neurons from junAA mice display a significant delay in apoptosis 
induced by trophic factor deprivation (C. G. Besirli et al., 2005). Other in vitro 
experiments in rat cerebellar granule cell cultures (cgcs) and rat sympathetic 
neurons demonstrated that overexpression of a dominant negative c-Jun 
construct protects these neurons from apoptosis, thereby supporting the model 
that N-terminal phosphorylation of c-Jun is a crucial event in neuronal 
apoptosis (J. Ham et al., 1995; A. Watson et al., 1998). Apart from its role in 
neuronal apoptosis after insults, an active JNK pathway and phosphorylated c- 
Jun have been observed in neurodegenerative diseases. In brains from patients 
with Alzheimer’s disease (AD) activated c-Jun was found in neurofibrillary 
tangles and was connected to amyloid depositions (A. G. Pearson et al., 2006; 
A. Thakur et al., 2007). Furthermore c-Jun phosphorylation has been linked to 
Huntington’s disease (HD) (M. Garcia et al., 2004) and the death of 
dopaminergic neurons in a mouse model for Parkinson’s disease (PD) (M. G. 
Willesen et al., 2002). In summary, while c-Jun is dispensable for brain 
development, c-Jun and c-Jun phosphorylation play an important role in axonal 
regeneration, neuronal apoptosis, and neurodegenerative diseases.
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In 2004 it was found that the F-box protein Fbw7 targets specifically 
phosphorylated c-Jun for subsequent proteasomal degradation (A. S. Nateri et 
al., 2004). Fbw7 is one component of a so-called SCF-E3 ligase complex, 
which mediates the attachment of small ubiquitin molecules to a substrate and 
thereby marks it for subsequent degradation. Since I was investigating the role 
of Fbw7 in the nervous system, I will give a short overview about 
ubiquitination, E3 ligases and c-Jun degradation in the following section. I will 
then summarise the literature on Fbw7, its substrates and regulation and give a 
short introduction into the nervous system.
1.2 Protein ubiquitination. E3 liqases and c-Jun
1.2.1 Ubiquitination targets proteins for different intracellular 
events
Ubiquitin is a 76 amino acid molecule, which can be attached to other 
proteins either as a monomer or as a chain of ubiquitin residues and thereby 
alter the fate of the modified protein. An ubiquitin chain is generated by the 
linkage of ubiquitins via lysine residues present at various positions in the 
ubiquitin molecule whereby the lysine residues that are used for the ubiquitin 
linkage determine the fate of the ubiquitinated protein (Figure 1.2A). The 
presence of a chain of multiple ubiquitin residues that are linked via their lysine 
48 (K48 linkage) marks a protein for subsequent proteasomal degradation. A 
polyubiqutin chain that is linked via lysine 63 (K63 linkage) is not targeted for 
degradation but is instead involved in other cellular processes such as 
intracellular signalling, transcription, transformation or DNA repair (reviewed
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in (A. Isaksson et al., 1996; M. Muratani and W. P. Tansey, 2003; D. 
Mukhopadhyay and H. Riezman, 2007)). In addition there is also the possibility 
that a protein can be monoubiquitinated at either one or multiple sites, which 
was shown to regulate endocytosis of receptor tyrosine kinases (Figure 1.2B) 
(K. Haglund et al., 2003). In any ubiquitination reaction the ubiquitin 
attachment is mediated by a cascade of enzymes that finally leads to the 
formation of a thioester-bond between the C-terminus of ubiquitin and the e- 
amino group of a lysine in the substrate. The enzymes involved in this 
ubiquitination process are the ubiquitin-activating enzyme (El), the ubiquitin 
conjugating enzyme (E2) and the ubiquitin ligases (E3s). E3 recognise and bind 
the substrate and finally mediate the attachment of ubiquitin moieties (see 
below) (Figure 1.2C). The initial steps of the ATP dependent ubiquitin 
activation and E2 conjugation are not described in detail in this introduction as 
my work focussed on the E3 ligase Fbw7 and for a review of the initial 
ubiquitination steps see (C. M. Pickart and M. J. Eddins, 2004).
Interestingly the number of E3 ligases is higher than the number of E2 
ligases, which in turn is higher than the number of E l enzymes identified so far 
(C. M. Pickart, 2001). The E3 ligases are the final and crucial adaptor 
molecules between the ubiquitination complex and the substrate, and are 
therefore responsible for the specificity. The high number of E3s may reflect 
the number of target proteins, however, this does not mean that any given E3 
ligase has only one substrate. Indeed one E3 ligase can have many substrates 
that all share a specific recognition sequence, for instance a so-called phospho- 
degron, where a protein is recognised for ubiquitin attachment depending on its 
phosphorylation state. Additionally one substrate can also be targeted for
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degradation by more than one E3 ligase, which has been shown to be the case 
for c-Jun (see below 1.2.3).
The result of the multi step ubiquitination cascade is always the 
attachment of an ubiquitin moiety to the substrate. Originally it was believed 
that all three enzymes are necessary for the ubiquitination of a protein and it 
was only elucidate recently that ubiquitination can also take place in the 
absence of an E3 ligase. Even more, in addition to the attachment of one 
ubiquitin molecule after the other to form a chain on the substrate also whole 
previously assembled ubiquitin chains can be attached (W. Li et al., 2007).
Ubiquitination is not a final modification and can be reversed by means 
of deubiquitinating enzymes (DUBs) and ubiquitin specific proteases (USPs) 
and an increasingly complex network of regulated ubiquitination and 
deubiquitination of proteins emerges. For instance, the Anaphase Promoting 
Complex (APC) E3-ligase activity in yeast is antagonised via USP44, which 
deubiquitinates the APC coactivator Cdc20 (F. Stegmeier et al., 2007). 
Importantly the first USP for the E3-ligase Fbw7, USP28, was recently 
identified and found to antagonise Fbw7 mediated ubiquitination (N. Popov et 
al., 2007).
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Figure 1.2 Ubiquitination targets proteins for a variety of processes
A) The 76 Amino acid ubiquitin molecules contains a variety of lysine 
residues (K6 to K63) that are used to link the ubiquitins to the substrate 
and during the polyubiqutin chain formation. Figure from Woelke et al., 
2007 B) Proteins can be ubiquitinated in different ways. Ubiquitination 
was shown to be involved in a variety of cellular events listed below the 
different ubiquitination modes C) Ubiquitination is mediated via a cascade 
of three different enzymes. The E1 ubiquitin activating enzyme and E2 
ubiquitin conjugating enzyme prepare the attachment of the ubiquitin 
moiety via the E3 ligase to the substrate. Figure modified from Haglund& 
Dikic,2005.
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1.2.2 E3 ligases mediate the attachment of ubiquitins to 
substrates
1.2.2.1 HECT and RING E3 ligases
The two classes of HECT (homologous to E6-AP-carboxy terminus) 
and RING (really interesting new gene) E3 ligases form together with the F-box 
ligases the superfamily of E3 ligases. As also HECT and RING E3 are involved 
in the degradation of c-Jun (see 1.2.3), I will give a short introduction on them.
In contrast to the F-box ligases (discussed below) HECT and RING E3 
ligases interact directly with the E2 and mediate the ubiquitination of the 
substrate. In HECT domain proteins the N-terminus interacts with the substrate 
that will be ubiquitinated, and the C-terminal HECT domain binds to the E2 
enzyme (S. Kumar et al., 1997). The prototype of the HECT proteins is the 
E6-AP protein, which is mutated in the neurodegenerative disease Angelman 
syndrome and causes severe mental retardation in patients (T. Kishino et al., 
1997). In a knockout mouse model for this disease Jiang et al. could show that 
the protein levels of the tumour suppressor protein p53 are elevated and that 
these mice have deficits in contextual learning and memory, indicating this 
particular E3 ligase has an essential function in the nervous system (Y. H. Jiang 
et al., 1998). Another example for a HECT-E3 is Itch, which regulates the 
degradation of Notch, c-Jun and JunB and which will be described in more 
detail later (see 1.2.3) (L. Qiu et al., 2000; D. Fang and T. K. Kerppola, 2004; 
M. Gao et al., 2004).
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RING E3 ligases were named after their characteristic cross brace 
structure that coordinates two zinc ions in its core and have been divided into 
two subgroups, one group contains the RING proteins that exert their function 
as monomers, whereas the other group contains RING E3s that are part of 
multimeric complexes such as the Skpl-Cull-F-box (SCF) complex or the Von 
Hippel Lindau (VHL) complex (T. Kamura et al., 1999). In the case of single 
subunit RING E3s the RING domain facilitates the ubiquitination o f a substrate 
that is recognises by another domain of the protein. Examples for such a single 
subunit RING-E3 ligase are c-Cbl where the target protein is recognised via its 
SH2 domain (C. A. Joazeiro et al., 1999) and Mdm2, which has a crucial role in 
mediating the degradation of the tumour suppressor p53 (S. Fang et al., 2000). 
There is also emerging evidence that the interaction between these E3-ligases 
and their substrates is tightly regulated by posttranslational modifications. In 
case of Mdm2, for example, it was demonstrated that not only p53 is protected 
from Mdm2 mediated degradation when acetylated, but also that acetylation of 
Mdm2 itself impairs its function on p53 (X. Wang et al., 2004). Additionally 
specific adaptor molecules have been identified that can interact with E3 ligases 
that were originally thought to act as monomers. The adaptor molecule Numb, 
for instance, binds to the transcription factor glil thereby targeting it for Itch 
mediated degradation (L. Di Marcotullio et al., 2006).
1.2.2.2 F-box E3 ligases and the SCF complex
The SCF complex is a multi protein complex named after its 
components Skp-l:Cull:F-box (Figure 1.3 A) A further component of the SCF 
complex is the Rbxl RING protein, which in this context acts as an adaptor for
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the E2 ligase and not as a self-standing E3 ligase. An ubiquitin will be attached 
to a substrate via the E2 enzyme bound to Rbxl, which in turn is bound to the 
Cull C-terminus. The Cull N-terminus binds to Skpl, which also binds the 
conserved F-box domain of the F-box proteins (P. K. Jackson and A. G. 
Eldridge, 2002).
F-box proteins, such as Fbw7, act as a connector between the otherwise 
conserved complex and the specific substrate. There are three groups of F-box 
proteins and while the F-box domain is common to all of them, they differ in 
their C-termini, which can be composed of either a so-called WD-40 repeat 
region, a leucine rich repeat region or a variable region (J. T. Winston et al., 
1999). In all cases the C-terminus is responsible for the binding of the substrate 
that is to be ubiquitinated. Ten WD-40 repeat F-box proteins have been 
identified so far and they have various functions, expression patterns and 
substrates. Fbwl for example can be found in the nucleus as well as the 
cytoplasm and mediates the degradation of p-catenin (M. Kitagawa et al.,
1999). Fbw2 is mainly expressed in the liver but not in the brain and localises 
to the cytoplasm (M. Miura et al., 1999). Another example is Fbw8, which 
forms a complex with Cul7 and Cull and Tsunematsu et al. showed that Fbw8 
is required during the development of the placenta in mice (R. Tsunematsu et 
al., 2006). Thus, although these proteins share the same conserved domains 
such as the F-box and the WD-40 region, and bind to the same components of 
the SCF complex, their function is highly specific and diverse. Fbw8, for 
example, was found to interact with c-Myc but does not bind within the myc- 
box domain 1 as Fbw7 does (see also 1.3.3.2). Instead Fbw8 interacts with c- 
Myc via the myc-box domain 2 and the helix-loop-helix motif (H. B. Koch et
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al., 2007). Considering that with Fbw7 and Skp2 there are already two E3 
ligases involved in c-Myc degradation (see also 1.3.3.2) the interaction of Fbw8 
with c-Myc adds further complexity to this mechanism and shows again that 
one substrate can be targeted by different E3 ligases for degradation. 
Nevertheless it remains largely elusive how these interactions are orchestrated. 
The studies published so far for c-Jun and c-Myc degradation usually focus on 
one particular E3 ligase in but do not consider effects of the other known 
specific E3 ligases on the given target protein.
1.2.3 c-Jun degradation
The first reports describing that c-Jun can be ubiquitinated and degraded 
via the proteasome pathway were published in 1994 and 1996 (M. Treier et al., 
1994; A. M. Musti et al., 1996). Treier et al. demonstrated that the 6 domain of 
c-Jun is important for its degradation and Musti et al. observed that differences 
in the 6 domain of c-Jun, and JunD account for their different ubiquitination 
kinetics and thus different half live times of the proteins (A. M. Musti et al., 
1997). However, in those two publications, however, no specific E3 ligases for 
the Jun family members were identified.
In 2003 it was shown that c-Jun binds to the RING protein Copl and 
that Copl binding to c-Jun downregulates AP-1-dependent transcription (E. 
Bianchi et al., 2003). A year later in 2004 Wertz et al. described a ternary 
complex consisting of Copl, hDetl and Cul4A, which mediates the degradation 
of c-Jun independent of JNK signalling or the presence of the 6-domain (I. E. 
Wertz et al., 2004). While it is not clear whether this complex acts in a 
phosphorylation independent manner or requires the phosphorylation at other
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sites outside the 6-domain, an regulatory mechanism for the Copl-hDet-c-Jun 
interaction has recently been elucidated. Savio et al. showed that a splice 
variant of Copl, Cop ID, acts as a dominant negative regulator of Copl. Savio 
et al observed an initial decrease in the Copl /Cop ID ratio in response to UV, 
which is then followed by an increase in Copl/Cop ID ratio. Savio et al 
conclude that these alterations in the Copl isoform ratios offer a mechanism for 
the finetuning of c-Jun levels in response to UV. Immediately after UV 
irradiation c-Jun activity increases the sensitivity of cells to p53 mediated 
apoptosis and c-Jun levels can be downregulated by the Copl-hDetl-Cull 
complex. Once Cop ID is sufficiently upregulated it dimerises with Copl and 
sequesters it away from the E3 ligase complex. This leads to an increase in c- 
Jun levels, which mediate cell cycle re-entry (M. G. Savio et al., 2007).
Apart from Copl the F-box protein Fbw7 (A. S. Nateri et al., 2004; 
W. Wei et al., 2005) and the HECT-E3 ligase Itch (M. Gao et al., 2004) were 
found to mediate c-Jun ubiquitination and degradation (Figure 1.4A). Firstly, 
Gao et al. observed that the overexpression of an upstream kinase of the JNK 
signalling pathway such as MEKK1 or a dominant active JNKK2-JNK1 
construct in 293 cells caused polyubiquitination of c-Jun in an Itch dependent 
manner. However, also c-Jun constructs harbouring either single or double 
mutations of the S63 and S73 residues to alanines were ubiquitinated to the 
same degree as wt c-Jun. Gao et al. next analysed the ubiquitination of a junAla 
mutant where additionally to the S63/73 and T91/93 residues the threonine 
residues at positions 89, 90 and 95 were changed to alanines. In the presence of 
Itch this junAla construct was ubiquitinated to the same extent as wt c-Jun. 
Based on these experiments Gao et al. concluded that Itch mediates the
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ubiquitination of c-Jun independent of the phosphorylation status in the c-Jun 
transactivation domain (M. Gao et al., 2004). Interestingly, Gallagher et al. 
showed in 2006 that Itch itself is phosphorylated and thereby regulated by JNK 
signalling (E. Gallagher et al., 2006). The phosphorylation of Itch at various 
residues in its proline-rich region results in the disruption of an intramolecular 
interaction between its N- and C-terminal region, which on the one hand allows 
Itch to exert its function as an E3 ligase, but on the other hand decreases its 
stability by promoting its autoubiquitination. Additionally to Itch, the F-box E3 
ligase Fbw7 can antagonise the levels of phosphorylated c-Jun and two 
different Fbw7 binding sites were identified, whereby one lies within the 6 
domain and the other one is located more c-terminal (see also chapter 1.3.3.1) 
(A. S. Nateri et al., 2004; W. Wei et al., 2005). By using c-Jun constructs, in 
which the phosphorylated residues were mutated to alanines both groups 
established that c-Jun has to be phosphorylated to be ubiquitinated by Fbw7 (A. 
S. Nateri et al., 2004; W. Wei et al., 2005).
In summary, three different E3 ligases for c-Jun have been identified so 
far: Itch, Cop-1 and Fbw7. The analysis of the binding sites for these E3 ligases 
reveals that all three ligases recognise different motifs in the c-Jun protein 
(Figure 1.4B). Furthermore the initial characterisation of these E3:c-Jun 
interactions demonstrated that the recognition of c-Jun as a substrate is 
regulated by a variety of different mechanisms: the phosphorylation of either 
the substrate (Fbw7:c-Jun interaction) or the E3 ligase itself (Itch-c-Jun 
interaction). Furthermore the recognition of c-Jun as a ubiquitination target can 
be regulated by other factors that sequester components of the ubiquitination
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machinery as shown for the Cop-l:c-Jun interaction. The existence of different 
mechanisms that regulate c-Jun abundance suggests that dependent on the 
cellular context or extracellular stimulus different E3 ligases might be involved 
in regulating c-Jun levels. However, how the activity of the different E3s 
towards c-Jun is orchestrated still remains to be investigated.
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1.3 The Fbw7 protein
Fbw7, also known as Sel-10 in c.elegans, Cdc4 in yeast and Ago in 
drosophila, was initially named Fbxw6 in mice (S. Maruyama et al., 2001) but 
was later renamed Fbw7 when the nomenclature of F-box proteins was unified 
in 2004 (J. Jin et al., 2004). Originally Flubbard et al. (E. J. Flubbard et al., 
1997) identified Fbw7 as a negative regulator of Notch/lin-12 signalling in 
c.elegans. Since then various other substrates have been described including c- 
Jun, c-Myc, and cyclin E. I will now summarise how Fbw7 interacts with its 
substrates and as many of these substrates are known oncogenes, I will also 
focus on the role of Fbw7 as a tumour suppressor.
1.3.1 Fbw7 isoforms and localisation
Fbw7 has 3 isoforms a , p and y, which are generated using an 
alternative first exon, followed by 10 common exons (Figure 1.5A) The unique 
exon 1 of the Fbw7 isoforms plays a crucial role in determining their 
localisation and function. While the a  and y isoforms are present in the nucleus 
and nucleoli, the p isoform is found in the cytoplasm (M. Welcker et al., 
2004a). In addition the three isoforms show a tissue specific expression pattern 
with the p isoform being expressed mainly in brain, heart and testis, while the 
other isoforms are found in various tissues (C. H. Spruck et al., 2002).
A detailed study, conducted by Welcker et al. identified several 
localisation signals within the Fbw7 sequence that can explain the distinct
39
Chapter 1
localisation patterns of the different isoforms (Figure 1.5B)(M. Welcker et al., 
2004a). A nuclear localisation signal (NLS) in the a-exon of Fbw7 is 
responsible for its nuclear localisation and upon deletion of the respective 
residues this nuclear isoform localises to the cytoplasm. Additionally the N- 
terminus of the a-isoform is sufficient to translocate GFP to the nucleus, clearly 
indicating the presence of an isoform specific NLS (M. Welcker et al., 2004a). 
Furthermore, Welcker et al. could demonstrate that the N-terminus of the (3- 
isoform contains a nuclear export signal (NES). In addition to the localisation 
signals identified by Welcker et al., I identified another NLS in the common 
region in between the F-box domain and the WD40 repeat region. Mutagenesis 
of this NLS (GFP-Fbw7-AN-4A) abolishes the nuclear localisation of a GFP 
fusion construct, containing only the common region of Fbw7 
(GFP-Fbw7-AN), and distributes it back to the cytoplasm (A. Jandke, 2003).
The ability of Fbw7 to translocate between different cellular 
compartments, either upon deletion or mutagenesis of various domains, gives 
rise to the speculation that Fbw7 localisation might be regulated by yet to be 
defined mechanims. It is feasible to speculate that substrate recognition might 
be achieved or impaired via signals that bind and mask localisation signals, and 
thereby affect the localisation and subsequently access to substrates in different 
cellular compartments.
1.3.2 Fbw7 isoforms can act sequentially on a substrate and 
dimerise
Various studies have demonstrated that the different Fbw7 isoforms can 
interact and cooperate in their action towards substrates. A study by van Drogen
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et al. demonstrated that multi-ubiquitination of cyclin E, one of the Fbw7 
substrates, is achieved by the initial binding of Fbw7-a to cyclin E, which is 
followed by binding of the prolyl isomerase Pinl to this complex (F. van 
Drogen et al., 2006). This in turn facilitates the binding of the second isoform, 
Fbw7-y, to cyclin E. Their finding of a sequential interaction of both Fbw7 
isoforms is supported by the existence of a cancer mutation in Fbw7-a, which 
cannot interact with Pinl and thereby stabilises cyclin E (F. van Drogen et al., 
2006). Data from p in l7‘ mice strengthen this model, as in these animals cyclin 
E protein levels are deregulated (E. S. Yeh et al., 2006). Van Drogen and 
colleagues speculate that the sequential binding of different Fbw7 isoforms to a 
single substrate might be a general mechanism for the action of Fbw7 on its 
targets and a recent study using p in l ^.pSS ^ mice supports this model(K. 
Takahashi et al., 2007). In this study the authors observed an increase in Notch- 
1-intracellular domain (Notch 1-ICD) and Presenilin levels with both proteins 
being Fbw7 targets (see chapter 1.3.3.4). However, the authors did not relate 
the observed increase of these substrates to the role of Pinl in Fbw7-mediated 
protein degradation and did not look at the effects on other substrates of Fbw7 
such as c-Jun or c-Myc.
In line with the idea that Fbw7 isoforms can cooperate or interact, a so- 
called D-domain (dimerisation domain) directly upstream of the F-box domain 
was recently identified (W. Zhang and D. M. Koepp, 2006; M. Welcker and B.
E. Clurman, 2007). Both groups investigated the interaction of different Fbw7 
isoforms and used N- and C-terminal truncated constructs to map possible 
Fbw7 dimerisation sites. They observed that all isoforms have the ability to 
homo- and heterodimerise in various combinations in vitro (W. Zhang and D.
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M. Koepp, 2006) and in vivo (W. Zhang and D. M. Koepp, 2006; M. Welcker 
and B. E. Clurman, 2007). Co-immunoprecipitation experiments showed that 
homodimerisation is more efficient than heterodimerisation. Additionally the 
heterodimerisation of the p-isoform with the others (a  or y) was very weak, 
which is perhaps not surprising considering the different cellular compartments 
where these isoforms are expressed (M. Welcker and B. E. Clurman, 2007). 
The same study also demonstrated that the dimerisation can alter the 
localisation of the complex. Performing co-overexpression studies in U20S 
cells the authors observe that a cytoplasmic mutant of the y-isoform, localises to 
the nucleus upon dimerisation with the a-isoform, whereas co-overexpression 
of the p and y isoform did not result in an altered localisation (M. Welcker and
B. E. Clurman, 2007). Welcker et al. further investigated whether the 
dimerisation affects the substrate ubiquitination. By using a dimerisation 
defective mutant where the four amino acids that are required for dimerisation 
are deleted, and by monitoring cyclin E levels, they observed that dimerisation 
is not strictly required for Fbw7 to exert its function. This is in contrast to the 
study of Zhang et al. who found that dimerisation is essential for cyclin E 
proteolysis. These authors used a cycloheximide protein synthesis block to 
determine the proteolysis of the cyclin E pool over time and observed a 
stabilisation when using the D-domain mutant, which contains a deletion of 
exon2, 3 and 4. Since the deletion domain mutant used by Welcker et al. spans 
only the 4 amino acids that are required for dimerisation this shows that 
dimerisation is indeed not completely required for Fbw7 function. Furthermore
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both studies concluded that the functionality of the D-domain is not dependent 
on the presence of the F-box domain or the WD-40 repeats.
In summary it has been clearly demonstrated that more than one Fbw7 
molecule can be involved in the ubiquitination of a substrate and that a ternary 
complex might be formed, either involving an Fbw7 dimer or another 
intermediate such as Pinl. Hao et al. have recently confirmed the dimerisation 
model for SCF-mediated ubiquitination by providing crystallographic data and 
additionally suggest that a model of “substrate cross-ubiquitination” is also 
feasible (B. Hao et al., 2007). This model proposes that a ubiquitin moiety can 
be attached more efficiently by a second SCF complex, present on the same 
substrate molecule, or even on a different E3 substrate molecule in close 
proximity (Figure 1.5C) Therefore, the interaction between the different Fbw7 
isoforms and between Fbw7 and its substrates appears to be highly complex 
and most likely not all mechanisms or even substrates have yet been identified. 
As all substrates are potentially affected in Fbw7 knockout animals, I will now 
recapitulate the published data on the substrates known to date.
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Figure 1.5 Genomic locus and domain structure and dimerisation of 
Fbw7. A) The fbw7 gene is located on Chromosome 3 and has 3 isoforms 
that result from an alternative exon 1. Exon 2 to 11 are common to all 3 
isoforms. Figure from Spruck et al., 2002 B) Domain structure of the Fbw7 
protein. In addition to the F-box domain and the WD-40 propeller Nuclear 
Export Signals (NES) and Nuclear Localisation Signals (NLS) are located 
at the indicated locations. A dimerisation domain is located directly N- 
terminal to the F-box domain, Figure modified from Welcker & Clurman,2007
C) Models of substrate ubiquitinination by multiple SCF ligases. With either 
one substrate bound (left), or two substrates (right) it is feasible that the 
lysine residue for ubiquitination is better presented to the adjacent SCF 
complex than to the originally binding one (Figure from Hao et al., 2007)
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1.3.3 Fbw7 substrates
1.3.3.1 Fbw7 and c-Jun
Since N-terminal phosphorylation was shown to be important for many 
functions of c-Jun, Nateri et al. performed a yeast two-hybrid screen to identify 
phosphorylation dependent c-Jun interactors. They observed that the E3-ligase 
Fbw7 interacts specifically with phosphorylated c-Jun (A. S. Nateri et al., 
2004). In the yeast screen a temperature sensitive cdc25 mutant yeast strain, 
which lacks Ras activity and grows only at 25°C was used. The Ras activity can 
be rescued by introducing human oncogenic Ras, which enables the yeast to 
grow additionally at 37°C. A brain library, fused to a myristilation signal 
causing it to localise to the plasma membrane, was used to screen for c-Jun 
interactors. A truncated c-Jun construct, lacking the leucine zipper, fused to 
oncogenic RasV12 was the bait. Because of the myristilation signal, the 
interaction between proteins from the brain library with c-Jun had to take place 
at the plasma membrane and therefore activated the Ras signalling pathway and 
enabled the yeast to grow at 37°C. To make the screen c-Jun phosphorylation 
dependent, a constitutive active MKK7-JNK1 fusion construct under the 
control of the Met3 promoter, which caused reliable c-Jun phosphorylation in 
absence of Methionine, was employed. After identifying Fbw7 as an E3 ligase 
for phosphorylated c-Jun, the interaction was verified in an in vitro translation 
system where it was confirmed that Fbw7 and phosphorylated c-Jun co- 
immunoprecipitate. Using a peptide-binding assays Nateri et al. established that
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the interaction requires the phosphorylation of c-Jun at its S63/S73 and T91/93 
residues (A. S. Nateri et al., 2004). Therefore previous reports showing that 
the N-terminal region of c-Jun is involved in its degradation were confirmed 
(M. Treier et al., 1994).
More recently, another study also demonstrated the interaction between 
Fbw7 and c-Jun (W. Wei et al., 2005). However, regarding the location of the 
Fbw7 binding site on c-Jun both publications show conflicting data. Whereas in 
the study by Nateri et al. Fbw7-p binds the same residues that are also 
phosphorylated by JNK, namely Ser63 and Ser73, Wei et al. could not confirm 
this interaction but showed that all Fbw7-isoforms recognise c-Jun 
phosphorylated at Thr 239, which lies within a phospho-degron, a consensus 
sequence for Fbw7 recognition (Figure 1.6C). They further elucidated that an 
initial phosphorylation of Ser 243 is followed by GSK-3 mediated 
phosphorylation of Thr239 and this generates the recognition site for Fbw7 
(Figure 1.6A and C). Based on these data Wei et al. propose a model whereby 
the Fbw7 binding site is generated by two sequential phosphorylation steps 
whereby the second phosphorylation is mediated by GSK-3. This model is 
similar to the one previously identified for the binding of Fbw7 to c-Myc (see 
also 1.3.3.2). To support this model the authors present data for an inverse 
correlation between the GSK-3 activity and c-Jun levels in various cell lines 
and show that v-jun can escape Fbw7-mediated degradation because the 
required priming phosphorylation site at S243 is mutated to phenylalanine.
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Figure 1.6 Fbw7 recognises a phospho-degron in c-Jun and c-Myc
A) Two different models (blue and red) are proposed for Fbw7:c-Jun 
interaction. Nateri et al. published that c-Jun is recognised at S63/S73 
and T91/93 residues (blue). Wei et al (red) showed that Fbw7 binds in 
a C-terminal phosphodegron site, whereby S239 has to be phosphorylated 
by GSK3 after a priming phosphorylation of T243 by ERK. B) c-myc 
degradation is facilitated by three E3 ligases as indicated. Fbw7 requires 
a priming phosphorylation at S62 to allow GSK3 to phosphorylate T59 
which is subsequently recognised by Fbw7. Skp2 acts in a phospho- 
independent manner.The role of Fbw8 is not clarified yet. C) Phospho­
degron sites identified in Fbw7 substrates, Conserved residues are in 
red. Figure from Wei et al.,2005
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1.3.3.2 Fbw7 and c-Mvc
The proto-oncogene c-Myc is a transcription factor whose activity is not 
only regulated by cofactors such as the Mad/Max complex (reviewed in (B. 
Luscher, 2001; S. Rottmann and B. Luscher, 2006)), but also by ubiquitination 
and degradation. In 2003 two groups independently identified Skp2 as the first 
E3 ligase that regulates c-Myc (S. Y. Kim et al., 2003; N. von der Lehr et al., 
2003b). Both studies show that Skp2 binds in a phosphorylation independent 
manner and that it is not only an E3 ligase for c-Myc, but also acts as a 
coactivator. This apparent discrepancy is explained with a model whereby the 
binding of Skp2 causes the recruitment of the proteasome to the promoter and 
thereby mediates the degradation of inhibitory factors, thus facilitating the 
activation of c-Myc. Concomitantly, the presence of the proteasome causes the 
degradation and thus clearance of c-Myc from a promoter thereby allowing 
newly synthesised c-Myc to bind and the activation cycle to begin anew (N. 
von der Lehr et al., 2003a).
In 2004 Fbw7 was identified as an additional E3 ligase for c-Myc but in 
contrast to Skp2 Fbw7 represses c-Myc function (M. Yada et al., 2004). 
Welcker et al. characterised the mechanisms of Fbw7-c-Myc interaction in 
more detail and identified a complex cascade of events leading to Fbw7 
mediated c-Myc degradation (M. Welcker et al., 2004b). Using mutagenesis 
analysis of c-Myc and different truncated cDNAs for Fbw7, they demonstrated 
that GSK-3 mediated phosphorylation of c-Myc at residue T58 is required for 
Fbw7-mediated c-Myc turnover. However, a prerequisite for the
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phosphorylation of T58 by GSK-3 is, that the S62 residue is already 
phosphorylated (Figure 1.6B). Interestingly the phosphorylation of S62 is 
mediated by the Ras/Mek/Erk pathway and was previously shown to stabilise 
c-Myc in vivo (R. Sears et al., 2000). Furthermore, S62 is also phosphorylated 
by JNK (K. Noguchi et al., 1999) and thus it appears that the initial 
phosphorylation is required for signalling pathways, whilst the second one is 
required to target c-Myc for degradation and thereby effectively switches the 
pathway off. Interestingly, Welcker et al. mention in their discussion of this 
study that the nervous system specific form of myc family members, N-myc, is 
also a substrate of Fbw7 although data for this are not shown (M. Welcker et 
al., 2004a).
1.3.3.3 Fbw7 and cvclin E
Cyclin E promotes Gl/S transition in the cell cycle by binding to and activating 
the Cyclin dependent Kinase 2 (Cdk2) and cyclin E levels are tightly regulated 
on both the transcriptional level and the protein level during the cell cycle (H. 
Matsushime et al., 1994; T. Moroy and C. Geisen, 2004). Additionally different 
ubiquitination mechanisms ensure that cyclin E is expressed at appropriate time 
points in the cell cycle. Cul3, for instance, mediates the degradation of cyclin E 
when it is not bound to Cdk2, whilst cyclin E bound to Cdk2 is targeted for 
degradation by Fbw7 (J. D. Singer et al., 1999; H. Strohmaier et al., 2001; M. 
Welcker et al., 2003; J. D. McEvoy et al., 2007). Altogether four 
phosphorylation sites are essential for cyclin E degradation by Fbw7. They are 
T62, S3 72, T380 and T384 whereby the latter 2 are located within a phospho- 
degron sequence (Figure 1.6C). Also in case of cyclin E the second
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phosphorylation step, at T380, is mediated by GSK-3 and is dependent on a 
priming phosphorylation of S384 a kinase, here Cdk-2. Activation of Cdk-2 
therefore causes increased degradation and ubiquitination of cyclin-E as part of 
a regulatory feedback loop (M. Welcker et al., 2003).
Interestingly the Ras-MAPK pathway interferes with Fbw7 mediated 
degradation of cyclin E and overexpression of oncogenic Ras in rodent cells 
stabilised cyclin E levels (A. C. Minella et al., 2005). Surprisingly this report 
showed that there is no change in the phosphorylation status of the phospho- 
degron in cyclin E. However, this could be explained by the fact that the a  and 
Y isoform can cooperate in the attachment of ubiquitins to cyclin E upon Pinl 
mediated isomerisation of the initial Fbw7-a binding site (F. van Drogen et al.,
2006). If Ras signalling would either directly or indirectly affect the function of 
Pinl, cyclin E could accumulate without alterations in its phosphorylation at the 
Fbw7 substrate recognition site. It was for example shown that Pin-1 cooperates 
with oncogenic Ras, binds to phosphorylated c-Jun and thereby increases its 
transcriptional activity towards the cyclinDl promoter (G. M. Wulf et al., 
2001). Thus the Pin-1 isomerase could act to stabilise Fbw7 substrates in the 
context of Ras signalling.
1.3.3.4 Fbw7. Notch and Presenilin
The Notch signalling pathway plays a crucial role during cell 
differentiation and development of the nervous and vascular system. Notch 
signalling and subsequent expression of Notch target genes is tightly regulated. 
Notch signalling is triggered by the binding of ligands such as 
Delta/Serrate/Lag to Notch. These ligands are present on the surface of a
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neighbouring cell and bind to the extracellular domain of the full length Notch 
protein, which then leads to the sequential cleavage of Notch by several 
proteases. The result of this cascade is the release of the Notch intracellular 
domain (Notch-ICD). The Notch-ICD then translocates to the nucleus to 
activate Notch target genes. Presenilin is part of the y-secretase complex that 
cleaves Notch to generate the Notch-ICD but is also involved in the cleavage of 
the amyloid precursor protein APP, a protein involved in AD (reviewed in (J. 
Shen and R. J. Kelleher, 3rd, 2007)). By mediating the degradation of 
Presenilin and the intracellular domains of Notch 1 and Notch4, Fbw7 regulates 
the Notch pathway on two levels (G. Wu et al., 1998),(C. Oberg et al., 2001; J. 
Li et al., 2002). Firstly, it determines the abundance of an enzyme required for 
Notch cleavage. Secondly, Fbw7 mediates the degradation of the nuclear 
Notch-ICD and thereby antagonises the active signalling pathway.
Notch signalling is also a major determinant for cell fate decisions in the 
nervous system. It is involved in maintaining neuronal progenitor cells at the 
precursor stage and promotes an astrocytic cell fate in glial progenitor cells 
(reviewed in (A. Louvi and S. Artavanis-Tsakonas, 2006)). Thus deletion of 
Fbw7 could have severe effects on cell fate decisions and development. Since 
deletion of Fbw7 should lead to an accumulation of Presenilin, this would cause 
an increase in the Notch-ICD and increased target gene activation. Furthermore 
the ubiquitination of the Notch-ICD would be impaired. Therefore one would 
expect an upregulation of Notch signalling in Fbw7 knockout animals leading 
to a differentiation defect. Interestingly Notch4 was found to be upregulated in 
a tumour study using Jbw7+/~ mice in a p53~A background, demonstrating that 
Fbw7 deletion causes an increase in the Notch-ICD (J. H. Mao et al., 2004).
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Moreover the early embryonic lethality at E l0.5 and vascularisation defects of 
JbwTf embryos were attributed to elevated Notch 1 and Notch 4 levels (see also 
1.3.6) as Notch signalling is also a major pathway in vascularisation processes 
(A. Karsan, 2005).
In addition to Fbw7, Notch can also be degraded by the RING E3 ligase 
Itch which recognises the N-terminal region of the Notch-ICD (L. Qiu et al.,
2000). So far one model proposes that Itch mediates the degradation of the 
Notch-ICD in the cytoplasm whilst Fbw7 exerts its function in the nucleus (E.
C. Lai, 2002). However, the detailed mechanisms of how these two E3s are 
orchestrated, have not been investigated.
1.3.3.5 Fbw7 and SREBP
The sterol regulatory element binding protein (SREBP) family of 
transcription factors is involved in regulating cholesterol and lipid metabolism. 
SREBPs have to be cleaved in a similar manner to Notch to become active and 
these active fragments can then exert their function on target genes before 
subsequently being degraded (M. T. Bengoechea-Alonso and J. Ericsson,
2007). In 2005 Sundqvist et al. demonstrated that SREBP la, SREBP lc and 
SREBP2 are degraded by the Fbw7-a and Fbw7-y isoforms (A. Sundqvist et 
al., 2005). As with the other Fbw7 substrates including c-Jun, c-Myc and cyclin 
E, the recognition of SREBP’s by Fbw7 depends on GSK-3 mediate 
phosphorylation. Inhibition of SREBP phosphorylation prevents Fbw7 
mediated degradation and siRNA mediated depletion of Fbw7 enhanced 
SREBP levels in U20S cells. Thus these data add another substrate to the list of 
Fbw7-targets.
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1.3.4 Fbw7 and Parkin
Parkin is a 52 kD RING E3, which is frequently mutated in autosomal- 
recessive juvenile Parkinsonism (AR-JP). Mutations in Parkin were found in all 
domains of the protein including the N-terminal Ubiquitin like domain (UBL), 
the C-terminal RING1 and RING2 domains and the In-Between-Ring domain 
(IBR) (reviewed in (I. F. Mata et al., 2004)). Parkin-substrates include a- 
synuclein, synphilin-1 (K. K. Chung et al., 2001) and PAEL-R (Y. Imai et al.,
2001). a-synuclein is a protein found in Lewy-bodies, one hallmark of 
Parkinson’s disease (PD) (M. G. Spillantini et al., 1997). Furthermore, 
mutations in a-synuclein are found in an autosomal-dominant form of PD (M. 
H. Polymeropoulos et al., 1997). In 2003 Staropoli and colleagues reported that 
Fbw7 interacts with Parkin and thereby enhances ubiquitination of cyclin E (J.
F. Staropoli et al., 2003). They mapped the interaction between Parkin and 
Fbw7 to the Fbox domain of Fbw7 and the two RING domains of Parkin. An 
additional weaker interaction takes place between the UBL domain of Parkin 
and the WD-40 repeat region of Fbw7. Considering the binding domains 
identified, one would expect that Fbw7 and Parkin might degrade each other. 
However, even though Fbw7 mediates some ubiquitination of Parkin, the 
majority of the Fbw7-Parkin-complex regulates the degradation of cyclin E. 
The authors went on to investigate the function of Parkin in a neuronal model 
system and observed that Parkin protects postmitotic neurons (cerebellar 
granule cells as well as dopaminergic midbrain neurons) from kainate induced 
excitotoxicity. At the time of publication c-Jun and c-Myc had not been 
identified as a substrate for Fbw7, however, it would be interesting to test what
53
Chapter 1
other substrates Fbw7-Parkin complex targets for ubiquitination. Given that c- 
Jun is upregulated in response to kainate administration it would be interesting 
to examine whether a Parkin-Fbw7 complex is able to antagonise the 
accumulation of phospho-c-Jun as well (A. Behrens et al., 1999).
1.3.5 Fbw7 in tumoriaenesis
Since many substrates of Fbw7 are involved in cell cycle progression as 
well as tumorigenesis, it is not suprising that mutations of Fbw7 have been 
found in various cancers. In 2004 Reed et al. studied several cancer cell lines 
and tumours and found a correlation of loss of function mutations of Fbw7 and 
elevated cyclin E level (S. Ekholm-Reed et al., 2004). In this study 20% of the 
investigated endometrial tumours showed Fbw7 mutations and an 
accompanying loss of heterozygocity. Mutations in the a-isoform of Fbw7 
correlated strongly with a misregulation of cyclin E whereas the Fbw7-p- 
isoform specific mutations did not. Misregulation in the context of this study 
meant not only elevated expression levels but also expression of cyclin E at 
non-appropriate timepoints during the cell cycle.
Another role of Fbw7 in tumorigenesis was elucidated in 2003 in a 
study by Kimura et al. (T. Kimura et al., 2003), who identified Fbw7-(3 as a 
transcriptional target gene of the tumour suppressor p53. In this study a 
microarray on a p53-mutated gliobastoma cell line was performed after 
wild-type (wt) p53 was transferred back into the cells. Here Fbw7 was found to 
be upregulated after p53 transfer. Furthermore electro-mobility shift assays 
identified a p53-binding site in exon 1 of the p-isoform. Accordingly, Fbw7-p 
expression is upregulated in a p53 dependent manner after UV and genotoxic
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stress, whereas the induction of the Fbw7-a isoform is not dependent on p53 
proficiency. Additional luciferase assays demonstrated that p53 could bind to 
the identified site and induce Fbw7-(3 expression. Based on these data a model 
was proposed, wherein the p-isoform is needed to maintain cells in a permanent 
cell cycle arrest and this would correlate with the observed high Fbw7-P 
expression levels in the brain.
In line with the above study a role for Fbw7 as a p53-dependent haplo- 
insufflcient tumour suppressor was elucidated in 2004 (J. H. Mao et al., 2004). 
This study is based on the multiple-hit-theory for cancer. Using mice 
heterozygous for p53 (p53+A), which form tumours after a longer latency than 
p53'A mice, the question arose whether there are any differences in the tumours 
of those two mouse strains. Using microsatellite markers to detect loss of 
heterozygocity (LOH) in these two groups of mice the authors found an 
extensive LOH on chromosome 3 in tumours from p53+A mice. LOH on 
chromosome 3, which also harbours the fbw7 gene, was apparent in almost 
100% of p53 heterozygous mice and this loss of one Fbw7 allele was sufficient 
to accelerate tumour development in the p53+/~ background, but not in the p53‘/‘ 
mice. Therefore these data suggest that loss of Fbw7 and/or other genes 
precedes the loss of wt p53 allele (J. Perez-Losada et al., 2005). In addition to 
the previously identified p53-binding site, this study identified further nine 
putative response elements in the Fbw7-a, four in the Fbw7-P and five in the 
Fbw7-y promoter. However, the extent to which these putative response 
elements are indeed targets of p53-mediated regulation remains elusive.
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The finding that Fbw7 expression can be used as a prognostic marker in 
tumour analysis and that expression of the |3 isoform is suppressed in gliomas 
further supported the role of Fbw7 as a tumour suppressor, (Z. Gu et al., 2007; 
M. Hagedom et al., 2007).
1.3.6 The Fbw7 knockout mice
Based on the diverse nature of the Fbw7 substrates such as the 
oncogenes c-Jun and c-Myc, the cell cycle regulator cyclin E, and cell fate 
determining factor Notch, it was expected that a knockout of Fbw7 has 
detrimental effects on cell growth and differentiation and is incompatible with 
viability in a mouse model. In November 2004 Tetzlaff and colleagues 
demonstrated that deletion of Fbw7 causes embryonic lethality at E l0.5 (M. T. 
Tetzlaff et al., 2004). A month later Tsunematsu et al. (R. Tsunematsu et al.,
2004) came to the same conclusion. Both studies generated a germline 
knockout of Fbw7 but used different targeting strategies.
Tetzlaff et al. aimed to conditionally delete exon 5 and 6 by flanking 
them with two loxP sites and flank the neomycin cassette with Flp sites, 
altogether a very similar approach to the one presented in this thesis. However, 
the authors did not observe any Flp mediated deletion of the selection marker at 
ES cell level after electroporation of a Flp expression vector. As the Cre 
electroporation was more successful, they generated fbw 7+/~ mice, which 
developed normally and did not show any tumours for up to one year. 
Intercrosses of those animals were subsequently used to generate the fb w T f~ 
mice. However, the intercrosses did not produce any knockout offsprings and 
the time of embryonic lethality was determined to be E l0.5. At E8.5 mutant
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animals were indistinguishable from wt animals whereas at E9.5 mutants were 
smaller, developmentally delayed and neural tube closure was incomplete.
On the other hand, Tsunematsu et al. decided to generate Fbw7 
knockout animals by replacing the first five exons with a neomycin cassette. 
Like Tetzlaff they found that knockout of Fbw7 is lethal at E l0.5 and resulted 
in an incomplete closure of the neural tube. Interestingly the Fbw7 knockouts 
generated by both groups demonstrate similar, but not identical abnormalities in 
heart and vascular development.
Tetzlaff found that there were subtle delays in heart chamber maturation 
as well as defects in yolk sack vascularisation. Furthermore the embryos 
showed defects in vessel formation and had nucleated blood cells. Western 
blotting for the Notch intracellular domain and for Notch target genes showed 
that the Notch dependent transcripts of Hesl, Herpl and Herp2 are more 
abundant in knockout animals. In addition the protein levels of the Notch 1 and 
Notch4 ICDs were increased, which was also the case for cyclin E protein 
levels relative to the amount of mRNA. Therefore Tetzlaff et al. came to the 
conclusion that the defects in haematopoietic and vascular development cause 
the observed lethality.
Tsunematsu et al. performed a similar analysis of the fb w T A embryos, 
did not find any accumulation of the ICD of Notch 1 or Notch3 but also 
observed accumulation of Notch4. The expression of the Notch target gene 
Heyl, was also enhanced. This led to the conclusion that elevated Notch4-ICD 
levels are responsible for the observed phenotype, which is supported by data 
on Notch4 transgenic mice, which show similar vascularisation defects (H. 
Uyttendaele et al., 2001). With regards to cyclin E as an Fbw7 substrate,
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Tsunematsu et al. did not find changes in cyclin E protein levels or in its 
associated kinase Cdk2. However, in contrast to Tetzlaff et al., the relative 
protein levels in relation to mRNA amounts were not assessed.
Given that other targets of Fbw7, such as c-Jun and c-Myc, were 
identified in the same year as the Fbw7 knockout was published, neither of the 
groups investigated the effects of Fbw7 deletion in relation towards these 
substrates.
1.3.7 Summary
The studies on Fbw7, its substrates and interaction partners 
demonstrated that Fbw7 is involved in a great variety of cellular processes such 
as transcriptional regulation, cell cycle, neurodegeneration and tumourigenesis. 
Furthermore it became apparent that in many cases more than one E3 ligase is 
involved in targeting a substrate for degradation. However, it is still an open 
question how the interaction of the different E3s is orchestrated in the cell and 
to date no regulatory mechanism for Fbw7 or the orchestration of different E3s 
on c-Jun have been published.
Interestingly, Fbw7 only targets phosphorylated proteins for 
degradation and thus often mediates the termination of an active signalling 
cascade. A prerequisite for the recognition by Fbw7 is a GSK-3 
phosphorylation of a serine residue often located in a so-called phospho-degron. 
This in turn requires an initial priming phosphorylation by another kinase such 
as JNK, ERK or Cdk2. Furthermore the involvement of Pinl-mediated 
isomerisation appears to be a common denominator in creating the recognition 
sites for Fbw7 binding and subsequent degradation.
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It is also obvious from the literature that the a  and y isoform are similar 
in their nuclear localisation and have, at least a partially redundant function. 
Both are involved in the degradation of c-Myc, cyclin E and SREBP. Fbw7-p is 
not only localised differently and is less stable than the other isoforms, but is 
also the isoform that was found to act as a p53-dependent tumour suppressor (S. 
Ekholm-Reed et al., 2004) (J. H. Mao et al., 2004). Moreover the P-isoform is 
brain specific and its substrate, c-Jun, was shown to regulate neuronal apoptosis 
and axonal regeneration. Therefore to elucidate the role of Fbw7 and 
particularly Fbw7-P towards c-Jun, I generated various conditional Fbw7 
knockout lines. As the conditional knockouts were directed to the nervous 
system, I will now give a brief introduction into neuronal development and the 
nervous system.
1.4 The m ouse nervous system
1.4.1 Development of the nervous system
During the initial gastrulation the different germinal layers known as 
endoderm, mesoderm, and ectoderm are established. Neurulation is the next 
step in embryonic development and occurs around E8.5 in the mouse. Out of 
the three germinal layers, the ectoderm, and more precisely the neural plate, 
gives rise to the nervous system which is initiated by the formation of the 
neural tube (reviewed in (A. J. Copp et al., 2003)) Subsequently the three 
primary brain vesicles, the prosencephalon (forebrain), mesencephalon 
(midbrain) and rhombencephalon (hindbrain) are formed at the rostral end of 
the neural tube and subsequently give rise to all parts of the brain.
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During the development of the brain, cells proliferate, differentiate and 
migrate, sometimes over long distances, to reach their final position. Over the 
last decades neuronal development and cell migration have been extensively 
studied. One of the most investigated brain regions with regards to neuronal 
development is the cerebral cortex. I will summarise some of the data 
concerning the cortical development in the following section, as this brain 
region is also affected in the Fbw7 conditional knockout lines presented in this 
thesis.
1.4.2 Neuronal differentiation in the cerebral cortex
After the primary brain vesicles have formed, the secondary vesicles of 
the forebrain, the telencephalon and the diencephalon, are generated (Figure 
1.7A). The pallium gives rise to the cerebral cortex and the hippocampus and 
the formation of all brain regions relies on an orchestrated interaction of 
morphogenic clues, differentiation steps and migratory events. As a first step 
distinct anterior-posterior and dorsal-ventral domains are defined as the result 
of the coordinated expression of different morphogenic factors (reviewed in (S. 
W. Wilson and J. L. Rubenstein, 2000)). Finally, two different modes of cell 
migration lead to the cortical layering that is observed in the adult. One form of 
migration is the radial migration of cells from the inside towards the brain 
surface. The other mode of migration is the tangential migration, whereby cells 
migrate orthogonal to the radial direction (Figure 1.7B, green arrow). Both 
pathways are important during cortical development and were reviewed 
extensively (O. Marin and J. L. Rubenstein, 2001, 2003). Most of the cortical 
neurons that use y-aminobutyric acid (GABA) as a neurotransmitter originate in
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the telencephalon and reach the cortex via tangential migration where they then 
switch to a radial migration pattern. In contrast, cortical pyramidal neurons and 
some inhibitory neurons originate in the ventricular zone (VZ) and the 
subventricular zone (SVZ) of the cortex and move radially outwards (Figure 
1.7B). Radial migration is largely, but not solely, dependent on glia cells (radial 
glia) that form a scaffold along which neurons are able to migrate during 
development. After the migration is finished radial glia cells become astrocytes. 
As corticogenesis takes place between E ll  and E18 in the mouse embryo, the 
initial cortical structure, the so-called preplate, is split into the marginal zone, 
and subplate. The cortical layering then takes place in an inside out pattern 
(Figure 1.7C), whereby earlier bom neurons lie deeper within the cortex and 
mainly originate from the VZ. The SVZ is involved in the generation of the 
outer cortical layers.
The importance of correct cortical layering is revealed in a number of 
mouse mutants but also in human diseases. In humans defects in the lisl and 
doublecortin genes result in a severely impaired cortical lamination and a 
disease called lissencephaly where patients are often mentally retarded 
(reviewed in (C. Lambert de Rouvroit and A. M. Goffmet, 2001)) Doublecortin 
interacts with the ubiquitin protease DFFRX which ubiquitinates it and is 
involved in regulating the localisation of doublecortin (G. Friocourt et al., 
2005). One of the earliest models for cortical dysplasias in animals was the 
reeler mouse, which displays severe cortical and cerebellar lamination defects, 
resulting in an ataxic phenotype (G. D*Arcangelo et al., 1995). Polleux et al. 
later demonstrated that the rate of neurogenesis at early developmental stages is 
slower with a lower frequency of differentiating cell divisions in reeler mice.
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However, at the end of corticogenesis neurons are generated at a higher rate and 
together these alterations ultimately lead to the observed aberrant cortical 
lamination (F. Polleux et al., 1998). Another molecule involved in neuronal 
migration is Cdk5 and in animals that lack Cdk5 the cortical inside out 
lamination is inverted and earlier bom neurons are found superficial to later 
bom neurons (E. C. Gilmore et al., 1998). One activator of Cdk5 is p35 and it 
was demonstrated that mice lacking p35 also display cortical lamination defects 
(T. Chae et al., 1997). Interestingly, p35 is regulated via the ubiquitin- 
proteasome-pathway and although the responsible E3 ligase has not been 
identified to date, it was shown that phosphorylated, activated p35 is 
ubiquitinated and degraded (G. N. Patrick et al., 1998). The cytoplasmic 
adaptor protein Dabl which is involved in regulation of neuronal migration, is 
phosphorylated and degraded in response to reelin signalling and is then 
recognise by the E3 ligase component Cullin5 (L. Feng et al., 2007; G. Kerjan 
and J. G. Gleeson, 2007).
Together these studies demonstrate that defects in cortical lamination 
can arise at different stages of cortical development during the initiation or stop 
of migration but also during migration itself. A number of cytoskeletal 
associated proteins and signalling molecules are involved in neuronal migration 
and also the ubiquitin/proteasome system has recently emerged as a potential 
regulator of this process.
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Figure 1.7 Anatomical organisation of the developing forebrain and 
cerebral cortex A) Anatomical organisation of the developing forebrain. 
Scheme of a sagittal section through the brain of an E12.5 mouse showing 
the main subdivisions of the forebrain, the diencephalon and the 
telencephalon. In the telencephalon, the pallium is depicted in lighter gray 
than the subpallium.Figure from Marin and Rubenstein, 2003. (B) Scheme 
of a transverse section through the telencephalon of an E12.5 mouse 
indicating the two migation modes, radial migration and tangential migration. 
Neurons that use different neurotransmitter originate in distinct brain regions 
and migrate over long distances.Depending on the neurotransmitter and 
other morphogenic clues they bypass brain regions (green arrow)or switch 
migration modes from tangential to radial (green askterisk) Figure from 
Marin and Rubenstein, 2001 C) Corticogenesis lasts from E11 to E18 in 
the mouse embryo. The early formed preplate (PP) is split by later generated 
neurons into the Marginal zone (MZ) and the subplate (SP). Neurons in 
the Cortical Plate (CP) are generated in an “inside-out” pattern whereby 
later generated neurons have to pass previously generated ones. In the 
adult cortex the different neurons are visible as layers 1 to 6. Figure from 
Gupta et al, 2002.
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1.4.3 Cerebeilar development
As part of my work I have generated and analysed a cerebellar specific 
knockout of Fbw7. Therefore I will give a short introduction into mouse 
cerebellar development in the following section.
The function of the cerebellum is to coordinate movement by 
integrating the input from the cortical brain regions into a fine tuned motor 
output. During embryonic and early postnatal development the cerebellum 
undergoes major morphological changes from a planar structure at E l l  to a 
highly foliated and compartmentalised structure in the adult (Figure 1.8). 
Almost 100 years ago Cajal already described 6 of the 8 different cell types 
present in the adult cerebellum namely Golgi cells, Lugaro cells, granule cells, 
basket cells, stellate cells and Purkinje cells (Figure 1.9A) The other two 
cerebellar cell types, unipolar brush cells and candelabrum cells, were 
identified only within the last 20 years (J. Laine and H. Axelrad, 1994; E. 
Mugnaini and A. Floris, 1994). I will now focus on Purkinje cells and granule 
cells and the way information is relayed within the cerebellum.
64
Adult
Stage of development
SOOf/m
p**j  n o n ,  hrtxu
FM> Wr,H * * »  * * T !  < * *  c a r n m c
Mm n.M 9 AH faU etm
________ UncSM  Bdnt _____
* 8 S s 2 £ 2 r : i 2 f T
Figure 1.8 Structure and development of the cerebellum Sagittal 
sections of a mouse cerebellum from embryonic days E11, E13 and E15, 
PO (day of birth),P7 and adulthood, are shown from left to right in the 
center of the figure to highlight the changes in size and complexity during 
development. In the photomicrographs, asterisks denote the primary 
fissure, P (with accompanying small arrows) points to the Purkinje cell 
layer, IGL: internal granule cell layer and EGL: external granular layer. 
In the three embryonic pictures, the filled arrowheads point to the 
ventricular neuroepithelium, and the unfilled arrowheads point to the 
germinal trigone. The scale bar for all photomicrographs is the same. 
The graph in the lower inset emphasizes the change in cerebellar size. 
The axis on the left shows the area of the sections that are pictured, the 
axis on the right provides estimates of the total cerebellar volume at 
these ages. The timeline in the upper right inset illustrates genes/loci, 
known to have relatively specific effects on cerebellar development when 
mutated. The position of genes along the timeline denotes the most likely 
point at which the effects of the mutant gene are manifested. Genes 
critical to the earliest stages of cerebellar development are shown in 
green. Those genes that are specific to granule cell, Purkinje cell, or 
radial glial cell development are shown in blue, red, or black, respectively, 
with genes in parentheses of presumed cellular localisation. Figure and 
legend from D. Goldowitz et al.,1998.
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Figure 1.9 Cells, synaptic connections and migration in the cerebellum
A) Location and connection of the different cerebellar cells in the adult.
B) Synaptic circuits in the cerebellum. There are two main afferents to 
the cerebellar cortex: climbing fibres and mossy fibres.The ascending 
axons of the granule cells branch in the Molecular Layer (ML) to form 
the parallel fibres, which make excitatory synaptic contacts with Purkinje 
cells and ML interneurons i.e. stellate and basket cells. Figures A and 
B from Apps and Garwicz, 2005 C) Migration in the cerebellum. At E13 
(left), both of the principal neuron classes are specified. While Purkinje 
cells (PCs) become postmitotic (filled circles) and migrate through the 
wall of the cerebellar anlage, Granule cell precursors (unfilled circles) 
migrate along the roof. In the perinatal period,P6, granule cells become 
postmitotic and migrate inwards, along the Bergmann glia, to take their 
position below the PCs. In the adult (right), the connections of the granule 
neurons and thePCs are established. Granule cells extend parallel fibers, 
which synapse on dendrites of the PCs. EGL, External germinal layer; 
VZ,ventricular zone; WM, white matter; IZ, intermediate zone: IGL, internal 
germinal layer. Figure from Hatten et al., 1999.
Chapter 1
1.4.3.1 Purkinie and granule cell development and neuronal 
connectivity
Besides the neurons of the deep cerebellar nuclei, Purkinje cells are the 
first cerebellar neurons that are generated from the ventricular zone between 
E ll  and E13 (Figure 1.9C) (I. L. Miale and R. L. Sidman, 1961; E. T. Pierce, 
1975). Once Purkinje cells have migrated to the cerebellar plate they remain 
there until the final positioning and layering takes place shortly after birth. 
Granule cells on the other hand are generated from rhombic lip progenitor cells, 
which also give rise to other neurons in the hindbrain (Figure 1.9C) During 
embryonic development granule cell precursors first migrate tangentially in the 
cerebellum to form the External Granule Layer (EGL). This is completed by 
E l5 and is followed by a clonal expansion of granule cell precursors within the 
EGL. Only after birth the granule cells become postmitotic and migrate radially 
inwards along Bergman glia to finally generate the granule cell layer. Various 
factors have been identified to regulate cerebellar development, some of which 
are depicted in the graph in Figure 1.8. Of these factors Sonic hedgehog (Shh) 
is secreted by Purkinje cells during cerebellar development and was shown to 
be required for granule cell precursor proliferation and Bergman glia 
differentiation (V. A. Wallace, 1999; P. M. Lewis et al., 2004). In line with 
these findings are the observations that loss of Purkinje cells results in a 
reduction of granule cells, which is for example the case in the lurcher mice (N. 
Dumesnil-Bousez and C. Sotelo, 1992). Also in the staggerer mice, Purkinje
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cells degenerate, and this leads to an ataxic phenotype (R. L. Sidman et al., 
1962; K. Herrup and R. J. Mullen, 1979).
One crucial step in relaying information in the cerebellum, as well as in 
other parts of the brain, is the formation of synaptic connections (Figure 1.9B) 
There are two major input pathways in the cerebellum known as the climbing 
fibres and the mossy fibres. Of those two only the climbing fibres make direct 
contact with the Purkinje cells with a 1:1 match, meaning one climbing fibre 
contacts only dendrites from one Purkinje cell. On the other hand the input of 
mossy fibres is relayed to Purkinje cells via granule cells by means of the so- 
called parallel fibres. As parallel fibres extend perpendicular to the plane of 
Purkinje cell dendrites and can extend over several millimetres of respective 
cerebellar folia, the input from one mossy fibre has an effect on multiple 
Purkinje cells (Figure 1.9B). Additionally other cells of the cerebellum such as 
stellate and basket cells synapse on parallel fibres to participate in the 
integration of input signals. Therefore all information is relayed onto Purkinje 
cells. Interestingly it was found that, with exception of the granule cells, all 
other cerebellar cortical neurons form inhibitory synapses with their targets, 
which in many cases are Purkinje cells. Furthermore, Purkinje cells are the sole 
cerebellar output neurons of this signalling cascade and project to the deep 
cerebellar nuclei. Therefore they are key players in cerebellar information 
processing and it is perhaps not surprising that mutant mice with Purkinje cell 
defects display the above-described severe phenotypes.
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1.4.3.2 c-Jun in the cerebellum
S. Estus and J.Ham were the first to suggest that c-Jun is important in neuronal 
apoptosis based on in vitro experiments in which they used cultured 
sympathetic neurons (S. Estus et al., 1994) (J. Ham et al., 1995). They found 
that withdrawal of the trophic factor NGF from cultured rat superior cervical 
ganglia triggers the initiation of a cell death program, which includes the 
induction and phosphorylation of c-Jun. To assess whether c-Jun and other Jun 
family members are essential in mediating neuronal apoptosis Estus et al. 
microinjected purified antibodies against c-Jun, allowed the cells to recover and 
then either cultured them in the presence or absence of NGF for 40 hours. 
Subsequent fluorescent staining against rabbit IgG identified injected neurons 
and a Hoechst staining was used to score for chromatin integrity as either 
uniform, condensed or undetectable. Neurons deprived of NGF that were 
injected with antibodies against c-Jun but not JunB or JunD were largely 
protected from apoptosis and displayed normal chromatin whilst neurons in the 
presence of Control non-immune IgG underwent apoptosis and displayed a 
condensed or non-existent chromatin (S. Estus et al., 1994). At the same time 
Ham et al. demonstrated that the NGF withdrawal induced cell death in 
sympathetic neurons can be blocked by the microinjection of a dominant 
negative c-Jun expression vector, which lacks the N-terminal transactivation 
domain but is still able to dimerise and bind to DNA. Furthermore 
overexpression of c-Jun in this system is sufficient to induce cell death even in 
the presence of NGF (J. Ham et al., 1995).
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In 1998 the role of c-Jun phosphorylation was confirmed in an in vitro culture 
model of rat cerebellar granule cells (cgc). Cultured cgcs are maintained under 
depolarising conditions (i.e. high K+ levels) and lowering the potassium levels 
in the culture medium or serum withdrawal induces apoptosis (S. R. D'Mello et 
al., 1993). By using a phospho specific antibody for the c-Jun S63 residue 
Watson et al. observed in cgcs that phospho-c-Jun levels are elevated shortly 
after the reduction of K+ levels in the culture medium and occur before c-Jun 
protein levels are increased and apoptotic alterations in the chromatin appear 
(A. Watson et al., 1998). Experiments using either a phosphorylation 
mimicking construct (junAsp) or phopshorylation deficient construct (junAla) 
where the transactivation domain phosphorylation sites are mutated, confirmed 
that the death of cgcs upon either serum deprivation or low K+ level is phospho- 
c-Jun dependent and that overexpression of the junAsp construct is sufficient to 
induce apoptosis under normal growth conditions (A. Watson et al., 1998).
At the same time the role of c-Jun in the cerebellum was elucidated in vivo in a 
detailed analysis of naturally occurring mouse mutants that display cerebellar 
defects such as the weaver and Purkinje cell death (pcd) mice (F. Gillardon et 
al., 1995; A. Migheli et al., 1997). In both mouse lines either granule cell 
precursors or Purkinje cells die during early postnatal development. Migheli 
and Gillardon observed that in both cases the dying cells express high levels of 
c-Jun, thus indicating that c-Jun also plays a role in vivo in the regulation of 
neuronal apoptosis in the cerebellum.
In addition to the role for c-Jun in neuronal apoptosis, it has also been 
reported that c-Jun is upregulated in regenerating neurons after injury (J. D. 
Leah et al., 1991). It was shown that deletion of c-Jun in the nervous system
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leads to defects in axonal regeneration (G. Raivich et al., 2004). As Purkinje 
cells in the cerebellum were known not to possess regenerative capacities, 
Carulli et al. wanted to address the question whether overexpression of c-Jun in 
vivo under the Purkinje cell specific L7 promoter can induce Purkinje cell 
regeneration (D. Carulli et al., 2002). Overexpression of c-Jun does not affect 
the normal Purkinje cell development and is also not able to provide Purkinje 
cells with the ability to regenerate after injury, demonstrating that 
overexpression of c-Jun in Purkinje cells is not sufficient to trigger a 
regenerative program. However the Purkinje cell survival was reduced in the in 
vitro culture system of cerebellar slices derived from these c-jun transgenic 
animals, indicating that the effect of c-Jun is strongly dependent on the cellular 
and experimental context and that one has to be careful to draw conclusions 
from in vitro experiments about the in vivo effects and vice versa.
1.4.4 The niqrostriatal system
Since one of the mouse lines investigated in this thesis displayed 
behavioural defects that have been observed in neurodegenerative diseases such 
as Parkinson’s disease (PD) and Huntington’s disease (HD), I will give a short 
introduction into the nigrostriatal pathway and mouse models for both 
pathologies.
The nigrostriatal system is one of the different dopaminergic circuits in 
the brain (Figure 1.10A) and is involved in the regulation of voluntary 
movements. The loss of neurons in this particular pathway is the cause of PD 
and HD. The striatum is the crucial mediator of incoming cortical information 
and relays this information to neurons in the substantia nigra. Two different
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pathways are used to achieve this relay and to subsequently generate a 
controlled motor movement (Figure 1.1 OB). The first pathway is the direct 
pathway from the cortex via the striatum to the medial globus pallidus and 
substantia nigra (blue arrow Figure 1.1 OB). The second pathway is the indirect 
pathway (Figure 1.1 OB red arrows) that links the striatum with the globus 
pallidus from which neurons extend to the subthalamic nucleus and finally 
subthalamic neurons connect to the substantia nigra and the medial globus 
pallidus (the same target areas as in the direct pathway) (reviewed in (C. J. 
Zeiss, 2005)).
Neurons from the ventral tegmental area (VTA), which lies medial to 
the substantia nigra (Figure 1.10A, right), also project to the striatum and 
pallidum. The VTA is part of the so-called ventral mesostriatal system, which is 
involved in the regulation of motivated reward related behaviour (reviewed in 
(S. J. Cragg, 2006)).
All neurons of the striatal system use a variety of neurotransmitters such 
as GABA, glutamate but some of them additionally use dopamine. Dopamine is 
synthesised from the amino acid tyrosine (Figure 1.10C) and in histological 
sections the presence of the enzyme tyrosine hydroxylase (TH) is used to 
identify dopaminergic neurons. Additionally, stainings for the glutamate 
decarboxylase 67kD isoform (GAD-67), an enzyme needed for the generation 
of the inhibitory neurotransmitter GABA, can be used to characterise neurons 
and projections in the striatum. Administration of the neurotoxic drug MPTP, 
for instance, causes an increase in GAD-67 levels in the striatum whilst L-Dopa 
treated PD patients display normal GAD-67 levels (M. T. Herrero et al., 1996).
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Thus the analysis of TH and GAD-67 can give indications of whether the 
nigrostriatal pathway is lesioned or if neurons are degenerated or lost.
Degeneration and the subsequent loss of TH positive neurons in the 
substantia nigra pars compacta, which is part of the direct pathway, is the cause 
of PD. This loss leads to a decrease in dopamine levels and can be treated by 
the administration of the dopamine precursor L-Dopa. L-Dopa, in contrast to 
dopamine, is able to cross the blood-brain barrier and is converted into 
dopamine in the CNS (Figure 1.10C)(P. Huot and A. Parent, 2007). Concerning 
the genetic origin of PD, mutations in the Parkin RING E3 ligases itself as well 
as mutations in UCH-L1, an ubiquitin hydrolase associated with Parkin, and 
other genes have been identified (H. C. Ardley et al., 2004; I. F. Mata et al.,
2004). To date there are four studies in which the authors have deleted Parkin 
with the aim to elucidate the role of Parkin in the pathogenesis of PD (for an 
extensive review see (S. M. Fleming et al., 2005)). Interestingly, no 
degeneration of dopaminergic neurons could be observed in the substantia nigra 
or striatum in all four of these mouse models (M. S. Goldberg et al., 2003; J. M. 
Itier et al., 2003; R. Von Coelln et al., 2004; F. A. Perez and R. D. Palmiter,
2005). Only one study reported a loss of TH positive neurons in the locus 
coeruleus (R. Von Coelln et al., 2004). Although some of the Parkin deficient 
mice display behavioural defects in form of a reduced startle response, 
alterations in their exploratory behaviour or in learning (J. M. Itier et al., 2003) 
(R. Von Coelln et al., 2004), no striking phenotype such as a tremor or 
ubiquitin positive inclusions, which are hallmarks of PD, were found in any of 
these studies. Although the loss of the Parkin E3 ligase alone was not sufficient 
to cause PD symptoms, it lead to alterations in dopamine and norepinephrine
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levels. In all of these Parkin-knockout mouse studies the neurotransmitter 
levels, as determined by high performance liquid chromatography (HPLC), 
were changed. Itier et al. and Goldberg et al. observed that the levels of 
dopamine are increased in brains of Parkin deficient mice and von Coelln 
reported a reduction in norepinephrine levels due to the loss of TH positive 
neurons in the locus coeruleus. Norepinephrine as well as epinephrine are 
produced in chatecholaminergic neurons via the sequential action of different 
enzymes and can thus be also used as readout for the functionality of these 
neurons (Figure 1.1 OB).
Whilst dopaminergic neurons die in PD, the first neurons affected in HD 
are the medium spiny neurons in the striatum. In the striatum 95% of neurons 
are GABA-ergic medium spiny neurons and it appears that they are particularly 
sensitive to the presence of a polyglutamine segment. This polyglutamine 
segment is the result of a mutation of the Huntington gene. In normal conditions 
6-37 CAG repeats, which are translated into glutamines, are present near the 5’ 
end of the gene. In case of HD this glutamine repeats are expanded to around 
50 repeats and in severe cases to more that this (reviewed in (J. F. Gusella and 
M. E. MacDonald, 2000)). The overexpression of CAG repeats in mice results 
in a hindlimb clasping phenotype; a resting tremor and handling associated 
seizures and can therefore be used as a mouse model for HD (L. Mangiarini et 
al., 1996). Also in HD inclusions are formed. They are immunopositive for 
polyglutamine but also for ubiquitin, suggesting that the ubiquitin-proteasome 
system is important in this neurodegenerative disease as well (M. L. Maat- 
Schieman et al., 1999).
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Figure 1.10 The nigrostriatal pathway A)Dopaminergic neurons in the 
mouse brain, left sagittal right: coronal section cut at the level indicated 
left. OB: olfactory bulb RRF: retrorubral field VTA:ventral tegmental area 
SN:substantia nigra Hy:hypothalamus Figure from Smidt and Burbach, 
2007 B)There cerebral cortex and thalamus provide excitatory input (green 
arrows)to the striatum, the main nucleus of the basal ganglia. The output 
originates from the medial globus pallidus(GPm) and the substantia nigra 
pars reticulata(Snr) and is directed to the thalamic nuclei which project to 
the frontal areas of the cerebral cortex. The direct pathway (blue) originates 
from striatal projection neurons whose axon extend directly to the GPm 
and SNr output nuclei. The indirect pathway originates from striatopallidal 
neurons (red) whose axons terminate within the Globus pallidus(GP). 
Neuron in the GO project to the subthalamic nucleus (STN) which projects 
to the GPm and SNr. Thus striatopallidal neurons are connected indirectly 
through the GP and STN with the output neurons. Figure from Gerfen, 
2006,C) Dopamine, Norepinephrine and Epinephrine are synthesises 
sequentially from the amino acid tyrosine by means of the indicated 
enzymes.
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1.5 Aim of this Thesis
Given that Fbw7-|3 mediates the degradation of phosphorylated c-Jun 
and that previous publications demonstrated a role for phospho-c-Jun in 
neuronal apoptosis and axonal regeneration, we hypothesised that Fbw7 might 
act as a key regulator of phospho-c-Jun levels in the brain (A. Behrens et al., 
1999; A. S. Nateri et al., 2004; G. Raivich et al., 2004). Additionally in vitro 
experiments using siRNAs against Fbw7 in cgcs had demonstrated that 
depletion of Fbw7 induces apoptosis (A. S. Nateri et al., 2004). The idea that 
Fbw7 is involved in regulating phospho-c-Jun levels in the nervous system was 
further supported by the fact that among the three different Fbw7 isoforms, the 
(3 isoform, which interacts with c-Jun, is highly expressed in brain whilst the 
other isoforms are not (C. H. Spruck et al., 2002).
It was therefore feasible to assume that under basal conditions phospho- 
c-Jun levels are kept below a certain threshold by constitutive, Fbw7 mediated, 
phospho-c-Jun degradation. We further hypothesised that upon an insult, such 
as stress or injury, phospho-c-Jun levels rise above this threshold and thereby 
trigger apoptosis in neurons. According to this model, Fbw7 would be a crucial 
regulator of JNK signalling during neuronal development and differentiation.
To test the threshold model that Fbw7 targets phospho-c-Jun for 
degradation in the nervous system, we decided to conditionally delete Fbw7 in 
the nervous system. If Fbw7 would indeed be a key regulator of phospho-c-Jun 
levels in the brain, a lack of Fbw7 should result in elevated levels of
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phospho-c-Jun and possibly other Fbw7 substrates, as well as an increase in 
neuronal apoptosis.
To allow a temporal and spatial analysis of the role of Fbw7 in the 
nervous system we decided to generate various conditional knockout lines 
where Fbw7 is deleted in either different neuronal populations or at different 
timepoints during development. The obtained results should be further 
validated with regards to whether elevated c-Jun or phospho-c-Jun levels could 
be the cause of the phenotype. Therefore fbw7 conditional knockout mice 
should be crossed to floxed -c-jun mice (c-jur/^) that are available in the lab to 
obtain conditional double knockout animals. If the phenotype were c-Jun 
dependend, further crosses to mice homozygous for junAA allele, where N- 
terminal phosphorylation of c-Jun is no longer possible, would allow asking the 
question whether this effect is mediated via the phosphorylated form of c-Jun.
Taken together the overall aim of my thesis was to investigate the role 
of Fbw7 in the nervous system by generating condition Fbw7-knockout mice, 
with the focus on the role of Fbw7 in regulating phospho-c-Jun.
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2 MATERIALS AND METHODS
2.1 Reagents
2.1.1 Chemicals and enzymes
Reagents were obtained from Amersham, BDH, BioRad, Calbiochem, 
Cell Signalling Technologies, Clontech, Fisher Scientific, Gibco, Invitrogen, 
Merck, Molecular Probes, New England Biolabs, Qiagen, Sigma Aldrich, 
Stratagene and GE-Healthcare. Distilled H2O, PBS, 5M NaOH, 0.5M EDTA, 
LB medium, sterile glycerol were provided by Cancer Research UK Central 
Services.
2.1.2 Antibodies
All HRP-conjugated secondary antibodies used for western blotting 
were from Jackson laboratories. The secondary antibodies for 
immunohistochemistry were all from Vector laboratories: biotinylated goat and 
rabbit, biotinylated rabbit and rat, biotinylated horse and mouse. For 
immunofluorescence vector goat anti rabbit alexa 555 or 488 antibodies were 
used. The following primary antibodies were used. Dilutions are given for 
either use in Western blotting (WB) or immunohistochemistry (IHC). If 
antibodies were used for immunohistochemistry the antigen retrieval method is 
also indicated:
MW: microwaving, C: Citrate Buffer pH 6 
T: trypsin
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Table 2.1: Primary antibodies
Antigen Antibody
name
Source Dilution & 
application
Actin a-actin Sigma Aldrich 1:2000 WB
Calbindin a-Calbindin Chemicon 1:400 IHC 
MW/C
c-Jun c-Jun H79 Santa Cruz 1:500 WB 
1:120 IHC 
MW/C
Fbw7 F7-3B7 Cancer Research UK 1:500 WB
GAD67 a-G A D  67 Sigma Aldrich 1:1000 IHC 
MW/C, 12’
GFAP a-G FA P Dako Cytomation 1:400 IHC 
MW/C
NeuN a-N euN Chemicon 1:1000 IHC 
MW/C
Parvalbumin a-Parvalbumin Swant 1:1000 IHC 
MW/C
Tyrosin
Hydroxylase
a-T H Chemicon 1:500 IHC 
T
Vesicular 
glutamate 
transporter 1
a-V glutl Chemicon 1:1000 IHC 
MW/C
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Antigen Antibody
name
Source Dilution & 
application
Vesicular 
glutamate 
transporter 2
a-Vglut2 Chemicon 1:1000 IHC 
MW/C
2.1.3 Oligonucleotides
Oligonucleotides were obtained from Sigma Aldrich. The following 
primers were used.
Table 2.2 Primers for generation of conditional Fbw7 targeting construct.
Primer Sequence
Fbx7Fl(nt437) 5’-ctg cga ttg agg cat ttg agg gtg-3’
Fbx7F2(nt536) 5’-tac age act tgg tcc age etc ctc-3’
Fbx7F3(nt 5935) 5’-cac tgc ttc ate eta gtc tcc ctg -3’
Fbx7Rl(nt 4639) 5’-gca tat tct aga gga ggg tat egg -3’
Fbx7R2 (nt 4751) 5’-tea ctg gac age tgc cac tct agc-3’
Fbx7R3 (nt 8908) 5’-tgg tea tea tgc cct ttc age acc -3’
Fbx7F4Bcll(nt4428) 5’-actg tgatca ctt ttt aaa aat gac att gtc cca gaa g-3’
Fbx7R4Bcll(nt6032) 5’-agtc tgatca tac ctg ttt aca aaa cag aag att etc c-3’
Fbx7F5 (nt 4212) 5’-cat cat tea tac aat gat cct gaa ccc tc-3’
Fbx7R5 (nt 6169) 5’-cct cac teg tea gtg etc tct acc-3’
ScrFlrtl 5’- eg gtt gtt agt gaa gta ggt etc -3’
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Primer Sequence
ScrFlrt2 5’- tg eta ctt cca ttt gtc acg tcc -3’
ScrFbx7-l (nt 7635) 5’- at aca ggg act aca age atg tgg -3’
ScrFbx7-2 (nt 7778) 5’- at cac aca ctg tct caa etc acc-3’
Table 2.3 Primers for sequencing of knockout targeting construct
Primer Sequence
SeqFe4(nt3247) 5’- ctg tcc atg gtt cca ctg etc -3’
SeqRe4-l(nt 3530) 5’- gtt atg cac cca taa cca c -3’
SeqRe4-2(nt 3571) 5’- gtg tea acc ata atg age agg -3’
SeqFe4(nt 3247) 5’- ctg tcc atg gtt cca ctg etc -3’
SeqFe5 (nt 5426) 5’- gtc eta gca aga tgc tea gcc -3’
SeqRe5 (nt 5735) 5’- cat eta etc tea etc aca gcc -3’
SeqFe6 (nt7138) 5’- gtt cag tgc tgc aca gcc c -3’
SeqRe6 (nt 7475) 5’- gag tta cac tgc age caa cac -3’
Table 2.4 Primers for genotyping of used mouse strains
Target site Primer Sequence
Cre Cre 1 5’-egg teg atg caa cga gtg atg agg-3’
Cre 2 5’-cca gag acg gaa ate cat ege tcg-3’
Flp Flpl 5’-cac tga tat tgt aag tag ttt gc-3’
Flp2 5 ’-ctagtgcgaagtagtgatcagg-3 ’
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Target site Primer Sequence
fbw7-loxPl F7-PCR1 5’-cag tgg agt gaa gta caa etc tgg-3’
F7-R1 5’-gca tat tct aga gga ggg tat egg -3’
F7-Delta 2 5'-g gcc age ctg gtc tgt ata gag -3'
NeoS 5 ’-cctcgtgctttacggtatcgc-3 ’
fbw7-loxP2 Fbx7F3 (nt 5935) 5’-cac tgc ttc ate eta gtc tcc ctg -3’
Fbx7R5 (nt 6169) 5’-cct cac teg tea gtg etc tct acc-3’
Floxed c-jun LoxPCR5 5 ’ -ctcataccagttcgcacaggcggc-3 ’
LoxPCR6 5 ’-ccgctagcactcacgttggtaggc-3 ’
Table 2.5 Primers for RT-PCR
Target site Primer name Sequence
Fbw7-E2 F7-Fw 367 5’-cca tgt tea gca aca cca ac-3’
Fbw7-E7 Rev 925 5 ’-cggttgccaacaaaactgtag-3 ’
c-Jun Jun Ol 14 5 ’ -gccagcaactttcctgacc-3 ’
Jun O l 15 5 ’-ggttagcctgggctgtgcg-3 ’
GAPDH GAPDH 5'-gcc cat cac cat ctt cc-3'
GAPDH 5'-ggg atga tgt tct ggg cag c-3'
Table 2.6 Primers used for generation of in situ hybridisation probe
Probe Primer Sequence
Exon 2/5 F7-E2-BamH 1 -fw 5’-gga tcc gga cca tgg ttc tga agt tcg-3’
F7-E5-EcoRl rev 5’-gaa ttc tac att tct etc tcc aga gaa ggt t-3’
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Probe Primer Sequence
Exon4/5 F7-E5-BamHl fw 5’-gga tcc cac tct atg tgc ttt cat tcc tg-3’
F7-E5/2-EcoRl rev 5’-gaa ttc cct ctt ctt tac att tct etc tcc ag-3’
2.1.4 Bacterial strains
E. coli strain: Application:
DH5a cloning
XL 1 -blue cloning
Bacterial cultures were stored as 30 % glycerol stocks at -80 °C.
2.1.5 Plasmids
Plasmid Source Use
pcDNA 3.1 + Invitrogen knockout construct
pDTA (Asp) in house knockout construct
pFlrtl in house knockout construct
pgem3Z Invitrogen In situ probe
2.1.6 Mouse Strains
Mouse line Reference
Nestin-Cre (F. Tronche et al., 1999)
Engrailed2-cre (D. L. Zinyk et al., 1998)
Synapsin-cre (C. Hoesche et al., 1993; 
Y. Zhu et al., 2001)
TH-cre (D. M. Gelman et al.,
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Mouse line Reference
2003)
2.2 Methods
2.2.1 DNA techniques
2.2.1.1 Long template PCR for amplification of the fbw 7  locus 
fragments
The PCR for the amplification of the genomic sequences for the Fbw7 
knockout construct from isolated genomic DNA were performed using the 
Long-template-Expand-PCR kit (Amersham). The Polymerase therein is a 
mixture of the fast Taq polymerase and a slow proofreading Tgo-polymerase. 
Taq, which has no proofreading ability, tends to fall off the PCR template when 
it incorporates an incorrect base. In this case the proofreading Tgo polymerase 
can reinitiate at this position and correct the error (W. M. Barnes, 1994; S. 
Cheng et al., 1994). Therefore, by combining these two enzymes one gets quick 
amplification of long templates with the benefit of proofreading (B. Frey, 
Suppmann, B., 1995). For all PCRs Buffer 3, provided with the kit, was used. 
Final concentrations of reagents are listed in (Table 2.7). The two programs 
used for amplification of the long and short homology arm are listed below 
(Table 2.8,Table 2.9).
84
Chapter 2
Table 2.7 PCR composition for long template amplification of genomic 
DNA
Reagent Concentration o f  Stock Final concentration
Buffer 3 lOx lx
dNTP 2.5mM 0.35mM
Primer 1 25mM 0.5mM
Primer 2 25mM 0.5mM
Polymerase 5 U/pl 1.5 U/pl
Template 50ng/pl 2.5ng/pl
h 2o ad 20pl
Table 2.8 PCR program for amplification of genomic DNA between 0.5 
and 3 kb
Temperature Time Additional number of cycles
94°C 2:00
94°C 0:10
57°C 0:30 30 cycles
68°C 2:00
68°C 7:00
4°C for ever
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Table 2.9 PCR program for amplification of genomic templates between 3 
and 6 kb
Temperature Time Additional number of cycles
94°C 2:00
94°C 0:10
30 cycles63°C 0:30
68°C 4:00
68°C 7:00
4°C for ever
2.2.1.2 PCR for screening of ES cell clones for targeting
To screen the DNA from ES-cell clones for insertions of the knockout 
construct a nested PCR was performed using the Qiagen Taq polymerase. The 
primer pair ScrFbx7.2/ScrFlrt7.2 was used for the initial PCR from the isolated 
ES-cell clones with 2pl of DNA. For the nested PCR the primer pair 
ScrFbx7.1/ScrFlrt7.1. and 2pl of the initial PCR reaction were used (Table 
2 . 11).
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Table 2.10 PCR reaction for screening ES cell clones for gene target 
insertion
Reagent Concentration o f  Stock Final concentration
1 Ox Buffer lOx lx
dNTP 25mM ImM
Primer 1 lOOpM 0.12pM
Primer 2 lOOpM 0.12pM
Polymerase 5 U/pl 0.5 U/pl
Template 50ng/pl 2.5ng/pl
h 2o ad 20pl
Table 2.11 PCR program for screening ES cell clones and genotyping
Temperature Time Additional number o f  cycles
94°C 1:00
94°C 1:00
40 cycles52°C 1:00
72°C 3:00
72°C 10:00
4°C for ever
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2.2.1.3 Isolation of genomic DNA
Solutions: Proteinase K, Melford
lx Tail Buffer : 50mM Tris HC1, pH 8.0
lOOmM EDTA, pH 8.0 
lOOmM NaCl 
1% SDS (w/v)
0.5 mg/ml ProK (added fresh)
5M NaOH 
Isopropanol
Genomic DNA for genotyping of stock mice was either obtained from 
Ear- or tail biopsy samples. To detect Fbw7 deletion, samples of the respective 
organ were taken and processed in the same way. Samples were incubated 
overnight in 500pl tail buffer containing proteinase K at 56°C. The next day 
200pl 5M NaOH was added and mixed thoroughly. The sample was spun down 
at 16000g for 10 min and the supernatant transferred to a new tube. To this 
500pl isopropanol was added and mixed again. After 5 minutes of 
centrifugation at 16000g at room temperature the supernatant was discarded 
and the precipitated DNA left to dry. Finally the DNA was taken up in 300pl 
H2O and left to dissolve for at least 1 hour on a shaker. 2pi were subsequently 
taken for the PCR reaction.
2.2.1.4 Genotvpinq
Genotyping was performed using primers flanking the loxP sites and at 
intermediate steps screening for insertion and deletion of the Neomycin cassette
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(Figure 3.4). The PCR was carried out using the Qiagen Taq polymerase and 
PCR composition as described in Table 2.11. and primers as in Table 2.4.
2.2.1.5 Preparation of plasmid DNA
Plasmid purification on a small or large scale was performed with the 
Qiagen Mini or Maxi Prep kits, respectively. Bacteria were grown in 5 ml 
(Mini prep) or 250 ml (Maxi prep) cultures containing the appropriate selection 
antibiotic. Plasmid concentrations were determined as described in Chapter 
2.2.1.6. In the case of cloning experiments, the plasmid insert was sequenced 
using insert or plasmid specific primers (2.2.1.8).
2.2.1.6 Quantification of DNA
DNA concentrations were quantified in a spectrophotometer at a 
wavelength of 260 nm after dilution in H2O. An OD26o of 1 corresponds to 50 
pg DNA/ml double stranded DNA. To assess the purity the absorbance ratio 
OD26o/28o was recorded additionally. It was usually between 1.6 and 1.8.
2.2.1.7 Restriction digest
Restriction digests were carried out in 20 pi reaction volumes 
containing 1 pg DNA, 5 units restriction enzyme (New England Biolabs), 2 pi 
lOx restriction buffer supplied with the enzyme and lx  BSA if required. 
Samples were incubated according to the manufacturers instructions for 1 hour 
to overnight, before the reaction was stopped by adding 5x sample buffer 
(Bromphenol blue in 50% glycerol, ImM EDTA pH 8.0).
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2.2.1.8 DNA sequencing
Fluorescent cycle sequencing was performed with the AB1 dye 
terminator kit (Perkin Elmer). 3.2 pmol gene or vector specific primer were 
mixed with 500ng double stranded DNA, 8 pi ABI reaction mix and H2O to a 
final volume of 20pl. Cycle sequencing conditions were as below (Table 2.12).
Table 2.12 PCR program for DNA sequencing
Temperature Time Additional number of cycles
96°C 2:00
96°C 0:10
50°C 0:05 25 cycles
60°C 4:00
4°C for ever
To remove primers and dye terminators, samples were purified using 
ethanol precipitation of DNA. Capillary sequencing was performed on an 
Applied Biosystems 3730 DNA Analyser. Sequences were aligned with 
Sequence Navigator (ABI) using DNA strider software.
2.2.1.9 DNA aaarose ael electrophoresis
Depending on the size of the DNA, 0.8 -  2% (w/v) agarose was 
dissolved in TAE buffer (Tris-HCl pH 8.0, 20 mM acetic acid, 1 mM EDTA). 
Ethidium bromide was added to a final concentration of 0.5 pg/ml. Samples 
were mixed with 5x sample buffer (Bromphenol blue in 50% glycerol, ImM
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EDTA pH 8.0) and separated in TAE depending on the gel size between 50 and 
140 Volts constant.
2.2.1.10 Gel purification of DNA fragments
The desired DNA fragment was cut out from an agarose gel and the 
DNA was isolated and purified from the gel slice with the GFX PCR DNA and 
Gel Band Purification Kit (GE-Healthcare).
2.2.1.11 Liaation
Gel purified DNA fragments and vectors were mixed at a molar ratio of 
approximately 5:1 and ligated with 400 Units of T4 DNA-ligase (New England 
Biolabs) in a 20 pi reaction volume for either 1 hour at room temperature or 
overnight at 16 °C. 5 pi of the ligation was then transformed using competent 
bacteria (see also Chapter 2.2.1.12).
2.2.1.12 Bacterial transformation
A 50 pi aliquot of competent XL 1-Blue cells was mixed with 5 pi 
ligated DNA or 100 ng plasmid and incubated on ice for 30 minutes before 
being heat shocked at 42°C for 45 seconds and left on ice for further 5 minutes. 
450 pi LB medium was added and the reaction was incubated at 37°C for 
lhour. 150- 200pl were spread on a LB plate containing the appropriate 
antibiotic and incubated overnight at 37°C.
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2.2.1.13 Southern blotting
For southern blotting the digested DNA was run on an agarose gel as 
described in 2.2.1.9. The DNA was depurinated by soaking the gel in 0.25N 
HC1 for 15 minutes and the depurination was completed by rinsing the gel in 
dt^O. The DNA was subsequently denatured by immersion of the gel in a 
solution of 1.5M NaCl and 0.5M NaOH for 25 minutes. For further 
neutralisation the gel was soaked in a solution containing 1.5M NaCl and 0.5M 
Tris-HCl (pH8.0) for 30 minutes. The DNA was transferred onto a 
Nitrocellulose membrane by capillary blotting over night using SSC (3M NaCl, 
0.3M sodium citrate) as the transfer buffer and UV crosslinked using a 
Stratlink-crosslinker (Stratagene) onto the membrane at 700 for 30 seconds. To 
confirm the transfer from the agarose gel onto the membrane, the gel was 
stained with Ethidiumbromide after the transfer. The southern probe was 
radioactively labelled using the Stratagene Push column beta shield device and 
NucTrap probe purification column (Stratagene) according to the manufacturers 
instructions. For the probe hybridisation the Qick Hyb Hybridisation solution 
(Stratagene) was used to prehybridise the membrane for 15 minutes at 68°C. 
Boiling for 5 minutes denatured the labelled probe and it was left on ice for 3 
minutes before it was added to the prehybridised blot. The hybridisation 
reactions was left for 1 hour at 68°C. After the hybridisation the membrane was 
washed twice for 15 minutes at room temperature with 2x SSC buffer 
containing 0.1% (w/v) SDS. A further wash was performed at 60°C with a O.lx 
SSC buffer containing 0.1% (w/v) SDS. The signal was detected by exposing 
the membrane over the weekend at -80°C.
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2.2.2 RNA techniques
2.2.2.1 RNA extraction using TRIzol
Solutions: TRI-Reagent (Sigma)
Chloroform
Ethanol
Tissue samples were extracted and immediately snap frozen in liquid 
nitrogen. For RNA extraction the sample was homogenized in an appropriate 
amount of TRI reagent usinge a 25G needle. The mixture was incubated at RT 
for 15-30 minutes to allow complete homogenization. 0.2ml Chloroform was 
added per ml of TRI reagent used. The mix was shaken vigorously and 
incubated for further 2-3 minutes at RT to allow separation of phases. Samples 
were then centrifuged for 15minutes at 4°C and the aqueous phase transferred 
to a new tube. To this 0.5ml isopropanol was added per ml of TRI reagent used 
and the mix was shaken vigorously incubated at 15 to 30 minutes at RT 
followed by a further centrifugation step at 4°C for 15minutes. Finally the RNA 
was washed twice with 70% (v/v)Ethanol, dissolved in H2O and stored at -80°C 
for further use.
2.2.2.2 First Strand synthesis from RNA using Superscript! 11
Reagents: SuperscriptHI Kit (Invitrogen)
RNA was isolated as described above (2.2.2.1) and used as a template 
for first strand synthesis. The composition of the RT mix is given in Table 2.11 
and Table 2.14.
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Table 2.13 Composition of Superscript III first strand synthesis RT-PCR 
reaction initial mix
Reagent Final Concentration
RNA 5gg
Oligo dT primer 5pM
dNTP Mix 1 mM
DEPC treated H2O to 1 OjLtl
The initial mix (Table 2.13) was incubated at 65°C for 5 minutes and 
placed on ice for one minute. Subsequently the final reagents were added as 
listed in Table (Table 2.14) and the PCR done according to table 2.15. After the 
final incubation on ice samples were spun down, lp l Rnase H added and the 
samples incubated for further 20 minutes at 37°C to allow degradation of the 
initial mRNA template. The newly generated cDNA was stored at -20°C.
Table 2.14 Superscript RT PCR reaction mix
Reagent Amount
lOx RT buffer 2pl
25mM MgCl2 4pl
0.1MDTT 2pl
RNAse OUT (40U/pl) lp l
Superscript III RT (200U/ml) lp l
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Table 2.15: PCR program for first strand synthesis using Superscript!!!
Temperature Time/minutes
50°C 50:00
85°C 5:00
4°C for ever
2.2.2.3 In situ hybridisation
Probes for in situ hybridisation were generated using common DNA techniques 
described (2.2.1). The DNA for the probe was amplified from mouse-Fbw7-p 
cDNA using primers as in Table 2.6. The DNA was linearised and given to the 
Cancer Research UK in situ hybridisation service for labelling and incubation. 
Images were acquired using a darkfield microscope, Adobe Photoshop and the 
Q Capture imaging software plugin for photoshop.
2.2.3 Tissue culture techniques
2.2.3.1 Maintenance of mammalian cells
HEK293T cells (Invitrogen) were maintained in growth medium 
(DMEM supplemented with 10% foetal calf serum, 4.8 mM glutamine and 
antibiotics (penicillin/streptomycin, Gibco). For the passaging the cells were 
washed once with PBS (137 mM NaCl, 3.35 mM KC1, 10 mM Na2HP0 4 , 1.84 
mM KH2PO4, pH 7.2) and then incubated in lx trypsin (Gibco) until the cells 
detached from the plate. Cells were then either seeded into a new flask (1:5 for 
maintenance) or seeded into dishes or plates at the desired cell density for the 
experimental procedure.
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2.2.3.2 Transient transfection
Transient transfections in HEK293T cells were carried out with 
Lipofectamine 2000 (Invitrogen) according to the manufacturers instructions. 
Cells were then incubated in optimem in the presence of the reaction mix, 
containing plasmid DNA and Lipofectamine 2000. The reaction mix was 
prepared in polypropylene tubes. After 4 hours cells were washed with PBS and 
normal growth medium (DMEM with 10% fetal calf serum) was added back. 
The transfection efficiency was between 70 to 95% as judged by visual 
examination of GFP transfected cells under a tissue culture microscope 
equipped with a fluorescent unit (GFP filter set and a mercury lamp).
2.2.3.3 Storage and recovery of mammalian cells
For storage in liquid nitrogen HEK293A cells were trypsinised and spun 
at 200g for 5 minutes in swing bucket centrifuge (Heraeus). The cell pellet of 
one confluent T75 flask was resuspended in 3 ml growth medium, containing 
20 % foetal calf serum and 10 % sterile DMSO. Cells were frozen at -80 °C in 
1 ml aliquots in a Cryo-l°C-Freezing Container (Nalgene) filled with 
isopropanol to allow slow freezing (l°C/min). After a week, cells were 
transferred to liquid nitrogen for long-term storage. To recover cells, aliquots 
were rapidly thawed at 37 °C in a water bath and added to one T75 flask, 
containing 25 ml of growth medium. The medium was replaced the following 
day, after the cells had attached to the plastic.
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2.2.4 Protein techniques
2.2.4.1 Protein quantification
Protein concentrations of samples were measured using the BioRad 
protein assay reagent. BSA standards and samples were diluted in 800 pi H2O 
and incubated with 200pl protein assay reagent. The absorbance at OD595nm 
was measured and compared to the standard curve to calculate protein 
concentrations.
2.2.4.2 Preparation of cell Ivsates and SDS-PAGE
HEK293T cells were washed once with ice cold PBS, and then detached 
using a cell scraper. Cells were spun down for 3 min at 200g, and lysed on ice 
for 15 min in Cell Lysis Buffer (Cell Signalling) plus protease inhibitors (250 
pM PMSF, 50 pg/ml chymostatin, 0.5 pg/ml leupeptin, 50 pg/ml antipain, 0.5 
pg/ml pepstatin A, 0.1 mg/ml pefabloc). Nuclei and insoluble debris was 
removed from lysates by centrifugation in a microcentrifuge (10 min, 16000g, 
4°C). Protein concentrations were determined (Chapter 2.2.4.1) and samples 
were mixed with 4x sample buffer and loaded onto an SDS gel.
2.2.4.3 Preparation of tissue Ivsates and SDS-PAGE
Organs were removed and stored in ice-cold PBS containing protease 
inhibitors. They were passed through a 70pm cell strainer using a plunger of a 
syringe and taken up in lx Lysis buffer (Cell Signalling) and sonicated for 5 
intervals of 10 seconds at 10 microns amplitude. After further 10 minutes on 
ice, cells were spun for 10 min at 4°C to remove the insoluble fraction. The
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supernatant was transferred to a new tube, and the protein concentration 
determined (2.2.4.1)
2.2.4.4 SDS-polvacrvlamide gel electrophoresis
Solutions:
APS (Ammoniumpersulphate) 10% (w/v) in water 
TEMED (Sigma)
Acrylamide-Bisacrylamide Solution (Protran) 37.5: 1 
Running Buffer: 50x, for 10 litre
Glycine 1400g
Tris 300g
SDS 50g
Laemmli sample- buffer: 4x :
4ml 10% SDS (w/v)
1.6ml 1M Tris (pH 6.8)
20% Glycerol (v/v)
5% p-Mercaptoethanol (v/v) 
ad 10ml H20 
Bromphenol Blue 
The stock solution is stored at -20°C without (3-mercaptoethanol
Before loading, samples were boiled for 3 minutes. Equal amounts of 
protein were loaded per lane, and separated on either 8 % SDS-PAGE gels or 
10 % SDS-PAGE gels using a 45mA current until the dye front reached the 
bottom of the gel. See below for composition of gels. Gel systems used were
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either 1.5mm Cambridge electrophoresis mini gels or if stated NuPage-4%-12% 
Bis-Tris pre-cast gels.
Table 2.16 Composition of SDS-PAGE running gel
Component 8% Gel 10% Gel
h 2o 18.5 ml 15.9 ml
30% acrylamide mix 10.7 ml 13.3 ml
1.5M Tris (pH 8.8) 10 ml 10 ml
10% SDS 0.4 ml 0.4 ml
10% APS 0.4 ml 0.4 ml
TEMED 0.024 ml 0.016 ml
Table 2.17 Composition of SDS PAGE stacking gel
Component Volume
h 2o 6.8 ml
30% acrylamide mix 1.7 ml
1.5M Tris (pH 8.8) 1.25 ml
10% SDS 0.1 ml
10% APS 0.1 ml
TEMED 0.01 ml
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2.2.4.5 Western blotting
Solutions:
Transfer buffer:
Dilution to lx in:
lOx Stock 
390mM Tris 
480nM Glycine 
0.37% SDS 
ad 1 litre 
200ml Methanol 
100ml lOx Stock
700ml H20
Blocking Buffer: 5% (w/v) Milk in TBST
TBST: 137mM NaCl
lOmM Tris,pH 7.4 
0.1% (v/v) Tween
For transfer of the separated proteins from the SDS-Page a semi-dry 
blotting chamber was used. Whatmann 3 mm filter paper and the nitrocellulose 
membrane were cut to the size of the running gel. Both were equilibrated in 
transfer buffer prior to use. The transfer-sandwich is built from the anode to the 
cathode as follows: 3 slices of filter paper, nitrocellulose membrane, gel and 
three slices of filter paper. Possible air bubbles in the blotting sandwich were 
removed by rolling a pipette over the sandwich. The proteins were transferred 
at 0.8 mA/cm2 for lhr. Transfer and equal protein loading was tested with 
Ponceau S (Sigma-Aldrich) staining. Blots were blocked by incubating the
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membrane in blocking buffer for 1 hour at room temperature or overnight at 
4°C. Membranes were then incubated with the primary antibody in blocking 
buffer for at least 1 hour at room temperature, after which they were washed 3x 
in TBST and incubated with the secondary HRP-conjugated antibody (Jackson) 
diluted 1:10000 in blocking buffer. Membranes were washed 3 x 10 minutes in 
TBST incubated in enhanced chemiluminescence substrate (ECL, GE 
Healthcare) and developed.
2.2.4.6 Immunohistochemistrv on paraffin embedded tissues
Solution: 10%NBF:
10% Formalin 
4g NaH2P 0 4 
6.5g Na2H P04 
ad 1 litre
Tissues were dissected and fixed overnight at room temperature in 10% 
NBF. On the following day the NBF was replaced with 70% (v/v) Ethanol. The 
processing, embedding and antibody stainings were performed by the Cancer 
Research UK Experimental Histopathology laboratory. Briefly, formalin fixed 
paraffin embedded sections were de-waxed in xylene and dehydrated by 
passage through a graded series of IMS washes ultimately into water. Sections 
were microwaved in citrate buffer for 15 minutes and then transferred to PBS. 
Slides were incubated in 1.6% hydrogen peroxide for 10 minutes. Normal goat 
serum diluted to 10% in 1% BSA was used as a blocking step for 30 minutes. 
Primary antibodies diluted in 1% BSA was added for 1-2 hours. Sections were 
washed in PBS prior to applying secondary antibody for 45 minutes at room
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temperature. Sections were washed in PBS and then incubated in ABC for 30 
minutes prior to washing. DAB solution was applied for 2-5 minutes and 
development of the colour reaction was monitored microscopically. Slides were 
washed in PBS, stained with a light haematoxylin, dehydrated, cleared and then 
mounted. The antibody dilutions and antigen retrieval method is given in Table 
2.1. Pictures were taken using an Axiovert upright microscope (Zeiss) with 
2.5x, 20x, 40x and lOOx objective. For the image acquisition and quantification 
of events and area measurements the axiovision software (Zeiss) was used.
The Experimental Histopathology Laboratory, CRUK, performed 
fluorescent staining of brain sections. For the imaging I used a Zeiss LSM 510 
confocal microscope equipped with a Zeiss 40x, 1.4NA Differential 
Interference Contrast (DIC) Plan-Apochromat or Phase Contrast oil-immersion 
objective, controlled by Zeiss LSM 510 software. Images were collected using 
the 493nm line of an argon laser and the 543nm and 633nm lines of a helium- 
neon laser with 4x or 8x averaging.
2.3 Animal Techniques
2.3.1 Animal housing and husbandry
Animals were housed according to the UK guidlines for the animal 
health and welfare in the animal facilities of Cancer Research UK either in 44 
Lincoln's Inn fields or Clare Hall facilities.
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2.3.2 Animal culling
Unless stated otherwise animals were culled according to Schedule 1 of 
the Animal Scientific Procedures Act 1986 either by lethal injection with 
Euthanal, placement in a CO2 chamber, or cervical dislocation. For preparation 
of cerebellar granule cells pups of 6-7 days of age were decapitated if needed.
2.3.3 BrdU injection
Solutions: 200mg/ml BrdU (Sigma Aldrich) in PBS
To investigate proliferation in the cerebellum, either the pups or the 
time mated pregnant females were injected intraperitoneal with BrdU at 
lOOpg/g bodyweight and housed for 2 hours after injection. At the end of the 2 
hour period animals were culled according to the home office guidelines (2.3.2) 
and brains were extracted. For birthdating experiments time mated pregnant 
females were BrdU injected at the indicated day of pregnancy with lOOpg/g 
bodyweight. At indicated timepoints, pups were extracted culled and subject to 
immunohistochemistry studies.
2.3.4 Behavioural Tests
2.3.4.1 Pole Test
The pole test was performed according to Matsuura et al with slight 
modifications (K. Matsuura et al., 1997). Animals of two month of age were 
acclimatised to the pole one day before the test and tested on day two. The pole 
consists of a retort stand wrapped in duct tape to generate a rough surface. The 
half and bottom of the pole are marked for time measurements. The pole was
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wiped with 70% (v/v) ethanol between animals. On acclimatisation day the 
animals were placed on top of the pole and allowed to walk down the pole 3 
times without taking the time. At the bottom of the pole a thick layer of nesting 
material ensured that no mice were hurt in case they fall. On the test day 
animals were placed on top and the walk down the pole was monitored with a 
Digital camcorder (Sony). This was carried out in 3 consecutive runs. The time 
needed to walk down was subsequently stopped on the video recording. 
Behavioural abnormalities such as stopping and letting go of the pole were 
noted as well. The two best times (judges as continuous runs, no falls) were 
taken and averaged per animal.
2.3.4.2 Hanging wire test
2 month old animals were used for the hanging wire test. The experiment was 
performed over a two-day period leaving one day for acclimatising the animals 
to the experimental set-up and using day two for testing. Animals were placed 
on top of a wired cage lid and the lid was raised up and down 3 times to 
promote the animal to grip. Afterwards the cage lid was turned resulting in the 
animal hanging below the cage lid. The time until the animal either falls or 
climbs on top was measured. A cut off time of 30 seconds was chosen after 
which the cage was turned back to starting position if the animal did not let go 
or climb on top. A thick layer of nesting material was placed at the bottom to 
ensure no animal was hurt if it fell. After 3 times the animal was either valued 
“Hang” if the animal kept hanging over the 30 seconds or climbed on top 2 out 
of 3 times. Animals were counted as “Fall” if they let go 2 out of 3 times.
104
Chapter 2
2.3.4.3 Gait analysis
To assess whether animals are ataxic a gait analysis was performed. Briefly, the 
animals’ front paws were marked with orange non toxic ink and the back paws 
with purple non toxic ink. Animals were placed in a U-chanel layered with 
filter paper. As the mouse walks along, one can trace the footprints and measure 
stride length, distance of front paws and back paws thereby seeing whether the 
mouse is ataxic.
2.3.5 Statistical Analysis
The statistical analysis of data was performed using the Graphpad Prism 
software. If two groups of mice were compared, an unpaired two-tailed T-test 
was performed. When more than one group were compared, analysis of 
variance (Anova) was used with a Kruskal Wallis Post test. Unless otherwise 
stated the Data are presented as Mean+/-SD and p values are indicated as 
follows: p<0.05: * , p < 0.01: **.
2.3.6 Quantification of neurons:
All neurons quantified were counted manually and comparable brain 
regions for each experiment were chosen. Do to the chosen brain regions and 
different stainings (HE, NeuN in different experiments different counting 
methods were used for the analysis. At least 3 animals were quantified per 
genotype, the numbers of animals are indicated as n in the respective chapters.
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2.3.6.1 Purkinie cell quantification
The number of Purkinje cells was counted in mid-sagittal sections. The 
length of the Purkinje cell layer in the whole cerebellar section was measured 
using the Axiovision software (Carl Zeiss). The Purkinje cell density was 
obtained by dividing the number of Purkinje cells counted devided by the 
Purkinje cell layer length.
2.3.6.2 Quantification of neurons in E 18.5 brains
Comparable regions of interest (ROIs) with a fixed size in the cortical 
plate, intermediate zone and midbrain were chosen in sagittal sections as 
indicated in Fig 4.3. The neurons were counted manually in H&E stained 
sections taken at 20x and lOx magnification using the event count tool in the 
metamorph software (Molecular devices). To obtain comparable datasets, the 
neuron number counted was normalised to the fixed sized area as cells/mm2.
2.3.6.3 Quantification of neurons in adult cortices of fbw7^ Nanimals
Comparable Regions of interest (ROIs) of the different cortical layers 
were chosen in coronal sections of comparable regions as indicated in Fig 6.8. 
The neurons were quantified manually in NeuN stained sections taken at 20x 
magnification using the event count tool in the metamorph software (company). 
To obtain comparable datasets, the neuron number was normalised as 
cells/mm .
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2.4 Supplementary material on DVD
2.4.1 Description of movies M1 and M2
f b w 7 ^  animals display a strong hindlimb tremor when allowed to grip 
a cage lid with their front paws. M l: control M2: Jbw7ApN
2.4.2 Description of movies M3 and M4
fbw7*pN animals display a caterpillar like walking pattern in the pole 
test and need longer to climb down the pole. M3: control M4: Jbw7*pN
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3 GENERATION OF THE FBW7 
CONDITIONAL KNOCKOUT MICE
3.1 Generation of the targeting construct for Fbw7 
deletion
The Cre-loxP system is a widely used system to generate conditional 
knockout mice and it is based on the activity of the Cre recombinase towards so 
called loxP sites, which are partially palindromic 34bp sequences (reviewed in 
(U. Muller, 1999)). The recombinase will excise the region in between two loxP 
sites if they have the same orientation, or will invert the region between them if 
they are orientated opposite to each other. If the Cre expression is driven by a 
tissue specific promoter, a selective deletion can be achieve in the respective 
tissue and the severe defects of a germline knockout can be avoided (reviewed 
(C. Gaveriaux-Ruff and B. L. Kieffer, 2007)). To obtain mice that harbour an 
allele where a specific sequence, such as an exon, is flanked by two loxP sites 
(“floxed”), a targeting vector has to be cloned first. In general, this vector 
contains the genomic target sequence and two loxP sites, one 5’ and one 3’ of 
the targeting sequence. Additionally, two homology regions to the genomic 
sequence that surround the targeting sequence have to be present so that the 
construct can insert into the genome by homologous recombination. The floxed 
targeting construct will be transfected into ES cells where it should integrate 
into the genome. Therefore to select for the stable insertion and against random
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integrants, a positive and negative selection marker have to be present in the 
targeting vector (reviewed (C. Gaveriaux-Ruff and B. L. Kieffer, 2007)).
For the fbw7  targeting construct I flanked exon 5 by two loxP sites in 
the same orientation and inserted the homology arms on either side of it. Exon 
5 was chosen because it encodes the major part of the F-box domain and is 
common to all isoforms (Figure 3.1 A). As exon 5 spans 125 bases, the deletion 
causes a frameshift mutation and thus the resulting message should be be 
subjected to nonsense mediated decay and subsequently lead to the loss of the 
Fbw7 protein (reviewed in (M. W. Hentze and A. E. Kulozik, 1999)). A 
neomycin cassette was used as a positive selection marker and Frt sites that 
flanked the neomycine cassette allowed that it could be excised after the 
successful targeting. The negative selection marker was a Diphteria-toxin-a 
(DT-a) cassette, located outside of the homology arm. Therefore cells that have 
randomly integrated the whole targeting vector die due to the toxin expression, 
whereas cells that integrated the vector by homologous recombination will have 
lost the DT-a cassette and are viable (Figure 3. IB). The presence of loxP sites 
around the targeting region and Frt sites around selection marker allows the 
sequential crossing of mice to firstly obtain the floxed f b w animals and 
subsequently to generate the tissue specific knockout of Fbw7 (Figure3.1 C).
The targeting construct for the floxed fbw7  allele was generated using a 
four step cloning strategy (Figure 3.2). The single cloning steps are described 
below. For all cloning techniques such as digest, PCR and sequencing the 
methods described in Chapter 2.2.1 were used.
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Figure 3.1 Targeting construct and strategy to obtain Fbw7 conditional 
knockout mice. A) genomic organisation of the fbw7 locus. fbw7 contains 
11 exons (rectangles) whereby exon 5 encodes for the major part of the 
F-box domain (dark filled rectangles). B) targeting construct used to insert 
loxP sites around exon 5. Blue: DT-a-negative selection marker, pink: 
neomycin cassette as a positive selection marker.The DT-a cassette is 
lost upon homologous recombination indicated by the dashed crosses C) 
final crossing strategy after obtaining animals harbouring the targeted 
floxed allele of fb w 7  to generate conditional knockout mice.
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3.1.1 Long arm of homology
The sequence for the long arm of homology, covering exon 4 and parts 
of the surrounding introns, was cloned from mouse genomic DNA using primer 
pairs Fbx7Fl/Fbx7Rl in a long template PCR reaction (chapter 2.2.1.1). The 
purified PCR product was digested with Seal and the resulting fragment cloned 
into the EcoRV site of the pDTa-vector. The relative orientation of the 
fragment (see arrows in Figure 3.2) was confirmed by restriction digest and 
sequencing using the primers SeqFe4 and SeqRe4-l and SeqRe4-2 (Figure 3.2 
A).
3.1.2 Short arm of homology
The short arm of homology, spanning exon 6 and parts of the 
surrounding introns, was generated using the primers Fbx7F3 and Fbx7R3. The 
amplified fragment was digested with Xbal/Nhel and inserted into Xbal cut 
pcDNA 3.1+ whereby the Nhel site was destroyed. The resulting fusion 
construct was test digested and sequenced with SeqFeb and SeqRe6 primers 
(Figure 3.2B).
3.1.3 Insertion of two lox P sites around exon 5 of Fbw7
To flank exon 5 of fbw7  with two lox P sites, two Bell sites were 
introduced by PCR on genomic wt DNA. For this purpose the primers 
Fbx7F4BclI and Fbx7R4BclI contained a Bell site each. The amplified 
fragment was cut with Bell and cloned into the pFlrt vector, which contains a
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BamHI site in between two loxP sites that can be ligated to Bell cut ends. This 
ligation additionally destroys the BamHI site. The sequence was confirmed 
using primers SeqFe5 and SeqRe5 (Figure 3.2C).
3.1.4 Construction of the final targeting vector
The short arm of homology was excised from the initial pcDNA3.1 
vector using a Xhol/Kpnl digest and inserted into the pFlrt vector which 
already contained the region spanning exon 5 flanked by two loxP sites (3 .1.3). 
The long arm of homology including the negative selection marker DTA was 
cloned via Notl/Sall into the pFlrt vector. The final outcome is a targeting 
vector that contains the positive and negative selection marker in one 
orientation and the region of interest, here exon5 flanked by loxP sites, in the 
other orientation (Figure 3.2D).
3.1.4.1 Linearisation of the final targeting vector
The targeting construct was linearised using Notl and purified using 
common DNA methods (chapter 2.2.1) and given to the Cancer Research UK 
transgenic services for the ES cell transfection.
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3.2 Confirmation of targeting by PCR and 
southern blotting
3.2.1 Screening PCR for target insertion in ES cells
The transfected ES cells were sent back to me in 96 well plates. I 
extracted the DNA and screened for the insertion of the targeting construct into 
the genome by nested PCR. The initial PCR used the primers 
ScrFlrt-2/ScrFbx7-2 and the second PCR was performed with the primers 
ScrFlrt-l/ScrFbx7-l (Figure 3.3A). These primers bound either inside the PGK 
promoter of the positive selection cassette or in the genomic region outside of 
the targeting construct, therefore ensuring the screen recognises only the 
construct inserted by homologous recombination. Out of 864 transfections 
seven clones were initially positive for the targeting PCR. These clones were 
expanded by the transgenic service and I re-tested them using the above 
described nested PCRs. From the seven initially positive clones one clone 
remained positive after the expansion phase.
The insertion of the targeting construct was additionally confirmed by 
southern blotting. To do this, I designed a probe that binds in the genomic 
region after the end of the short homology arm. A Stul digest was performed to 
determine whether the targeting was successful (Figure 3.3A). In the genomic 
fbw7  locus there is a Stul site before exon 4 and after exon 6, resulting in a 
5735 bp fragment that is recognised by the probe upon digestion with Stul. Due 
to a Stul site present in the neomycin cassette, the probe detects a 2560 bp
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fragment in the targeted fbw7  locus. The southern blotting confirmed that the 
insertion of the targeting construct was successful (Figure 3.3B). The targeted 
ES cell clone was also used to establish the genotyping PCR. Using the primers 
F7-PCR1/F7R1 the amplification of the wt allele generates as expected a 287bp 
fragment whilst amplification of the floxed allele produces a 394 bp fragment 
(Figure 3.3C).This targeted ES cell clone was expanded and used for the 
injection into C57B1/6 blastocyst (performed by the CRUK Transgenic 
services). A high level of coat colour contribution together with a bias to male 
chimeras (as the ES cell line is male) was indicative of an ES cell clone that 
contributes to the germline. After the expansion of the targeted mice by 
crossing them to B16, and removing the selection marker by breeding them with 
Flp-transgenic animals, f b w mice were obtained.
3.2.2 Genotvpinq
The genotyping of the fbw7  targeted and conditional knockout animals 
was performed using various primer combinations. For the genotyping of the 
targeted allele together with a deleted allele where the neomycine cassette was 
still present, a three primer PCR with primers F7-PCR1, F7-R1 and NeoS was 
(Figure 3.4A and C lane 1 and 3). The genotyping for mice derived from fb w 7^ 
animals where the selection marker was excised, was performed using the 
primer combinations F7-PCR1, F7-R1 and A2 (red askterisks, Figure 3.4C). 
These three primers are able to detect the wildtype, floxed and deleted fbw7  
allele. An alternative genotyping PCR for the second loxP site was also 
established (Figure 3.4B). The size of the PCR fragments for the various 
possible alleles is given in Figure 3.4C.
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Figure 3.3. Southern blot, screening and genotyping PCR on the 
targeted fbw7tneo allele A) Probe and primer design for southern 
blotting, screening and genotyping PCR. The genomic fbw7 locus contains 
a Stul site before exon 4 and after exon 6. These sites and an additional 
site within the neomycin selection cassette were used to confirm the 
targeting by performing a Stul digest. The probe detects a 2.6 kb band 
upon targeting and a 5 kB band in the wt fbw7 locus. Positions of primers 
used for the initial screening of ES cells are indicated. B) Southern blotting 
confirmed the targeting of the construct in the selected ES cell clone C) 
A PCR around the inserted 5’ loxP site results in a 80 bp difference of 
the floxed versus wt PCR product. F7-PCR1 and F7-R1 primers are 
chosen within the intronic region around Exon 5 as indicated by the 
arrows in (A).
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Figure 3.4 Genotyping primers for the targeted and deleted fbw7 allele
A) Targeted fbw7 locus containing the positive selection marker. Primer 
sites for genotyping are indicated B) Magnification of final floxed fbw7  
locus containing only exon 5 flanked by two loxP sites and the one 
remaining Flp site after excision of the positive selection marker. Annotations 
in red indicate additional bases that were inserted due to the cloning 
strategy.Numbers above the line indicated 500 bp distances on the genome 
and were used to locate the primer binding sites. C) Expected size of 
genotyping PCR bands using different primer combinations. Red askterisks 
indicate primers used for routine genotyping. The blue askterisk indicates 
primers used for genotyping fbw7x allele that still contained the neomycine 
cassette.PCR products in brackets indicate that PCRs were not performed 
because the product would be very long for a conventional PCR.
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3.3 Verification of Fbw7 deletion in conditional 
knockout animals
The first step in the analysis of the conditional fbw7  knockout mice, was 
to confirm the knockout. To do this, I used various approaches and samples 
from the different knockout lines. Therefore table 3.1 summarises where the 
deletion in these mouse lines takes place. For the detailed analysis of the Fbw7 
conditional knockout lines, the reader is referred to chapters 4 to 6.
Table 3.1 Deletion pattern of the used mouse lines
Cre line Deletion Reference Chapter
Nestin Cre Neural lineage (F. Tronche et al., 
1999)
4
Engrailed-2 Cre Cerebellar vermis (D. L. Zinyk et al., 
1998)
5
Synapsin Cre Postmitotic
neurons
(Y. Zhu et al., 
2001)
6
3.3.1 Confirmation of Fbw7 deletion by RT-PCR
To investigate to what degree deletion can be obtained on the message 
level, I used fbw7ACb :c-junACb animals where fbw7  and c-jun should be deleted 
in the cerebellar vermis but not the lateral sides (for a detailed description of 
this mouse line see chapter 5.). I extracted RNA from both parts of the
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cerebellum and performed a reverse transcriptase PCR reaction using primers 
binding in exon 2 and 7 of Jbw7, primers for c-jun, which is only transcribed 
from a single exon, gapd was used as a control (Primers are listed in Table 2.5).
The RT-PCR on wt fbw7 message should yield a 558 bp fragment. As I 
anticipated that the exon 5-deleted message is subjected to nonsense-mediated 
decay, I did not expect to detect an exon 5 deleted PCR product of 433bp. For 
the lateral side I obtained the wt 558bp PCR fragment, however, I could also 
detect a 433bp fragment in the vermis of the fbw7ACb:c-junACb knockout 
animals, suggesting that the deleted fbw7 message at least partially escapes 
nonsense mediated decay. To verify that this smaller band is indeed fbw7  
message, I purified the PCR band from the gel and sequenced it with the same 
primers that I used to amplify it. The alignment to the wt sequence shows that 
upon Cre expression exon 5 is deleted as expected (Figure 3.5B). Therefore the 
message continues into exon 6, where two stop codons are present in a row 
(green circle in Figure 3.5C). Thus the remaining message cannot be translated 
into a functional protein since the F-box domain is missing and the WD-40 
repeat region not present. If this truncated message would be stable and 
translated, one could expect that three truncated proteins are generated, all 
consisting of the first exon for each isoform and the common sequence up to 
the stop codon. The predicted size for those proteins would be 20 kD (y), 25 kD 
(P) and 33 kD (a). However, this could not be verified as none of the available 
antibodies are able to detect the endogenous protein (see 3.3.4 and discussion).
In case of the c-jun RT-PCR, I could detect a strong band in the lateral 
part of the cerebellum and only a very weak band in the medial part, indicating 
that c-jun was efficiently deleted (Figure 3.5A). The residual signal can
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potentially be caused by contamination of the tissue preparation with non­
deleted cells or by contamination of the RNA preparation with DNA. Since the 
c-jun genomic organisation does not contain introns, even small DNA 
contaminations are likely to be amplified.
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Fig 3.5 RT-PCR to confirm deletion of exon 5 of Fbw7 in the vermis
of fbw7*CbcjunACb mice. A) Medial (M) and Lateral (L) samples of the 
cerebellar cortex were taken. RNA was extracted and RT-PCRs were 
performed for fbw7, c-jun, gapdh  was used as control. The lower fbw7  
band in the medial sample and the band from the lateral part were excised 
and sequenced with the same PCR primers as used for amplification. B) 
Sequence alignment of the deletion PCR product to wt cDNA. Exon 5, 
which encodes for the major part of the F-box domain (red underlined) 
is deleted. C) Translation of obtained sequencing of the A band. The 
deletion of exon 5 causes a frameshift upon transition to exon 6 and a 
stop codon (green circle).
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3.3.2 Fbw7 expression in the wt brain
To characterise the expression pattern of Fbw7 in wt brain and to verify 
the various knockout lines, I cloned in situ hybridisation probes for the fbw7  
message. One probe was designed to cover the sequence from exon 2 to 5, and 
named “generic probe”. The other probe was designed to span only a small part 
of exon 4 and exon 5 and therefore called “exon5 specific probe” (Figure 3.6A). 
These probes were given to the in house in situ hybridisation service and brain 
sections from different conditional knockout lines and controls were hybridised. 
I then evaluated the slides using a dark-fleld microscope. A sense construct 
spanning the bases as the generic probe was used on a wt cortical sample to test 
the specificity of the probe (Figure 3.6B). No staining could be detected using 
the sense probe, confirming the specificity of the signal obtained antisense- 
signal. Having established the specificity of the in situ hybridisation, I first 
wanted to analyse the expression of Fbw7 in the adult wt brain. Therefore a 
midline sagittal section from a wt mouse was probed with the generic probe and 
analysed. I observed that the Jbw7 message is widely present in the adult mouse 
brain with particular high expression in the cerebral cortex, hippocampus, 
dentate gyrus and in some nuclei such as the pons and the inferior olive whilst 
in other regions such as the thalamus hardly any signal can be detected (Figure 
3.7, Figure 3.10). Fbw7 is also expressed in the cerebellar granule cell layer, 
which is discussed below in more detail. The exon 5 specific probe gave a 
slightly weaker but otherwise identical signal as the generic probe on wt brains 
(data not shown).
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Figure 3.6 Design and validation of Fbw7 in situ hybridisation probes.
A) Partial cDNA sequence of the mouse Fbw7-p isoform with annotated 
exon boundaries. The sequence of the generic fbw7  in situ hybridisation 
probe covers exons 2 to 5 and the exon 5 specific probe extends from 
exon 4 to 5. All exons from exon 2 onwards are common to all three Fbw7 
isoforms (see also Fig 1.5) B) A wt mouse cerebral cortex probed either 
with the sense negative control or the antisense probe. No signal was 
detected in the sense sample (which covers the same sequence as the 
generic probe) whereas the antisense sample gave a signal in the cortex 
indicating that probe binds specifically.
generic probe
Dentate
illary nucleusj
Figure 3.7 Detection of Fbw7 message in the wt brain A) scheme of 
a midline sagittal cut mouse brain.(from, Paxinos, 2002) Red numbered 
rectangles indicated areas of Fbw7 expression that are magnified in B. B) 
Areas of Fbw7 expression detected with the generic Fbw7 probe. Shown 
are brightfield and darkfield images of the resprective regions.
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3.3.3 In  s i t u  hybridisation on Fbw7 conditional knockout brains
To verify the knockout of Fbw7 in the generated conditional knockout 
lines, sections of control and mutant animals were hybridised. In brains of E l8 
embryos where fbw7  is deleted in cells of the neuronal lineage, fbw7AN\ the 
strong signal in the embryonic cortex disappears in the knockout (Figure 3.8, 
panels 2, 2’). The message is also strongly reduced in the embryonic eye 
(Figure 3.8, panels 4, 4’), confirming previously published data that Nestin-cre 
mediated deletion also affects the eye (Y. Cang et al., 2006). A loss of the 
cortical fbw7  hybridisation signal could also be observed in the adult jbw7ApN 
animals where Fbw7 is deleted in postmitotic neurons (Figure 3.9 and Figure 
3.10). In a montage image using the generic probe distinct areas of high Fbw7 
expression such as the cortex, hippocampus, olfactory bulb are visible and in 
the fbw7ApN animal this signal is strongly reduced (Figure 3.9). The residual 
signal in the fbw7/SpN cortex compared to the fbw7AN brain that is present in 
brains probed with the generic (Figure 3.10 top panel) and the the exon 5 
specific probe (Figure 3.10, bottom), can be attributed to cells still expressing 
Fbw7 since Synapsin-cre mediated deletion selective affects postmitotic 
neurons while Nestin-cre mediated deletion also causes deletion in glial cells. 
Additionally the signal in the dentate gyrus is strongly reduced in fbw7*pN 
animals (Figure 3.10), confirming previously published results for the efficient 
cre-recombinase expression of the Synapsin-cre line in neurons and particularly 
the dentage gyrus (C. Hoesche et al., 1993). The Jbw7 message is also detected
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in the cerebellar granule cell layer and this signal is reduced upon Engrailed-2
AChmediated deletion in the fbw7  brain (Figure 3.11).
Taken together these data demonstrate that the deletion of Fbw7 results 
in a reduction offbw7  message in vivo and suggest that the message is removed 
by nonsense-mediated decay.
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Figure 3.8 Fbw7 in situ hybridisation on E18 Control and fbw7AA/ 
brains. A control and fbw7AhJ brain were hybridised with either the generic 
probe (A) or the exon 5 specific probe (B). Overview images (blue panels) 
covering the cerebellum (left), cortex (middle) and eye (right) were taken 
at 5x magnification. Numbered areas were chosed for 50x magnification 
darkfield images. The reduction in signal particularly in the cortex (2,2’) 
and eye (4,4’) is visible in both probes.
generic probe
fbw7ApN
Figure 3.9 Reduction of in situ hybridisation signal in fbw7^PN brain, I. The generic probe was used to highlight fbw7 
message levels in the brain. The montage of transmissive images (blue) shows that the signal, visible as a grey/black staining, 
is strong in areas such as the cortex, hippocampus and olfactory bulb. Images of the areas indicated were taken at 10x 
magnification as darkfield images. The hybridisation signal is weaker in in the knockout brain. Regions that give a strong 
signal such as the cerebral cortex (C, D). hippocampus (E) and olfactory bulb (G) can be distinguished from regions with 
low fbw7 message such as the superior colliculus (B), thalamus (F) or nucleus accumbens (H). Message levels in the 
cerebellum (A), pons (I) and inferior olive (J) are also high.For more detailed images on the loss of hybridisation signal in 
the knockout brain see Figure 3.10.
A Cerebellum Cortex Hippocampus Olf. bulb Pons
Cerebellum Cortex Hippocampus Olf. bulb Pons
Figure 3.10 Reduction of in situ hybridisation signal in the fbw7*PN brain, 2. Pictures of high expressing 
areas were taken at 20x magnification of sagittal cut brains hybridised with either the generic probe (A) or the 
exon 5 specific probe (B). The reduced hybridisation signal in the fb w 7 ^ N brain is visible with both probes althouqh 
a stronger reduction is detected with the exon 5 specific probe.
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Figure 3.11 Reduction of in situ hybridisation signal in the fbw7ACb 
cerebellum. A control and fbw7ACb brain were hybridised with either the 
generic probe (A) or the exon 5 specific probe (B). Overview images (blue 
panels) covering the cerebellum (left) to the Hippocampus (right) were 
taken at 5x magnification. Numbered areas were chosen for 50x 
magnification darkfield images. The reduction in signal is present in both 
probes and in both cerebellar lobes (panels 1,2) whilst the dentate gyrus 
(panel 3) is not affected.
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3.3.4 Assessment of a monoclonal Fbw7 antibody on transfected 
cells and tissue extracts
To detect the Fbw7 protein, an in-house monoclonal antibody that was 
raised against a peptide sequence within the first common exon (exon 2) of 
Fbw7 was generated by the CRUK monoclonal antibody service (in-house 
Fbw7 antibody). To test this antibody 293T cells were transfected with different 
mouse GFP-Fbw7-p fusion constructs that either contained or did not contain 
the antibody epitope (Figure 3.12A). Cells were harvested 24 hours post 
transfection and western blotting for Fbw7 or GFP was performed. Specific 
bands that correspond to the molecular weight of the Fbw7 construct fused with 
the 29 kD GFP protein were detected (Figure 3.1 OB). Upon the deletion of the 
antibody-epitope no band was recognised with the in-house Fbw7 antibody. As 
the expression of the construct could be confirmed using a GFP antibody, this 
demonstrates that the generated in-house Fbw7 antibody recognises Fbw7 
specifically (Figure 3.12B lane 3). This Fbw7 antibody also detects the 3 
different isoforms of the human Fbw7 protein as shown by transient 
transfection of human Fbw7-a, -P and -y Flag-myc-expression constructs 
(Figure 3.12C). These overexpression data suggested that this antibody could 
be a useful tool in studying the conditional knockout mice. In tissue extracts 
from wt mice run on a 10% SDS-PAGE the in-house Fbw7 antibody detects a 
band of 80 kD kidney, liver, spleen and thymus (Figure 3.13A and data not 
shown). However, this band is hardly detectable in brain extracts (Figure 
3.13A). The only strong band that is present in brain extracts of all animals
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including B16 controls is a small non-specific 35kD band. I decided to test the 
Fbw7 antibody on fbw7ACh :c-junACb protein extracts from the cerebellar vermis 
and lateral sides. In these extracts western blotting for c-Jun can act as a 
positive control as to whether the deletion is taking place as expected. With 
regards to Fbw7 I observed that in this 8% SDS-PAGE a weak duplet of 85 and 
75kD is detected. However, this duplet is still present in extracts from the 
fbw7ACb:c-junACb vermis, indicating that this band is not specific as western 
blotting for c-Jun showed an efficient deletion (Figure 3.13B). Also in protein 
extracts from fbw7AN E18 cortices or fbw7ApN brains no specific band for Fbw7 
could be detected when using the in-house antibody that was previously 
established to recognise Fbw7 in transfected cells. Ponceau staining, actin blots 
and one lane loaded with a cell lysate of GFP-Fbw7-|3 transfected cells were 
used as controls in these experiments to ensure that a) the proteins from the cell 
lysates were transferred onto the nitrocellulose membrane and b) that the 
antibody staining protocol worked. I tested different membranes (nitrocellulose, 
PVDF), blocking agents (Milk, BSA) and buffers (TBS, PBS, TBST, PBST) to 
ensure that the absence of a signal is not cause by the experimental setup. I 
furthermore tested different Fbw7 antibody concentrations as well as different 
tissue lysis protocols (data not shown).
Additionally to the in-house Fbw7 antibody there are commercial 
antibodies available. These antibodies differ in their epitopes in comparison to 
the in house antibody. A polyclonal Fbw7 antibody recognises a C-terminal 
epitope (AB 12292, abeam) and should therefore recognise all Fbw7 isoforms 
as the C-terminus is conserved. However, the provided datasheet does not
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provide convincing information regarding the specificity for Fbw7. Another 
tested polyclonal Fbw7 antibody (PAB-10565) is directed against the N- 
terminus of the Fbw7-|3-isoform. To assess these antibodies GFP-mFbw7-p was 
transfected into 293T cells and western blotting was performed with the same 
constructs as described in Fig.3.12. Whilst the in house antibody was used as a 
positive control and recognised the GFP-Fbw7-P fusion construct as described, 
the actin staining confirmed equal loading and the functionality of the used 
rabbit secondary antibody, blotting with the commercial antibodies did not 
result in any bands in any of the tested experimental conditions (as described 
for the in-house antibody on on tissue extracts), (data not shown). As these 
commercial antibodies have been unable to detect the overexpressed Fbw7 
protein, they were not further analysed with respect to the endogenous protein. 
To overcome the lack of an antibody that can detect the endogenous Fbw7 
protein, I have initiated the generation of further monoclonal and polyclonal 
Fbw7 antibodies that recognise the F-box domain of Fbw7 and these are 
currently being tested.
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Figure 3.12 The F7-3B7 antibody is specific and detects all isoforms 
in transfected cells.(A) Scheme of GFP-Fbw7 fusion constructs used 
to test the Fbw7-3B7 antibody. The epitope is not present in the GFP- 
mFbw7-AN construct. B) 293T cells were transfected with the indicated 
Fbw7 constructs, whole cell lysates were prepared and western blotting 
performed. The Fbw7 Antibody recognises GFP-mFbw7-p fusion constructs 
that have the antibody epitope. The GFP-mFbw7-AN construct, which 
lacks the epitope, is not recognised, but it can be detected by reprobing 
the blot with a GFP antibody. The GFP band is not depicted in lane 1 as 
it runs at 30kD C) 293 cells were transfected with the three different 
human, flag-myc tagged Fbw7 isoforms. The antibody recognises all 
isoforms. The GFP-mFbw7-p fusion construct (Lane 5) is also recognised 
and runs 30kD higher than the Flag-myc-tagged human p-isoform (Iane3) 
due to its fusion to GFP. The expression level of the Flag-myc tagged 
constructs is much lower than that the GFP fusion construct.
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Figure 3.13 The F7-3B7 antibody does not work on brain tissue. A)
Kidney and cortical sample of a control, fbw7ApN and BI6 animal were 
homogenises as described. The F7-3B7 antibody recognises different 
bands in kidney and cortical sample,but none is specific. C57-BI6 and 
fbw7f/f cortical samples display the same pattern as the fbw7ApN sample.
B) The Fbw7 antibody does not work in fbw7ACb:c-junACb brains where 
protein extracts were prepared from either the medial (M) or lateral (L) 
sides. c-Jun protein levels are strongly reduced in the cerebellar vermis 
in conditional double knockout animals, but no specific band for Fbw7 
can be detected, ns: non specific
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3.4 Discussion
I have described the generation of the targeted j b w r °  mice and the 
confirmation of the targeting by southern blotting. Using the crossing strategy 
outline in Figure 3.1. Figure 3.3 shows a genotyping PCR on targeted ES cells 
where the floxed band is stronger than the wt band. A random integration of the 
targeting construct at another site in the genome could explain the stronger 
band but the targeting construct was designed to harbour a negative selection 
cassette to prevent this. Furthermore offsprings were bom with mendelian 
frequence indicating that germline transmission had taken place and in 
subsequent genotypings of different genotypes ifbw?f/f, f b w / /A, fbw7A/+ or 
fb w / /+) I did not observe this discrepancy in band intensities anymore. I 
obtained f b w f /f animals after the removal of the selection marker and having 
bred these fb w 7 ^  mice to various Cre-expressing lines, I wanted to confirm the 
Fbw7 knockout by RT-PCR and western blotting.
Using RNA isolated from fbw7ACb:c-junACb cerebella I could clearly 
demonstrate a strong reduction of the wt Jbw7 message in the medial part of the 
cerebellum compared to the lateral non-deleted part. Unexpectedly however, I 
detected a lower molecular weight band in the RT-PCR on the medial part of
AC'h j /^Lthe fbw7 :c-jun cerebellum (Figure 3.5). The sequencing confirmed that 
this band corresponds to the exon-5 deleted fbw7  message and contained a 
premature stop codon and thereby confirmed that the Cre-mediated deletion 
takes place as anticipated. However, as exon 5 is in the middle of the fbw7
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locus, I expected that the truncated message is subjected to nonsense-mediated 
decay upon successful recombination and is therefore not detectable by 
RT-PCR. The presence of the deleted band could indicate that the message is 
stable and has escaped nonsense-mediated decay. However, an alternative 
explanation may be that the observed band and especially its amount in 
comparison to the wt band in the lateral sample is the result of a saturated PCR 
amplification. Since I used 40 cycles in the PCR it is likely that amplification 
has reached saturation and therefore masks the real difference in the amounts 
between the wt Jbw7 RNA in the lateral sample and the truncated message in 
the medial sample. While this result clearly shows that exon 5 has been 
efficiently deleted from the medial part of the cerebellum it is more difficult to 
assess how much truncated message is present in relative terms, something 
which could be better addressed by quantitative PCR.
An additional approach that I used to verify the Fbw7 knockout was the 
analysis of the fbw7  message levels by in situ hybridisation. For this purpose I 
analysed brain sections of the various conditional knockout lines that I 
generated during my PhD. I observed a strong reduction in the Fbw7 signal in 
all knockout brains (Figures 3.8 to 3.10). Especially in E l8 fbw7AN brains there 
was an almost complete loss of message indicating that the Fbw7 knockout was 
successful. This confirms the result from the RT-PCR that Fbw7 can be 
efficiently deleted upon cre-mediated recombination. Furthermore the in situ 
data strongly suggests that the strong band for the exon 5-deleted RT-PCR is 
indeed the result of a saturated PCR reaction and that the truncated Fbw7 
message is indeed subjected to nonsense-mediated decay in vivo.
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The confirmation of the Fbw7 knockout on protein levels by western 
blotting did not work so far. I used an in-house monoclonal Fbw7 antibody and 
I could clearly demonstrate that it recognises overexpressed Fbw7 constructs of 
all isoforms (Figure 3.10). Depending on the organ taken for western blotting, 
the in-house Fbw7 antibody recognises a band of an apparent molecular weight 
80 kD in other organs than the brain. In brain samples there is a duplet present 
of 85kD and 75D (Figure 3.1 IB), however, when western blotting protein 
extracts from fbw7ACb:c-junACb mice, no loss of bands could be detected. In 
contrast, the deletion of c-Jun was confirmed, demonstrating that these samples 
allow the comparison of deleted (medial) and non-deleted (lateral) parts of the 
cerebellum. In combination with the results obtained from the RT-PCR, in the 
in situ hybridisation this suggests that the observed bands are unspecific. The 
lack of a band, which can be clearly identified as Fbw7, could be explained by 
the instability of the protein. It is possible that Fbw7 is rapidly degraded and 
thus the detection is very difficult. Alternatively the two non-specific bands in 
organ extracts could mask an even weaker specific band.
When using the commercial antibodies on GFP-Fbw7 transfected cells, I 
could not observe any band in western blots (Data not shown), which was the 
reason why I did not continue to use them on tissues. Interestingly however, 
none of the companies provides convincing western blots in the datasheets that 
demonstrates that their antibodies work. I have therefore initiated the generation 
of further monoclonal and polyclonal antibodies that are directed against the 
F-box domain of Fbw7, however, these antibodies are still to be tested.
In conclusion I have generated fb w /^  mice that allow a tissue-specific 
deletion of Fbw7 upon crossing them to Cre-transgenic lines. I furthermore
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confirmed by RT-PCR and in situ hybridisation and RT-PCR experiments that 
Fbw7 deletion takes place as expected in the mouse lines that I characterised 
during my PhD.
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4 UBIQUITOUS AND NESTIN-CRE 
MEDIATED FBW7 DELETION ARE 
LETHAL
4.1 PGK-cre mediated deletion of Fbw7 is lethal
When I started cloning the targeting construct for the conditional Fbw7 
knockout, the function of Fbw7 in vivo had not been investigated. However, 
during the generation of the conditional knockout mice two papers were 
published, that demonstrated that the germ line deletion of Fbw7 is lethal (M. 
T. Tetzlaff et al., 2004; R. Tsunematsu et al., 2004) (see also chapter 1.3.6). In 
both studies the authors obtained fbw7+/~ mice but intercrosses never resulted in 
any fbw T 1' offsprings. To confirm their results I decided to use the PGK-cre 
line and breed them to mice harbouring the targeted allele. The presence of the 
Cre-recombinase under the PGK promoter leads to ubiquitous deletion at early 
embryonic stages (Y. Lallemand et al., 1998). This cross leads to mice that 
harbour the deleted Fbw7 allele with the positive selection marker still present 
(Jbw7Aneo/+) (Figure 4.1 A). Intercrosses of these mice did not give any 
homozygous fbw7Aneomeo offsprings at weaning age (data not shown), thereby 
reproducing the data by Tetzlaff and Tsunematsu.
To further confirm their results that at E 9.5 fb w T f~ animals are still 
present, I set up a time mating of an fbw7Aneo/+ intercross and genotyped the 
embryos at E9.5. In a litter of seven three animals were fbw7Arteo//Aneo as seen by
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the presence of only the A band in the genotyping PCR. The genotyping PCR of 
the other animals amplified an additional wt band, demonstrating that they are 
heterozygous,fbw7Aneo/+ (Figure 4.IB). Thus PGK-cre mediated deletion results 
in a null allele and reproduces the published data for the germline knockout. 
Since the other two groups had already characterised the effect of the 
ubiquitous Fbw7 deletion (summarised in 1.3.6), I did not pursue this analysis 
further and focussed instead on the generation and analysis of the conditional 
knockout offbw7  in the nervous system.
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Figure 4.1 fbw7Aneo/Ar?eo animals are still present at E 9.5 A) Mice 
harbouring the targeted fbw7 allele were crossed with PGK-cre transgenic 
mice to obtain ubiquitious deletion of Fbw7. The neomycin cassette is 
still present in these crosses. Primers used for genotyping are indicated. 
B) Genotyping PCR on E 9.5 embryos from time mated fbw 7Aneo'+ x 
fbw7Aneo/+ crosses. fbw7Aneo homozygous mutant animals (numbers 
1,2,4), detected by a PCR band amplified with primers F7-NeoS are still 
present at this developmental stage.
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4.2 Nestin-Cre Mediated deletion of Fbw7 is lethal
Having confirmed previously published data that ubiquitous Fbw7 
deletion is lethal, I wanted to investigate the role of Fbw7 in the nervous system 
using the Nestin-cre line. Expression of the Cre recombinase under the Nestin- 
enhancer starts as early as E9.5 and causes deletion before the separation of the 
neuronal and glial lineage (F. Tronche et al., 1999; D. Graus-Porta et al., 2001) 
(reviewed in (C. Gaveriaux-Ruff and B. L. Kieffer, 2007)). Using this line, I 
generated Fbw7 conditional knockout mice (fbw7***) as well as double knockout 
animals for Fbw7 and c-Jun (fbw7AN:c-junAN) in the nervous system. This was 
based on the hypothesis that, even if fb w 7 ^  mice displayed the same severe 
defects (including lethality) as the germline knockout, one would expect that 
the phenotype is rescued in the Jbw7AN:cjunAN animals, if the phenotype was c- 
Jun dependent since c-jun^anim als are viable (G. Raivich et al., 2004).
The genotyping of 94 mice at weaning age, did not result in a single 
f b w N e s t i n - c r e  positive (Jbw7AN) animals whilst the other genotypes were ./~ 
observed with the expected mendelian frequency (Figure 4.2A). The same was 
true for the fbw7AN:c-junAN animals where out of 38 mice no double mutants 
could be found at weaning age (Figure 4.2B). The fact that concomitant 
deletion of c-Jun was not able to rescue the lethality, was a first indication that 
the observed phenotype is not solely c-Jun dependent. To check at what time of 
gestation fbw7  deletion is lethal, I set up time-matings and the embryos were 
analysed at different time points. fbw7AN animals are present throughout
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embryonic development and are slightly smaller than the wt littermates (Figure 
4.2C). As there are fb w 7 ^  animals present at E l8, this led to the conclusion 
that fb w 7 ^  animals most likely die during or shortly after birth, at least eight 
days later than the germline knockouts, which display an incomplete closure of 
the neural tube and die around E l0.5. These results clearly demonstrate that 
Fbw7 plays a role not only during very early development and neurulation but 
is essential also at later stages in the nervous system development.
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fbw 7^+, Nes-cre x 
fb w T ,+ weaned 15 11 - 5 3 5
fb w 7 J .t :c-jun?,+ :N es-cre  
fb w r '* c - ju irn  * *
weaned 7 11 - 12
fb w 7 J*  Nes-cre x weaned 9 9 - 7
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Figure 4.2 Nestin-cre mediated deletion of Fbw7 is lethal. A) Frequency 
of indicated genotypes at either weaning age and E 18.5. No fbw 7AN 
mutant are found at weaning age, whereas they were present at E18.5. 
(**: all animals are c-junf/+ as this breeding was used to generate double 
knockout animals). B) No fbw7AN:c-junAN are among animals aenotyped 
at weaning age from crosses indicated right. No fbw7AN: c-jun A" or fbw7AN 
animals were found, whereas c-junAN animals are viable, confirming 
published results. C) Photographs of control and fbw 7AN animals at 
indicated timepoints. fbw7AN animals are smaller than wt littermates and 
are present at E13.5 and E18.5.
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4.2.1 Reduced cellularitv in fb w 7 * N animals at E18
H&E staining in fb w 7 ^  E l8.5 embryos showed that the brain does not display 
gross morphological defects however the cellularity appeared reduced (Figure 
4.3B). To quantify this comparable regions were chosen in the cortical plate, 
intermediate zone and the midbrain and the cell density was quantified as 
described in 2.3.6. All three quantified regions display a significant 20-30% 
reduction in cellularity (Figure 4.3C). The reduced cellularity in the cerebellar 
primordium was not quantified due to the disruption of it in some samples and 
therefore too small sample numbers. The reduced cellularity is preceded by an 
increase in pyknotic nuclei at E l6.5, a stage at which fb w 7 ^  mutant animals 
also showed elevated phospho-c-Jun levels (Figure 4.4). This observation is 
consistent with the hypothesis that lack of Fbw7 leads to increased phospho-c- 
Jun levels since phosphorylated c-Jun is no longer targeted for degradation. 
However, as concomitant loss of Fbw7 and c-Jun did not rescue the phenotype, 
c-Jun cannot be the major mediator of the observed lethality. Therefore other 
substrates such as Notch and c-Myc are likely to play a role observed apoptosis 
and decreased cellularity, however immunohistochemistry stainings for c-Myc, 
N-myc, Notch-1 and cyclin E were inconclusive to date (data not shown). 
Additionally I performed western blotting experiments on brain lysates of 
control and knockout animals but was unable to detect any specific bands for 
these substrates (Data not shown).
Jorg Hoeck, another student in the lab, continued the analysis of the 
fbw7*** animals. He cultured neurospheres derived from E l3.5 of fbw7Ah\
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fbw7AN:c-junAN and control brains to investigate the role of Fbw7 in neuronal 
development further. By culturing the neurospheres in differentiation medium, 
Jorg could show that cell fate decisions such as differentiation into 0 4  positive 
oligodendrocytes, tujlll positive neurons is impaired and that these normally 
exclusively expressed markers can in some cases be found in the same cells 
(J.Hoeck personal communication). Additionally he observed that the number 
of Nestin positive precursor cells is reduced in undifferentiated fb w 7 ^  
neurospheres Therefore Jorgs work demonstrated that the lineage decision is 
impaired in fbw7AN animals and he continues to investigate this (see also 
discussion chapter 4.3).
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Figure 4.3 Reduced cellularity at E18 in fbw7AN brains A) H&E stain 
on sagittal sections from E18 embryos. Areas outlined in A are shown 
in B. B) The reduced cellularity is apparent throughout the brain Cx: 
Cortex with ventricular zone (VZ), intermediate Zone (IZ) and cortical 
plate (CP) , Mb: midbrain, Cbp: cerebellar primordium. Regions of the 
same size were used from the Cortical plate, Intermediate Zone and the 
midbrain as indicated and the number of cells quantified . The Mean +/- 
SEM of the number of cells in comparable regions for 3 control and 3 
fbw7AN animals is shown in C),p(MB)=0.0101, p(,z)=0.0011,p(CP)=0.0032
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Figure 4.4 Increased apoptosis and elevated phospho-c-Jun levels
at E16 in fbw 7AN animals A) H&E stainings on sagittal cut E16.5 brains 
indicates that the cellularity is still preserved at this stage but that the 
number of pyknotic nuclei (arrows) is elevated. B) Phosphorylated c-Jun 
levels in the developing mouse brain. E16 cereberal cortices of indicated 
mice were stained for phospho-c-Jun S 73 and a composite image 
taken.High phospho-c-Jun levels are present in the ventricular zone 
(Arrow) Picture in B courtesy of Gennadij Raivich, Department of Perinatal 
Brain repair, UCL, London
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4.3 Discussion
In 2004 Tetzlaff and Tsunematsu (M. T. Tetzlaff et al., 2004; R. 
Tsunematsu et al., 2004) demonstrated that deletion of Fbw7 in the organism 
has detrimental effects and is incompatible with viability as fb w T ; embryos die 
in utero at E l0.5. By using the PGK-cre line, which leads to a ubiquitous 
deletion of Fbw7, I could recapitulate these results and confirmed that deletion 
of Fbw7 results in a null allele. Furthermore these data underline that due to its 
essential function in the organism, the only feasible approach to study the role 
of Fbw7 in vivo is the use of conditional knockout mice.
I used a Nestin-cre line to obtain mice where Fbw7 is deleted in cells of 
the neural lineage. Deletion of Fbw7 causes an increase in apoptosis and 
elevated phospho-cJun levels at E l6.5, which subsequently leads to a reduced 
cellularity at E l8.5. This demonstrates that Fbw7 is crucial during embryonic 
development for the survival of cells in the neural lineage. Interestingly, Fbw7 
is highly expressed in the developing cortex as detected by in situ hybridisation 
(Figure 3.8), while phospho-c-Jun levels are high in the ventricular zone 
(Figure 4.4). The inverse correlation of Fbw7 and phospho-c-Jun expression 
patterns suggests that Fbw7 could regulate c-Jun levels during brain 
development. One could envisage that in differentiated cortical neurons high 
levels of Fbw7 antagonise phospho-c-Jun levels. As neurons differentiate 
during development they migrate radially from the ventricular zone toward the 
pial surface of the cortex. If phospho-c-Jun levels were downregulated by Fbw7
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when cells exit the proliferative VZ and migrate towards the surface, Fbw7 
deletion could impair migration and/or differentiation and this could ultimately 
lead to the increase in apoptosis at E l6 inT&wZ^mice.
The fact that the Fbw7:c-Jun double knockout did not rescue the 
phenotype strongly suggests that elevated phospho-c-Jun levels alone are not 
the reason for the observed lethality. It is feasible to assume that Fbw7 might be 
required to down regulate other substrates such as Notch or N-myc during this 
period of embryonic development. Notch signalling is involved in maintaining 
cells in a progenitor state during neuronal development and the regulation of 
Notch levels by Fbw7 during nervous system development could explain the 
differentiation defects that Jorg has observed in fb w 7 ^  neurospheres (reviewed 
in (A. Louvi and S. Artavanis-Tsakonas, 2006)). After 11 days of culture in 
differentiation medium the morphology of Jbw 7^  Tuj-1 positive neurons and 
04  positive oligodendrocytes was severely impaired while the morphology of 
GFAP positive cells (astrocytes and progenitors) was normal (Jorg Hoeck, 
personal communication). This is in line with the fact that Notch signalling 
promotes the astrocyte lineage decision and that therefore Fbw7 deficiency 
might not affect cells of this lineage (W. Ge et al., 2002). Furthermore Notch 
signalling needs to be antagonised to allow differentiation of progenitors into 
neurons and oligodendrocytes (reviewed in (A. Louvi and S. Artavanis- 
Tsakonas, 2006)). It is therefore conceivable that Fbw7 deletion impairs Notch 
downregulation, leading to the observed phenotype. To test the hypothesis that 
Notch signalling is indeed the major mediator of the observed phenotype, one 
could differentiate fbw7AN neurospheres in the presence of Notch signalling
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inhibitors to see whether the differentiation defect can be rescued. Additionally, 
a similar role as for Notch in maintaining cells in a progenitor state was 
described for N-myc, another substrate of Fbw7 (P. S. Knoepfler et al., 2002) 
(M. Welcker et al., 2004a). It is therefore important to establish whether N-myc 
or Notch cause the observed phenotype. The reduced cellularity at E l8 and the 
increase in pyknotic nuclei show that cells die in the fb w 7 ^  brain. It will be 
essential to establish whether the remaining cells are cells that have not been 
deleted or whether these cells are deleted and follow a different lineage fate that 
is not affected by Fbw7 deletion. The use of lineage markers such as tuj-1, 
NeuN, 04  on brain sections of different embryonic developmental stages will 
help to investigate this phenotype further. The set up of an Fbw7-antibody 
staining for immunohistochemistry to identify deleted cells is also essential as 
this would allow the discrimination of Fbw7 expressing and non expressing 
neurons.
Taken together the data obtained from the fb w 7 ^  embryos and 
neurospheres demonstrate that Fbw7 plays a role not only in very early 
neuronal development as shown by Tetzlaff and Tsunematsu, but also at later 
stages in brain development. The non-redundant role of Fbw7 in the brain is 
emphasised by the fact that the selective Fbw7 deletion in the neuronal lineage 
is sufficient to causes perinatal lethality. In vitro cultures of neurospheres 
showed that Fbw7 is required for proper lineage decisions as Fbw7 deletion 
impairs neuronal and oligodendrocyte differentiation. Although the lethality 
cannot be rescued by concomitant c-Jun deletion, the nature of the 
differentiation defects indicates that a major substrate of Fbw7 during neuronal 
differentiation might be Notch.
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Having observed a severe phenotype upon deletion of Fbw7 in the 
neuronal lineage, I wanted to investigate whether Fbw7 plays a role in the adult 
nervous system as well. I therefore generated two further conditional Fbw7 
knockout lines with Fbw7 being deleted either in the cerebellar vermis 
(fbw7ACh) or in postmitotic neurons {fbw7^N).
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5 FBW7 DELETION IN THE CEREBELLUM 
LEADS TO A SMALLER VERMIS AND 
LOSS OF PURKINJE CELLS
To further investigate the role of Fbw7 in the nervous system I used the 
Engrailed-2-cre line and generated mice with a tissue specific deletion of Fbw7 
in the cerebellar vermis (Jbw7ACh). The Engrailed2-cre mouse line was 
generated by Zinyk et al. with the aim to map the fate of cells in the mouse 
midbrain-hindbrain constriction (D. L. Zinyk et al., 1998). Zinyk et al. 
generated transgenic mice that express ere from the En2 enhancer and 
determined the time window of Cre-recombinase expression from E9 to E l2. 
They crossed these animals with c-|3-STOP-lacZ reporter line and obtained 
mice where Engrailed2-cre activity causes the excision of a floxed STOP and 
thus permits lacZ expression. Since the Cre mediated excision is heritable, all 
cells derived from cells where Cre was expressed between E9 and E12 remain 
lacZ positive even after the Cre expression is switched off (D. L. Zinyk et al., 
1998). The analysis of lacZ positive cells showed that Purkinje cells and 
granule cells are affected by this deletion particularly in the medial part of the 
cerebellum, the vermis. Thus cells located in the dorsal midbrain-hindbrain 
constriction during Cre expression populate the medial cerebellum and although 
Purkinje cells and granule cells are not clonally related, there is a pool of 
precursors that specificially generate the medial domain of the cerebellum. This 
conclusion by Zinyk et. al supported a previous finding by Mathis et al. who
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also identified a pool of precursors specific for the generation of the cerebellar 
vermis (L. Mathis et al., 1997). The engrailed2-cre line was subsequently used 
for the conditional knockout of the Rb protein in the cerebellum (S. Marino et 
al., 2003). Marino et al confirmed the specific deletion in the cerebellar vermis 
by a deletion PCR on En2cre:Rblox/lox cerebella. For the deletion PCR cells were 
fractionated on a percoll gradient into one fraction containing larger cells such 
as astrocytes and Purkinje cells whilst the other fraction contained smaller cells 
such as granule cells and granule cell precursors and both fractions showed 
recombination (S. Marino et al., 2003) Additionally Marino et al performed a 
wholemount (3-galactosidase staining in En2cre:ROSA26loxP cerebella and 
presented a low resolution figure showning that (3-galactosidase expression 
extends throughout the cerebellar vermis. However a high-resolution image for 
the cerebellar vermis was not presented. Marino et al also used the engrailed-2 
cre line to analyse the conditional knockout of PTEN in the cerebellum and 
observed an enlargement of the cerebellar vermis (S. Marino et al., 2002). To 
re-analyse the affected cell population in the cerebellar vermis I obtained an 
En2-cre+:pter/Iox/+p53^lox/+: Rosa2(fox/+ cerebellum and performed a p- 
galactosidase stain on a coronal cryosection (see appendix). In agreement with 
the previously described data the p-galactosidase stain was restricted to the 
cerebellar vermis. Higher magnification images confirmed that not only the 
granule cells are affected but also cells residing in the molecular layer and 
Purkinje cells are lacZ positive ie. derived from the Cre deleted precursor pool 
(see appendix bottom panel).
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5.1 f b w 7 A ° b  mice have a smaller cerebellar vermis
fbw7ACb mice were bom with mendelian frequency and mutant animals 
were indistinguishable from their wt littermates (data not shown). The 
macroscopic examination of the cerebellum showed that the cerebellar vermis 
is smaller in knockout animals, whereas the lateral sides of the cerebellum did 
not display a visible phenotype (Figure 5.1 A). Heterozygous animals did not 
display any phenotype. H&E stainings on midline sagittal sections confirmed 
the size defect in the vermis and revealed that with regards to the cerebellar 
foliation, fbw7ACh animals do display additional fissures (arrows in Figure 
5.IB). Otherwise the cerebellum was formed normally and no gross 
morphological defects in the molecular layer or granule cell layer could be 
identified in either the H&E or NeuN stain (Figure 5.1C). To analyse the
A C 'hfbw7  animals further, I used a number of histological markers for the 
different subpopulations of cells within the cerebellum (listed in Table 5.1). 
The GFAP stain demonstrated that although the morphology of the cerebellum
A C 'his preserved in fbw7  animals, they display a strong gliosis (Figure 5.2A). 
Such a gliosis can occur as a reaction to neuronal dysfunction and degeneration 
(J. L. Ridet et al., 1997). It is conceivable to assume that based on the 
phenotype which I will describe in the following sections, this is the case.
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Table 5.1 Histological Marker for cerebellar analysis
Marker Population stained
NeuN Granule cells
Calbindin Purkinje cells
Parvalbumin Stellate, Basket, Purkinje cells
GFAP Bergmann glia
Neurofilament 200 (NF200) Basket cell axons
BrdU Proliferating cells after BrdU injection
Vglut2 Climbing fibre terminals
Vglutl Parallel fibre terminals
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A Control fbw7ACb
Control
C Control fb w 7 ^ b
Figure 5.1 fbw7ACb animals have a smaller cerebellar vermis and 
foliation defects A) photographs of control and fbw7ACb brains. Arrows 
indicate the smaller cerebellar vermis and the foliation defects. B) H&E 
of midline sagittal brain sections of control and fbw7ACb animals confirming 
the smaller vermis and foliation defects. Arrows indicate the additional 
fissure observed in the mutants. High magnification pictures were taken 
from the region marked by a rectangle C) Normal morphology of the 
Molecular Layer and granule cell layer in fbw7ACb animals. ML: Molecular 
layer, PC: Purkinje cells, GC: granule cells
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5.2 Altered Neurofilament expression in f b w 7 A ° b  
mice
In order to investigate how the different cerebellar subpopulations are 
affected by the deletion of Fbw7, immunostainings were performed on midline 
sagittal and coronal sections using different histological markers (listed in table 
5.1).
To visualise the basket cell axonal arborisation the anti NF-H antibody 
(NF-200, Sigma N4142) was employed as over the last four decades antibodies 
directed against different neurofilament proteins have been used as a tool to 
study cerebellar development. Neurofllaments are intermediate filaments and 
together with microtubules, microtubule associated proteins (MAPs) and other 
proteins they are part of the neuronal cytoskeleton (reviewed in (P. Grant and 
H. C. Pant, 2000)). Neurofllaments consist of three different subunits of ca 70 
(NF-L), 160 (NF-M) and 200kDa (NF-H), which together form the 
neurofilament-triplet protein (A. Petzold, 2005). One of the first studies on the 
expression of neurofllaments in the brain was performed by Matus et al. and 
used an antiserum that was raised against isolated neurofllaments (A. I. Matus 
et al., 1979). Matus and colleagues observed an abundant staining in basket cell 
axons and small bundles of mossy fibre terminals without any staining in the 
cell bodies of the cerebellum. Electron microscopy showed enhanced 
neurofilament immunoreactivity in close proximity to Purkinje cells in the so- 
called basket or “pinceaus” of basket cells but no staining of Purkinje cells,
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glial or granule cells (A. I. Matus et al., 1979). Julien and Mushinsky 
demonstrated in 1982 that neurofllaments can be phosphorylated (J. P. Julien 
and W. E. Mushynski, 1982) and Sternberg and Sternberg investigated whether 
phosphorylation also affects the recognition of neurofllaments in tissue sections 
and preparations (L. A. Stemberger and N. H. Stemberger, 1983). After testing 
different antibodies by western blotting on cytoskeletal preparations and 
immunohistochemistry on cerebellar sections that were either untreated or 
phosphatase treated, the authors concluded that some cell bodies and dendrites 
as well as some proximal axons contain non-phosphorylated neurofllaments 
whereas long fibres and terminal axons contain phosphorylated neurofllaments 
(L. A. Stemberger and N. H. Stemberger, 1983). Thus by 1983 it was 
established that neurofllaments are composed of distinct polypeptide subunits 
and that their phosphorylation influences the recognition of the antibody 
epitopes. This then led to a number of studies where new antibodies against 
neurofllaments were generated, characterised and compared to earlier 
publications. One of these studies which used an antibody against the NF-H 
polypeptide and studied the neurofilament expression in the rat cerebellum 
confirmed the observation of Matus et al. of a strong stain in basket cell axons 
and the absence of any immunoreactivity in cell bodies or perisomatic 
processes (N. Leclerc et al., 1985). Leclerc furthermore observed that the NF-H 
immunoreactivity becomes apparent at P12 in basket cell axons i.e. only after 
basket cells are terminally differentiated, which occurs between P6 and P10 in 
the rat (N. Leclerc et al., 1985). Another study compared antibodies against the 
different sized neurofilament subunits and also analysed them with regards to 
their phosphorylation specificity(M. Vitadello and S. Denis-Donini, 1990). This
160
Chapter 5
study showed that the basket cell axonal staining observed by Matus and 
Leclerc is present upon the use of antibodies against the phosphorylated heavy 
neurofilament polypeptide whilst antibodies against NF-M and NF-L 
polypeptides additionally label parallel fibres (M. Vitadello and S. Denis- 
Donini, 1990). NF-L and NF-M are also expressed earlier, at P6 in the mouse 
cerebellum, than NF-H where immunoreactivity was absent again confirming 
the data obtained by Leclerc et al. in the rat cerebellum. A comparative study 
on the cat cerebellum by Riederer et al. summarised the data for different 
antibodies by presenting a series of sections stained at different developmental 
timepoints with various phospho-specific antibodies against either NF-H or NF- 
M (B. M. Riederer et al., 1996). This work confirmed that a phospho-specific 
NF-H antibody stains basket cell axons and pinceaus but not Purkinje cells. The 
antibody used in this thesis (Sigma, N4142) has been previously compared to 
the phospho-specific NF-H antibody NE-14 (characterised in (B. M. Riederer et 
al., 1996)) and gave a comparable staining pattern (J. Paysan et al., 2000). It has 
also has been used to visualise basket cell axons by immunohistochemistry (J. 
M. Huard et al., 1999). Furthermore this antibody has been employed in 
cerebellar cultures to distinguish axons from dendrites by using a co-stain with 
the SMB2 antibody that does recognise the non-phosphorylated form of the 
NF-H fragment thereby also stains dendrites (H. Marzban and R. Hawkes, 
2007).
Using the anti NF-200 (Sigma, N4142) antibody on midline sagittal and 
coronal sections I observed that in wt animals the neurofilament staining is 
present in a regular, organised pattern in the lower half of the molecular layer 
where the basket cells reside (Figure 5.2B). In agreement with published data
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the basket-like structures around the Purkinje cells, pinceaus, also display a
AC'hstrong immunoreactivity. In fbw7  animals the regular staining pattern is lost 
and the Neurofilament stain extends all through the molecular layer (Figure 
5.2B). The baskets around Purkinje cells are still formed but display a stronger 
Neurofilament immunoreactivity that in wt controls and additionally a punctate 
pattern can be observed in coronal sections of fbw7ACb animals (Figure 5.2C 
arrows). To investigate whether c-Jun plays a role in the observed altered 
Neurofilament expression, fbw7ACb :c-junACb double knockout animals were
a /~*l  i i f ’A  a
generated and analysed. Like the fbw7  animals, fbw7 \c-jun mice were 
bom with mendelian frequency and did not show a behavioural phenotype (data 
not shown). Interestingly, the Normal Neurofilament expression was restored 
upon concomitant deletion of c-Jun (Figure 5.2C compare right with left panel), 
demonstrating that the alterations in the Neurofilament expression occur in a c- 
Jun dependent manner. To investigate whether the increased Neurofilament 
expression is caused by an increase in the number of cells residing in the 
molecular layer such as stellate and basket cells, I quantified those cells using 
parvalbumin as a marker (Figure 5.3). I counted the parvalbumin positive cells 
within two adjacent molecular layers in equivalent sections from wt and
AC'hfbw7 animals. Parvalbumin positive Purkinje cells, which are bigger and lie 
at the interface between the molecular layer and granule cell layer, were not 
counted. Additionally I measured the thickness of the molecular layers to 
address the question whether the reduced cerebellar size is due to a reduced 
molecular layer thickness. No significant difference in the number of 
parvalbumin positive cells or in the molecular layer thickness could be
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observed (Figure 5.3B and C). This strongly suggests that the aberrant 
Neurofilament stain is not caused by alterations in cell number in the molecular 
layer, but is rather a defect in the arborisation of basket cells.
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Figure 5.2 Aberrant Neurofilament expression and gliosis in the 
molecular layer of fbw7ACb animals . A) Sagittal sections from control 
and fbw7ACb cerebella. Knockout animals have a strong gliosis shown 
by the intensive GFAP stain in the M olecular Layer (ML). B) 
Neurofilament200 (NF200) expression in basket cell axons extends 
through the Molecular Layer and around Purkinje cells (PC) and is less 
organised and more intense in fbw7ACb animals. C) Coronal sections of 
Fbw7 single mutant and Fbw7:c-Jun double Mutant cerebella stained 
with NF200. Top panelThe misorganisation of the cerebellar vermis is 
partially rescued upon concomitant c-Jun deletion. Bottom panel: The 
NF200 stain shows a punctate pattern (arrows) and is stronger in fbw7ACb 
animals. NF200 expression is rescued upon concomitant c-Jun deletion 
(right image).
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Figure 5.3 Thickness and cell number in the molecular layer are not 
altered in fb w 7 ACb and fb w 7 ACb:c-ju n ACb animals. A) Parvalbumin 
(PA) stained Molecular Layer in control, fbw7ACb and fbw7ACb:c-junACb 
animals. PA positive (PA+) cells were counted and the area of the 
Molecular Layer (ML) measured in this section. B) Quantification of 
Parvalbumin positive cells per square micrometer of ML shows no 
difference in the number of PA+ cells C)The thickness of the Molecular 
layer in control and mutant animals is similar. Mean +/- SEM shown
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5.3 Phospho c-Jun dependent loss of Purkinje 
cells in f b w 7 AC b mice
AC'hAs described above, fbw7  animals have a normal granule cell layer 
(Figure 5.1) and there is no difference in the number of parvalbumin positive 
stellate and basket cells. However, when analysing calbindin positive Purkinje 
cells, I observed a reduction in Purkinje cell number in fbw7ACh animals. To 
quantify this reduction, I counted the Purkinje cells in midline sagittal sections
AC'hfrom 7-month-old wt and fbw7 animals and measured the length of the 
Purkinje cell layer in the same section. I obtained the Purkinje cell density by 
calculating the ratio between Purkinje cell number and length of Purkinje cell 
layer (cell number/layer length) (Figure 5.4). Statistical analysis of these data 
showed a strong reduction in Purkinje cell number and density in Fbw7 
knockout animals (Figures 5.4D and E). The loss of Purkinje cells has been 
correlated to ataxia for instance in mouse mutants such as lurcher and staggerer 
(see chapter 1.4.3.1). Furthermore mice that show a progressive loss of Purkinje 
cells, such as mice overexpressing the truncated Prp protein in Purkinje cells, 
become ataxic as the Purkinje cells degenerate (E. Flechsig et al., 2003). 
Therefore I wanted to establish whether the reduction in Purkinje cell number 
and density is the result of a progressive loss of Purkinje cells. I performed the 
same quantification in younger animals and additionally fbw7ACh:c-junACh 
double conditional knockout animals were analysed to establish whether the 
Purkinje cell reduction is c-Jun dependent. The loss of Purkinje cells in Jbw7ACh
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animals is not progressive as in 2-month-old animals the Purkinje number and 
density were reduced to the same extent as in 7-month-old animals (compare 
fbw7ACb values in Figure 5.4 and Figure 5.5) suggesting that either the Purkinje 
cells are lost before this time point, or that there are less Purkinje cells present 
to begin with.
When comparing the double conditional knockouts I observed that the 
concomitant deletion of Fbw7 and c-Jun was not able to rescue the foliation
aC'Kdefects observed in the fbw7  cerebella (Figure 5.5A, arrows) although the 
size defect observed in fbw7ACb cerebella was partially rescued (Figure 5.5B). 
Interestingly the Purkinje cell density was fully restored in Jbw7ACt>:c-junACb 
cerebella, indicating that the loss of Purkinje cells is c-Jun dependent (Figure 
5.5E). According to the working hypothesis deletion of Fbw7 causes elevated 
phospho-c-Jun levels, which could then lead to apoptosis and finally a 
reduction in Purkinje cells.
To address whether the loss of Purkinje cells is phospho-c-Jun 
dependent, I crossed jbw7ACh:c-junACb mice with fbw7f/^ :junAA/AA animals to 
obtain fbw7ACb:c-junACb/AA mice. In addition to Fbw7, c-Jun is deleted on one 
allele and its N-terminal S63/S73 phosphorylation sites are mutated on the 
other, therefore the absence of Fbw7 can no longer lead to the accumulation of 
N-terminally phosphorylated c-Jun (A. Behrens et al., 1999). The quantification 
of Purkinje cell parameters demonstrated that the Purkinje cell density is 
rescued to the same degree as in fbw7ACb\c-junACb cerebella and thus proves the 
hypothesis that the reduction in the Purkinje cell density is phospho-c-Jun 
dependent (Figure 5.6). However, the cerebellar area and foliation were still
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altered, confirming the data from the Jbw7ACh:c-junACh cerebella which indicated 
that the cerebellar size and foliation defects are not solely c-jun dependent.
Purkinje cells are the cerebellar output neurons and receive their 
excitatory input from climbing fibres and parallel fibres and it has been 
demonstrated that Purkinje cell require synaptic input for the later stages of 
dentritogenesis ie the formation of their fine dendritic network (C. A. Baptista 
et al., 1994). Furthermore it has been shown that in the pcd mutants Purkinje 
cells degenerate during the early postnatal development presumably because 
they display disruptions in the synaptogenesis between the parallel fibres and 
the dendritic spines (S. C. Landis and R. J. Mullen, 1978). Therefore to 
investigate the Purkinje cell reduction further, the analysis was extended to the 
use of immunofluorescence of Purkinje cells and synaptic markers such as 
Vglutl and Vglut2, which can be used to visualised parallel and climbing fibre 
synapses in the Molecular layer. Additionally, cerebella from 7-day-old animals 
were analysed as this is the time when the granule cells differentiate, and the 
Purkinje cells align in their respective plane between the Molecular layer and 
the granule cell layers and the expansion and formation of the cerebellar 
fissures takes place.
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Figure 5.4 Loss of Purkinje cells in 7 month old fbw7ACb animals. 
A) Calbindin stain on adult cerebella for Purkinje cells The loss of Purkinje 
cells is apparent. B-D: Quantification of cerbellar parameters. B) The 
cerebellar area is reduced in fbw7ACb animals (p=0.0463) C)Length of 
Purkinje cell layer in pm. (p=0.1015) D) The number of Purkinje cells per 
cerebellum is reduced in fbw7ACb animals (p=0.0171) E) To obtain the 
Purkinje cell density the ratio of D) over C) was calculated.The Purkinje 
cell density is reduced in fbw7^Cb animals (p=0.0196) Controls: n=3, 
Mutants: n=3, Age 7 month, Mean+/-SD are shown
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Figure 5.5 Loss of Purkinje cells in fbw7ACb animals is c-Jun 
dependent. A) H&E and Calbindin stain of Control, fbw7ACb and fbw7ACb:c- 
junACb animals shows that the foliation defect is not rescued (arrows) 
B)-E) Quantification of cerebellar parameters B) The rescue in cerebellar 
sizeupon concomitant c-Jun deletion ip only partial C) The lenght of the 
Purkinje cell layer is similar in fbw7ACb and fbw7ACb:c-junACb animals. 
D) The Purkinje number is partially rescued upon concomitant c-Jun 
deletion. E) Rescue of Purkinje cell density in fbw7ACb:c-junACb animals. 
Deletion of c-Jun in the cerebellum did not result in any significantly 
altered cerebellar parameters and is ftherefore not indicated in the graphs 
Control: n=11, fbw7ACb: n=5, fbw7ACb:c-junACb n=8, c-junACb n=3, Age: 
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Figure 5.6 The loss of Purkinie cells is phospho-c-Jun dependent
Purkinje cell analysis in fbw 7ACb:c-junAA/ACb animals. A) H&E and 
Calbindin stain on adult cerebella of control and fbw 7ACb :c-junAA/ACb 
animals. B-D: Quantification of cerbellar parameters. B) The cerebellum 
is smaller than in controls, p=0.0138 C) The length of the Purkinje cell 
layer is not significantly altered, p=0.0813 D) The Number of Purkinje 
cells per cerebellum is reduced,p=0.0141 E) Purkinje cell density obtained 
by dividing Purkinje cell number bv Purkinje cell layer length, p=0.03429. 
Controls:r\=4, fbw7ACb:c-junAA/AC°:r\=4, Age: 4 Month, Mean+/-SD shown
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5.4 Altered Purkinje cell dendrite morphology and 
Valut 1 and Vqlut 2 expression In f b w 7 ACb  
cerebella
Af~*hSince fbw7  animals display a reduced Purkinje cell density, I was 
interested in addressing the question to what extent the loss of Fbw7 affects the 
molecular layer and the parallel and climbing fibres, which provide the synaptic 
input for Purkinje cells. I therefore analysed the climbing fibre terminals and 
parallel fibre terminals using antibodies against the vesicular glutamate 
transporter 1 (Vglutl) and vesicular glutamate transporter 2 (Vglut2). Vglutl is 
present in parallel fibres, which arise from granule cells. Vglut2 is present in 
climbing fibres, which originate from the inferior olive and by fluorescently co- 
staining calbindin positive Purkinje cells and the respective fibres, one can 
visualise the synapse formation between them (R. T. Fremeau, Jr. et al., 2001; 
R. T. Fremeau, Jr. et al., 2004). The fluorescent staining of Purkinje cells 
additionally allows a more detailed analysis of their dendritic morphology than 
the non-fluorescent immunohistochemistry.
Wt Purkinje cells extend their dendrites all through the molecular layer 
whereby the branching is increasingly refined towards the pial surface. In
aC'Kcontrast fbw7 cerebella display a reduced punctate pattern of climbing fibre
terminals and the arborisation of Purkinje cells is strongly reduced (Figure 5.7B
A{~*harrows). In fbw7  cerebella the dendrites do not branch to the same degree as 
in wt Purkinje cells and no organised increase in higher degree branches
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A C 'h  A C 'htowards the surface can be observed. In fbw7 :c-jun cerebella the Purkinje 
cell morphology is only partially rescued with Purkinje cells displaying more 
dendrites that in fbw7ACb animals but there is still an obvious lack of the 
organised refined arborisation that is observed in wt cerebella.
Vglut2 positive climbing fibre terminals are visible as green spots along 
the red calbindin stained Purkinje cell dendrites in wt cerebellar sagittal 
sections (Figure 5.7A white arrows). Parallel to the lack of fine dendrites there 
appear also less Vglut2 positive dots in the molecular layer, however a definite 
conclusion about this cannot be made as neither the arborisation or the number 
of Vglut2 positive dots/dendrite was quantified. Also in fbw7ACb :c-junACb 
cerebella (Figure 5.7B, right) the Vglut2 staining in respect to the present 
dendrites has to be quantified with regards to any possible rescue.
Within the cerebellum the parallel fibres form the only excitatory 
synapse on Purkinje cells dendrites. Originating from the granule cells, the 
parallel fibres extend along the cerebellar lobe and thus are able to make 
contact with a number of Purkinje cells. When comparing the staining pattern 
for parallel fibre terminals, using a co-stain for Vglutl and Calbindin, cerebella 
from wt animals display a punctate Vglutl staining pattern, which is apparent 
throughout the molecular layer (Figure 5.8A). The widely spread punctae 
indicate that synapses are formed on fine Purkinje cells dendrites. In fbw7ACb 
animals this staining has almost disappeared and only the stronger foci at the 
bigger Purkinje cell dendrites remained (Figure 5.8B). In Jbw7ACh:c-junACb 
cerebella, again a partial rescue of the fbw7ACh phenotype can be observed, with 
the punctate pattern being restored, but not to the full extent of the wt animal
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(Figure 5.8 compare B right panel with A). However, also for this staining 
quantification is needed to allow for a definite conclusion regarding the 
phenotype and the partial rescue of the phenotype (see also discussion).
Taken together the immunofluorescence has demonstrated that there are 
not only fewer Purkinje cells in jbw7ACb animals, but that their arborisation is 
also reduced and the dendrites appear to be less directional towards the surface. 
Furthermore the number of synapses of parallel and climbing fibres in the 
molecular layer could be reduced, although quantification is still missing. The 
above experiments do not clarify whether the observed Purkinje cell phenotype 
is due to the loss of Fbw7 in Purkinje cell or a secondary effect from Fbw7 
depletion in other cells such as granule cells (see also discussion chapter 5.7). 
However, the morphological defects of Purkinje cells as well as the Vglutl and 
Vglut2 staining appear to be partially rescued by concomitant c-Jun deletion, 
which would be consistent with the hypothesis that c-Jun is a substrate for 
Fbw7 in the nervous system.
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A Control
Calbindin/Vgiut2/Dapi
Figure 5.7 Impaired climbing fibre synapses in fbw7ACb animals. In
wt cerebella the climbing fibres, shown in green, synapse on shafts of 
Purkinje Cell dendrites (white arrows). Purkinje cell dendrites extend 
through the molecular layer and the fine arborisation increases towards 
the pial surface. B) As Purkinje cells are missing in fbw7ACb animals, the 
number of climbing fibre-Purkinje dendrite synapses is reduced. Purkinje 
cell dendrite arborisation is impaired in fbw 7ACbcerebella and no fine 
branching as in the wt is observed. In fbw7ACbc-junACb animals synapse 
formation is partially rescued. The Purkinje cell arborisation does not 
reach the same degree as in wt cerebella fbw 7ACbc-junACb cerebella.
A Control
Calbindin/ glut 1 /Dapi
Figure 5.8 Impaired parallel fibre synapses in fbw7ACb animals. A)
In wt cerebelli parallele fibres run along the folia and synapse on Purkinje 
cell dendrites which is visible as green dots which extend through the 
molecular layer (white arrows). B) The number of parallele fibres in the 
Molecular Layer as indicated by a green staining in the Molecular Layer 
is reduced in fbw7ACb animals. Again the impaired Purkinje cell morphology 
can be observed. In fbw7ACb:c-junACb animals the parallele fibre presence 
and synapse formation is partially rescued as also the Purkinje cell 
arborisation is partially rescued.
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5.5 The f b w 7 i C b  phenotype is already apparent at 
P07
To investigate the foliation and Purkinje cells defects further, I analysed
AC'hcerebella from 7-day-old fbw7  animals (P07) as this is the time where the 
cerebellar foliation is formed and cells migrate to their final position whilst at 
around PO the granule cell precursors are still present in the EGL some of these 
cells have already become postmitotic at P07 and some started their inwards 
migration, passing by the Purkinje cells, to finally form the granule cell layer 
(reviewed in (M. E. Hatten and N. Heintz, 1995) (M. E. Hatten et al., 1997)). At 
the end of this differentiation process, around P14-P21, the EGL has 
disappeared and the cerebellar foliation is established with the molecular layer 
and granule cell layer separated by a monolayer of Purkinje cells reviewed in 
(D. Goldowitz and K. Hamre, 1998) (R. V. Sillitoe and A. L. Joyner, 2007).
Analysis of midline sagittal cut fbw7ACb brains showed that at P07 the 
foliation defect and the gliosis that were observed in the adult animal are 
already present (Figure 5.9). The expression of NeuN starts when the precursor 
cells differentiate as they migrate inwards from the inner part of the EGL to 
form the granule cell layer (A. Sudarov and A. L. Joyner, 2007). In P07 fbw7ACh 
animals as in wt animals the NeuN expression pattern begins at the inner part of 
the EGL (Figure 5.9 and Figure 5.10A). The additional fissure in Jbw7ACb 
animals could be the result of a hyper-proliferation during the postnatal 
expansion of the cerebellum. Therefore to analyse the proliferation in the
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cerebellum, I injected P07 pups with BrdU and sacrificed the animals 2 hours 
post injection. I could find no difference in the BrdU positive cells outside the 
EGL at P07 suggesting that the migration is not altered at P07 in fbw7ACb 
animals (Figure 5.1 OB). As expected, the EGL is strongly labelled with BrdU 
(Figure 5.9 bottom panel), and it appears that there are slightly more BrdU 
positive cells in the EGL of Jbw7ACb animals. Since fbw7ACb animals display an 
additional fissure, which can be due to a hyperproliferation in the EGL, the 
number of BrdU positive cells in the EGL during the first weeks of postnatal 
development needs to be quantified (Figure 5.10). However, as at P07 the 
cerebellar foliation defect is already apparent, potential differences in the EGL 
proliferation might be more efficiently addressed at earlier time-points such as 
P03 to P05 when the secondary fissures are formed, (reviewed in (A. Sudarov 
and A. L. Joyner, 2007)).
In P07 fbw7ACb animals a reduction in Purkinje cell density is already 
apparent (Figure 5.11). The Purkinje cell morphology is also altered. Purkinje
A(~*hcells offbw7 animals have less dendrites and display a reduced arborisation 
pattern at P07 (Figure 5.12). In fbw7ACb:c-junACb P07 sections it was apparent 
that although the Purkinje cell number is rescued, the morphology of Purkinje
aCU
cells is only partially restored. Compared to Jbw7 P07 Purkinje cells, 
Purkinje cells of fbw7ACb:c-junACb mice have more dendrites, but full 
arborisation as seen in the wt cerebella is not recovered. The dendrites in 
fbw7ACb:c-junACb Purkinje cells are widened and show an intensive calbindin 
stain (Figure 5.12). Thus Fbw7 deletion impairs the maturation and arborisation
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of Purkinje cell in addition to playing a role during earlier Purkinje cell 
development, as the loss of Purkinje cells is already present at P07.
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Control fbw7ACb
Figure 5.9 Foliation defects and gliosis are present in P07 in fbw7ACb 
animals A) Histological analysis of control and fbw7ACb animals at P07. 
The additional fissure (arrows) and the gliosis indicated by the stron 
GFAP stain are already present. The NeuN stained granule cell layer is 
normal and has already formed. BrdU labelling for two hours shows a 
comparable labelling of the still proliferative EGL and comparable number 
of BrdU positive cells inside the cerebellum (For quantification see Figure
AControl fbw7ACb
BrdU+ cells outside the EGL
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Figure 5.10 Normal granule cells and no difference in BrdU+ cell 
inside the fbw7ACb P07 cerebella A)Midline sagittal sections of wt and 
fbw 7ACb P07 brains. Middle: The NeuN staining confirms that granule 
cell differentiation and migration is normal in fbw 7ACb animals. As cells 
leave the EGL and become postmitotic in the inner layer of the EGL, 
they start to express NeuN. Bottom: Proliferating cells were stained with 
BrdU for 2hours. No difference in the EGL thickness can be observed. 
B) Proliferation analysis of P07 brains following 2hrs after BrdU injection. 
BrdU positive cells outside the EGL were counted. No significant difference 
was observed. Mean +/- SEM shown, p=0.497: n.s.
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Figure 5.11 The Loss of Purkinje cells in fbw7ACb animals is present 
at P07. Purkinje cell parameters were determined as described previously 
in sagittal sections of 1 week old control and fbw7ACb animals A) There 
cerebellum is significantly smaller at P07, p=0.0103 B)Length of Purkinje 
cell layer, p=0.0019 C)The number of Purkinje cells per cerebellum is 
reduced, p=0.1143 D) The Purkinje cell density in knockout animals is 
reduced but not to the same extend as in adult animals, p=0.6704. 
Control:n=4,fibw7AC£,:n=4 Mean+/-SD shown
fbw7f/f:c-junm  fbw7ACb
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Figure 5.12 Concomitant c-Jun deletion partially rescues Purkinje 
cell arborisation defects in P07 fbw7ACb cerebella. The panel shows 
Calbindin stains on the indicated P07 cerebella.2 different area of the 
cerebellum were taken in A) and B) Purkinje cell arborisation in 
fbw7£Cbari\ma\s is severely impaired and partially restored in fbw7ACb:c- 
junACb animals (arrows). Purkinje cells from fbw7ACb :c-junACb do have 
more dendrites than fbw7ACb Purkinje cells, but they are less branched 
than in wt controls.The termini are wide and display a strong calbindin 
immunoreactivity.
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5.6 Proliferation defects in E18 f b w 7 ACb cerebella
To investigate whether there are any abnormalities in fbw7ACb cerebella 
before the foliation takes place, time mated pregnant females were i.p. injected 
with BrdU for two hours. Analysis of proliferating cells in E l8 fbw7ACb 
cerebella showed an aberrant migration pattern of BrdU positive cells in 
fbw7ACb cerebella (Figure 5.13). In wt animals the majority of BrdU positive 
cells are still residing in the EGL, start to migrate inwards to form the granule
aC'U
cell layer and a regular patterning is visible. The BrdU stain in fbw7  animals
in the inner part of the cerebellar primordium is more irregular (Figure 5.13, 
arrows). However, to assess the extent of the hyperproliferation, a 
quantification of BrdU positive cells in the EGL and inner part of the cerebellar 
primordium has still to be performed and further timepoints between E l8 and 
P07 have to be analysed. In E l8 cerebella the calbindin stain for Purkinje cells 
is less pronounced and appears more widely spread within the cerebellar
A(~*hprimordium offbw7  animals than in the wt control, where it is restricted to 
the future Purkinje cell layer (Figure 5.13 bottom panel). As described in the 
1.4.3.1 the fate of Purkinje cells is determined between E10 and E l3 which is 
also the time where the Cre recombinase is active (E8.5 -12.5) (D. L. Zinyk et 
al., 1998). Although expression of the Cre recombinase is switched off, cells 
derived from deleted progenitor cells, will be Fbw7 deleted at all subsequent 
developmental stages. To investigate whether the Cre activity has immediate 
effects at E l3, I analysed cerebella of E l3 fbw7ACb animals. The preliminary
184
Chapter 5
data suggest that the E13 cerebellar primordium is formed normally and no 
difference in Ki67 positive proliferating cells or c-Jun protein levels could be 
found (Figure 5.14A). The staining with a calbindin antibody for developing 
Purkinje cells is very weak in both cases, most likely due to the fact that 
Purkinje cells are just developing and does not allow conclusions about the 
number of Purkinje cells. Analysis of E16 BrdU labelled cerebella gave not 
indication of proliferation defects at this stage and in contrast to the altered 
proliferation at E l8, the number of BrdU labelled cells in E l6 cerebella 
appeared comparable (Figure 5.14B).
Taken together the data from the analysis of E13 to P07 fbw7ACb animals 
allow the conclusion that the effects of the Fbw7 knockout in the cerebellum 
appears between E l8 and P07 which is the time of extensive cell migration, 
expansion in cerebellar size and fissure formation.
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Figure 5.13 Aberrant proliferation in E18 fbw7ACb cerebella. Top: 
H&E (top), BrdU (middle) and Calbindin (bottom) stainings.The cerebellar 
foliation is not formed yet and there are no major differences in the gross 
appearence in the H&E stain of the cerebellar primordium. Middle: BrdU 
labelling (100ug/g bw. ip. 2hrs) shows a different proliferation pattern in 
fbw7AC° animals. More BrdU positive cells have migrated inwards (arrows) 
Bottom: The Calbindin stain is stronger and more evenly spread within 
the inner part below the EGL in control animals (arrows) than in mutants 
where it is weaker and more diffuse.
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Figure 5.14 No defects in the cerebellar primordium at E13 and E16
in fb w 7 ACb animals A) Cerebellar primordia of E13.5 embryos are 
comparable. Sagittal sections were stained with the antibodies indicated. 
Purkinje cell bodies cannot be detected with the Calbindin antibody at 
E13. Normal proliferation in the rhombic lip as indicated by Ki67 
immunoreactivity. c-Jun (H79) expression is ubiquitious and higher c- 
Jun levels are detected in the proliferating area of the rhombic lip B) 
E16.5 time mated females were injected with BrdU for two hours and 
pups were analysed. The cerebellar primordia are comparable in size 
and structure and no difference in BrdU labelling can be observed.
Chapter 5
5.7 Discussion
I have investigated the role of Fbw7 in the nervous system using a 
conditional knockout line where Fbw7 deletion is restricted to cells residing in 
the cerebellar vermis (see Appendix 1 and p. 151). The results obtained by RT- 
PCR (Figure 3.5) and in situ hybridisation (Figure 3.11) show that Fbw7 is 
expressed in the cerebellum and that Engrailed-2 cre mediated deletion of Fbw7 
takes place. Generally I observed that Fbw7 deletion caused a phenotype, which 
consisted of c-Jun dependent and c-Jun independent effects. Part of the c-Jun 
dependent phenotype is
1) The alteration in Purkinje cell density and morphology (5.7.1) and
2) The altered basket cell arborisation (5.7.2).
On the other hand there are aspects of the cerebellar phenotype in fbw7ACh mice 
that are c-Jun independent.:
3) The reduced cerebellar size (5.7.3) and
4) Additional fissures (5.7.4).
The in situ hybridisation detected fbw7  message in the granule cell 
layer, which is composed of granule cells, Golgi cells and mossy fibre 
terminals. Previous data from Nateri et al. demonstrated that in cultured cgcs 
Fbw7 message is present and that Fbw7 depletion by siRNA caused an increase 
in apoptosis suggesting that Fbw7 is indeed expressed in granule cells (A. S. 
Nateri et al., 2004). A detailed analysis regarding the Fbw7 protein levels and 
expression in different cerebellar populations has not been performed yet.
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However, this will be necessary to elucidate which cells express Fbw7 and thus 
contribute to the observed phenotype as for all points mentioned above the 
reason for the phenotype can either be direct due to the loss of Fbw7 expression 
in the respective cell type, or indirect due to secondary effects caused by Fbw7 
deletion elsewhere in the cerebellum. This is discussed in the following section.
5.7.1 Alterations in Purkinje cell density and morphology
Fbw7 deletion in the cerebellum results in a persistent 20% reduction in 
the Purkinje cell density in adult animals, which is rescued upon either 
concomitant deletion of c-Jun (Figure 5.5) or expression of a c-jun allele that 
cannot be phosphorylated (Figure 5.6). Therefore these data suggest that Fbw7 
mediated regulation of phospho-c-Jun is important for Purkinje cell 
development before P07. The Purkinje cell arborisation defect, on the other 
hand, is only partially rescued in the fbw7ACb :c-junACb and fbw7ACh:junAA 
animals which suggests that additionally other substrates of Fbw7 play a role in 
the fbw7  phenotype. Furthermore, from the experiments conducted in this 
thesis, it is not possible to conclude whether the observed reduction in Purkinje 
cells and their reduced arborisation are due to the loss of Fbw7 in them or due 
to a secondary effect from, for instance, the deletion of Fbw7 in granule cells, 
which have been shown to be important for Purkinje cell development. Both 
possibilities of a direct or indirect effect and the possible involvement of other 
substrates are discussed below (chapters 5.7.1.1 and 5.7.1.2 , chapter 5.7.4).
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5.7.1.1 Hypothesis I: The Purkinje cell defect is a secondary effect 
caused by Fbw7 deletion in other cerebellar cells
Jbw7 message was detected by in situ hybridisation in the granule cell 
layer, but no convincing hybridisation signal in the Purkinje cell monolayer at 
the outer part of the granule cells was observed (Figure 3.11). This suggests 
that Fbw7 levels might be absent or low in the adult Purkinje cells and argues 
in favour of the hypothesis that the loss of Purkinje cells is a secondary effect. 
Although Purkinje cells are generated early during cerebellar development they 
develop their dendritic tree during the first 2-3 postnatal weeks (reviewed in (J. 
P. Kapfhammer, 2004)). Briefly, Purkinje cells start to polarise shortly before 
birth and develop an axon and non-branched dendrite. During the first postnatal 
days Purkinje cells extend more processes from their cell body and assume an 
intermediate “stellate” morphology. At this time the first input that reaches 
these Purkinje cells are climbing fibres whilst parallel fibres are just starting to 
develop (reviewed in (J. P. Kapfhammer, 2004)). Following the first postnatal 
week the dendrites start to elongate and an extensive synaptogenesis between 
Purkinje cell dendrites and the parallel fibres takes place (J. Altman, 1972c, b). 
Another study by the same authors made use of X-irradiation to kill granule, 
stellate and basket cells in neonatal rats and this subsequently caused 
mislocalisation of Purkinje cells whose dendrites lost their pial orientation and 
extend in a random fashion (J. Altman and W. J. Anderson, 1972). Additionally 
Baptista et al. demonstrated that isolated Purkinje cells do develop dendritic 
arbours when co-cultured with granule cells but that in the absence of them or 
co-culture with cells that provide only inappropriate input, the arborisation is
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impaired and not as refined as under co-cultured conditions with granule cells 
(C. A. Baptista et al., 1994). Thus it has been shown that during early postnatal 
development Purkinje cells are dependent on appropriate afferent input from 
parallel fibres to form their characteristic dendritic tree. One could therefore 
envisage a model where Fbw7 deleted granule cells are not able to provide the 
required input and this subsequently leads to the observed defects in 
arborisation.
Another point supporting the hypothesis that the Purkinje cell defect is 
secondary to a granule cell phenotype is the reduced Vglutl staining in the 
fbw7ACh knockouts. Altman et al. have demonstrated in 1972 that the axons of 
granule cells, the parallel fibres, are formed before their cell bodies move 
inwards to form the IGL (J. Altman, 1972a). Furthermore Altmans studies 
describe that as Purkinje cells mature, parallel fibre-Purkinje cell synapses are 
not present on the smooth primary dendrite, but only on secondary and ternary 
dendrites and form first on dendritic spines in the lower part of the molecular 
layer and subsequently in the upper part (J. Altman, 1972c). As the number of 
secondary and ternary fine dendrites was strongly reduced in fbw 7ACb Purkinje 
cells, the reduced number of Vglutl positive dots that indicate parallel fibre- 
Purkinje cell synapses in the molecular layer could just reflect the above 
described possible defect of granule cells in providing an appropriate input for 
Purkinje cell dendrite maturation.
The observation that the Vglutl and Vglut2 stainings are only partially 
rescued upon concomitant deletion of Fbw7 and c-Jun (Figures 5.7 and 5.8) 
could be due to the fact that a potential granule cell defect is still present in 
fbw7ACb :c-junACb animals and especially the Purkinje cell dendrites are not as
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finely branched compared to wt animals at P07 (Figure 5.11). Nonetheless a 
partial rescue appears to take place with the Purkinje cell density being restored 
in the adult upon either deletion of c-Jun or expression of the junAA allele. The 
partial rescue of the phenotype where the foliation defect is not rescued in 
fbw7ACh:c-junACh animals but Purkinje cell density is rescued, furthermore 
indicates that other substrates mediate the phenotype. One particular substrate 
could be N-myc whose possible involvement is discussed in chapter 5.7.3.
The further analysis of the obtained fbw7ACb :c-junACh/AA cerebella by 
immunofluorescence with calbindin, Vglutl and Vglut2 antibodies will be 
valuable in investigating the effect of Fbw7 during the cerebellar development. 
In Drosophila, the AP-1 complex has been shown to regulate synaptic plasticity 
of neuromuscular junctions through activation of CREB (S. Sanyal et al.,
2002). Also in rats c-Jun and AP-1 have been implicated in memory formation, 
which is associated with formation of synapses (W. C. Abraham et al., 1993). 
Thus the generated cerebellar knockout lines could be a useful tool for the 
investigation of the role of c-Jun and phospho-c-Jun during synapse formation 
between parallel fibres and Purkinje cell dendrites. Purkinje cells and climbing 
and terminal fibre synapses can be labelled with the mentioned antibodies and 
one could therefore investigate the initial stages of the synapse formation in 
sections of cerebella from animals between P0 and P14 or culture cerebellar 
slices.
To test the hypothesis that granule cells are affected by the Fbw7 
deletion in the cerebellum and loose their ability to promote Purkinje cell 
maturation it is essential to analyse the expression of Fbw7 during the 
cerebellar development and to determine whether Fbw7 is expressed in the
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granule cell precursors and is required for their parallel fibre formation. The in 
situ hybridisation data obtained from the E l8 Jbw 7^  cerebellar primordium 
(Figure 3.8) do not allow a conclusion regarding the Fbw7 expression in 
distinct cerebellar populations in the cerebellar anlage. This could be either 
achieved by antibody stainings if in the future there are antibodies that can 
detect the endogenous protein, or by non-radioactive in situ hybridisation where 
cells of the cerebellar primordium can be additionally macroscopically 
characterised. A fractionation of cerebellar cells as performed by Marino et al 
could also be useful in distinguishing which cellular population is recombined 
successfully in the cerebellum and also expresses the Fbw7 protein. However, 
the latter would be dependent on a functional Fbw7 antibody (S. Marino et al.,
2003).
To address whether the observed Purkinje cell defect is secondary to a 
granule cell defect one could also employ a granule cell specific conditional 
knockout line. Two groups have generated Cre transgenic lines in which the 
transcription o f an activatable form of the Cre recombinase (CreER™ activated 
by tamoxifen and CrePR activated by antiprogestins) is either placed under the 
granule cell specific Mathl enhancer (L. M. Chow et al., 2006) or is expressed 
under the granule cell specific GluRe3 promotor (M. Tsujita et al., 1999). These 
lines could be useful to investigate to what extent granule cells cause the 
Purkinje cell defect. If the Purkinje cell defects were a consequence of Fbw7 
deletion in granule cells, one would predict that deletion of Fbw7 in granule 
cells alone causes the same Purkinje cell phenotype as observed in the Jbw7ACh 
mice.
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5.7.1.2 Hypothesis II: Purkinje cells require Fbw7 during development 
and the observed defect is the result of Fbw7 deletion in 
precursors
If the observed defect were caused directly by the loss of Fbw7 in the 
cerebellar Purkinje cell precursors one could speculate that Purkinje cells are 
particularly sensitive to elevated phospho-c-Jun levels during embryonic 
development and therefore require Fbw7 activity (see Model in Figure 5.15). 
As there is no progressive loss of Purkinje cells after birth in Jbw7ACb cerebella, 
one can further hypothesise that mature Purkinje cells do not express c-Jun and 
thus no regulation is required, possibly because they do not utilise an active 
JNK pathway. Alternatively Purkinje cells could be able to adapt and to tolerate 
increased phospho-c-Jun levels or that the JNK c-Jun pathway is controlled in 
an Fbw7 independent way.
Concerning the absence of the JNK-c-Jun pathway and c-Jun levels in 
the adult brain, a number of studies have demonstrated that in mature Purkinje 
cells c-Jun protein and message levels are below a detectable level, indicating 
that c-Jun is not employed during mature Purkinje cell function (T. Herdegen et 
al., 1995; M. Zagrebelsky et al., 1998; D. Carulli et al., 2002). Furthermore the 
JNK pathway does not appear to be active in mature Purkinje cells, as in mice 
overexpressing c-Jun under the Purkinje cell specific L7 promoter did not alter 
Purkinje cell arborisation, density or morphology. More importantly this did not 
result in elevated levels of phosphorylated c-Jun or an increase in Purkinje cell 
apoptosis (D. Carulli et al., 2002). As c-Jun phosphorylation is not induced in 
mature Purkinje cells, deletion of Fbw7 will most likely have no effect. The
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inactivity of the JNK pathway is therefore a possible explanation why there is 
no progressive loss of Purkinje cell in the adult.
The fact that proteins of the JNK signalling cascade such as MKK4, 
JIP-1 and JIP-3 are expressed in mature Purkinje cells, nevertheless indicates 
that this signalling cascade has been used at some point in their life, possibly 
during development (J. K. Lee et al., 1999; J. B. Pellet et al., 2000; E. Miura et 
al., 2006). It is therefore feasible to assume that the loss of Purkinje cells during 
development can be caused by elevated phospho-c-Jun levels. Regarding the 
analysis of c-Jun during Purkinje cell development stainings with phospho-c- 
Jun specific antibodies have to be performed. Interestingly, in cerebellar slices 
derived from P09 c-Jun transgenic cerebella, Purkinje cell survival was 
reduced, implying that the JNK cascade and subsequently phospho-c-Jun levels 
can be activated under stress conditions, such as the in vitro culture, and 
mediate Purkinje cell death (D. Carulli et al., 2002). Therefore one could 
culture cerebellar slices obtained from fbw7ACh animals and predict that 
Purkinje cells would die in a similar manner as in slices from c-Jun transgenic 
animals, since the stress implied by the culture conditions appears to be 
sufficient to activate the JNK-Jun pathway.
Purkinje cells from fbw7ACb animals display an altered morphology by 
P07 and the number of dendrites is greatly reduced (Figure 5.7). The altered 
Purkinje cell morphology could also affect the formation of synapses within the 
cerebellum such that fewer Purkinje cell-parallel fibre and Purkinje cells- 
climbing fibre synapses are present in fbw7ACb animals (Figure 5.7 and 5.8). To 
test whether this hypothesis is valid one could cross floxed fbw7 mice to 
animals that express the Cre-recombinase under the Purkinje cell specific L7
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promoter (J. Oberdick et al., 1990). If the defect were caused by loss of Fbw7 
in Purkinje cells, these animals should recapitulate the observed Purkinje cell 
phenotype.
5.7.2 Altered basket cell arborisation
In addition to the loss of Purkinje cells, the basket cell arborisation is 
altered in fbw7ACb animals and could be rescued upon concomitant deletion of 
c-Jun (Figure 5.2). Although I did not quantify apoptosis by TUNEL staining in 
the ML, I did not find any difference in the number of parvalbumin stained 
basket and stellate cells (Figure 5.3) and therefore conclude that loss of Fbw7 
does not lead to apoptosis in these cells but rather to an aberrant morphology of 
their axons. Interestingly the Neurofilament200 expressing basket cells and the 
stellate cells are derived from the same germinal layer, the ventricular zone, as 
the Purkinje cells. All three cell types belong to the class of GABA-ergic so it 
could also be possible, that loss of Fbw7 specifically affects neurons that use 
GAB A as a neurotransmitter and are derived from the ventricular zone. To 
address this hypothesis, one could for instance perform in situ hybridisation on 
E l3 and earlier cerebella. If Fbw7 were crucial in the ventricular zone, this 
would then lead to the prediction that also stellate cells should also display an 
altered morphology in the Fbw7 knockout. Whilst basket cells were 
investigated using a Neurofilament200 antibody, no detailed analysis of stellate 
cells was performed so far.
Basket cells inhibit Purkinje cells by means of their basket like synapses 
on the Purkinje cell somata but are at the same time connected to the parallel 
fibres which in the rat start to synapse on basket cells around postnatal day 8,
196
Chapter 5
(J. Altman and A. T. Winfree, 1977) (reviewed in (R. V. Sillitoe and A. L. 
Joyner, 2007)). Therefore the possibility that the altered basket cell axonal 
arborisation is due to defects in the parallel fibres or their development is also 
given. Experiments as outlined under 5.7.1.1 will help to clarify this question as 
well. Similar to the Purkinje cells one would expect a recapitulation of the 
phenotype upon a granule cell specific deletion of Fbw7 if the basket cell 
arborisation were impaired as a secondary effect.
5.7.3 Reduced cerebellar size
All Fbw7 cerebellar knockout mice investigated in this study have a 
smaller cerebellar vermis, indicating that this is a c-Jun independent effect of 
the Fbw7 deletion. This phenotype can be caused by either less cells being 
present, or by an increase in apoptosis. Nateri et al. demonstrated that in wt 
cgcs siRNA mediated Fbw7 depletion causes an increase in apoptosis and if 
this occurred in vivo in granule cells, this could explain the smaller cerebellum 
(A. S. Nateri et al., 2004). Alternatively apoptosis could also occur at the early 
progenitor was described for the Engrailed-2 mediated conditional knockout of 
Notch-1 where mice also display a smaller cerebellum and a reduction in 
Purkinje cell density due to the loss of early precursor cells (S. Lutolf et al., 
2002). The same study elucidated that in case of the Notch-1 cerebellar 
knockout the level of apoptosis in different progenitor populations peaks at 
E l2, a day earlier than the time points I have investigated in the Fbw7 
conditional knockout so far. Therefore the careful analysis of apoptosis in the 
granule cell layer by TUNEL assays at different timepoints during embryonic 
and postnatal development is mandatory to clarify whether apoptosis of granule
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cell precursors or mature granule cells causes the smaller cerebellar vermis in 
fi>w7ACb animals. Mathl, the earliest known marker for granule cells together 
with TUNEL staining on time mated embryos could provide essential insights 
of whether the defect in fbw7  animals is similar to the one observed in the 
Notch-1 cerebellar knockout and deletion of Fbw7 causes a depletion at the 
cerebellar precursor cell stage (F. Guillemot and A. L. Joyner, 1993; N. Ben- 
Arie et al., 1997).
5.7.4 Additional fissures
The fbw7ACb animals display additional fissures in the cerebellum (Fig
5.1) that is already present at P07 (Fig. 5.9), however, the overall structure of 
the cerebellar layers and shape is preserved. The formation of the cerebellar 
lobes occurs in distinct phases whereby first the so-called four cardinal lobes 
are formed at around E l7.5 in mice and the other finer fissures develop 
postnatally (reviewed in (R. V. Sillitoe and A. L. Joyner, 2007)). Work by 
Corrales et al has shown that the fissure formation depends directly on the 
levels of Shh signalling and that increased Shh signalling produces a more 
complex foliation (J. D. Corrales et al., 2006) whilst the loss of Shh activity 
causes a reduced foliation (P. M. Lewis et al., 2004). Shh is secreted by 
Purkinje cells during normal cerebellar development and induces proliferation 
in granule cell (V. A. Wallace, 1999; P. S. Knoepfler et al., 2002; A. M. 
Kenney et al., 2003). N-myc is a crucial mediator of Shh-signalling and is 
expressed in granule cell precursors where it is essential for proliferation (B. A. 
Hatton et al., 2006) (T. G. Oliver et al., 2003). Welcker and colleagues found 
that N-myc is also a substrate of Fbw7 and as the phospho-degron of c-Myc is
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conserved in N-myc, it is possible that Fbw7 also regulates N-myc (Figure 
5.16A)(M. Welcker et al., 2004a). Since the cerebellar foliation defects cannot 
be rescued by concomitant c-Jun deletion, this indicates that in addition to c- 
Jun other substrates that promote granule cell proliferation participate in the 
phenotype of the fbw7  animals. The hypothesis that granule cell precursors 
hyperproliferate is supported not only by the additional fissure but also the 
enhanced BrdU immunoreactivity at E l8 in the cerebellar primordium, which 
however still has to be quantified (Figure 5.14). If N-myc were a substrate of 
Fbw7 in the EGL, this could explain such a hyperproliferation of granule cells. 
If Fbw7 could not degrade N-myc, one would expect an increase in
, / - » L
proliferation, as observed at E l8 in fbw7  animals, which could ultimately 
lead to the generation of an additional cerebellar fissure (see model in Figure 
5.16B). The notion that there are more BrdU labelled cells in the EGL of P07 
BrdU injected Jbw7ACb animals does indicate that more proliferation takes place, 
and it is essential to quantify this in order to identify the precise timing of the 
hyperproliferation (Figure 5.10). The data from the Purkinje cell analysis also 
imply that cells of the granule cell layer proliferate more in the fbw7ACb animals 
than in wt animals. Whilst the Purkinje number is reduced to the same extent in 
P07 mice as in adult animals, the density is not. This indicates that the Purkinje 
cell layer length increases after P07 so that in the adult the Purkinje cell density 
is reduced in fbw7ACb vs. control cerebella. Since the Purkinje cell layer length 
is measured as the perimeter of the whole Purkinje cell layer, this furthermore 
predicts, that there must be more granule cells present.
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The hypothesis that N-myc is a substrate of Fbw7 in the cerebellum is 
based on the assumption that Fbw7 is not only expressed in mature granule 
cells (Figure 5.9) but also in granule cell precursors. Experiments that can be 
done to investigate this include in situ hybridisation for Fbw7 on E l8 cerebella 
when the EGL is still present as well as immunohistochemistry and western 
blotting experiments for N-myc to assess whether N-myc accumulates in the 
Jbw7ACh and Fbw7:c-Jun double mutants. The finding that Fbw7 is suppressed 
in gliomas, and that downregulation of Fbw7 inversely correlated with an 
increase in N-myc levels, further supports the hypothesis that N-myc could be 
one major substrate of Fbw7 during cerebellar development (M. Hagedom et 
al., 2007) (M. Bredel et al., 2005) In addition to the aforementioned stainings, 
another approach to investigate the Fbw7 deleted neurons in knockout mice 
would be to use GFP-reporter mice where Fbw7 deleted cells can be identified 
by their GFP expression. This cross would allow the tracing of Fbw7 depleted 
neurons in the cerebellum. This could also give insights whether Fbw7 
expression can be correlated with certain classes of neurons such as GABA- 
ergic or neurons or to what extent Fbw7 deleted neurons die during 
development.
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Figure 5.15 Model for Fbw7 mediated phospho-c-Jun regulation 
during cerebellar development Protein levels are indicated as ++ if 
present and -- if they are absent due to the knockout or successfully 
downregulated. Data obtained are summarised in this table. Left panel: 
As development from progenitor cells (purple) to mature Purkinje cells 
(red) and Basket cells (brown) proceeds, phospho-c-Jun levels need to 
be downregulated by Fbw7 to allow Purkinje cell maturation and dendritic 
arborisation.Basket cell axons (brown) surround Purkinje cells (red) and 
extend through the lower half of the Molecular layer (ML) and Purkinje 
cells receive input from basket cell axons. The Purkinje cell layer separates 
the ML from the granule cell layer (GL). In wt animals Purkinje cell 
dendrites form an elaborate network extending through the ML 2nd from 
left: If phospho-c-Jun accumulates due to the lack of Fbw7 less Purkinje 
cells are present, possibly because early precursors die, and the 
arborisation of the remaining Purkinje cells is reduces. The basket cell 
arborisation is impaired and extends through the whole Molecular layer. 
Concomitant deletion of c-Jun and Fbw7 (3rd from left) rescues the 
Purkinje cell number and basket cell arborisation. However, the number 
of dendrites is still reduced. The Purkinje cell number is also in fbw7ACb:c- 
JunACb/AA mice(right panel), indicating that phosphorylated c-Jun is the 
cause of the observed phenotype. However, a detailed analysis of Purkinje 
cell dendrites and Basket cell axon morphology has still to be carried out 
and the norm al m orpho logy are p red ic tio n s  (a sk te r isks ).
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Figure 5.16 Model for a putative role of N-myc as a Fbw7 target in 
granule cell development A) Alignment of the mouse c-myc and N-myc 
amino acid sequence. The phospho-degron is conserved (red rectangle), 
indicating that N-myc is likely to be a substrate of Fbw7. B) Granule cell 
development in the fbw7ACb cerebellum. In the normal cerebellum Sonic 
hedgehog (Shh) induces N-myc expression. N-myc is degraded by Fbw7, 
and granule cell precursors (dark blue) differentiate (light blue) and migrate 
inwards. In fbw7ACb animals N-myc induction by Shh is reduced due to 
the lack of Purkinje cells. However, as N-myc is not degraded by Fbw7, 
N-myc accumulates induces proliferation in the EGL which subsequently 
lead to more granule cells and the formation of an additional fissure in 
fbw7ACb brains.
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6 FBW7 DELETION IN POSTMITOTIC 
NEURONS CAUSES A TREMOR, 
HINDLIMB DEFECT AND REDUCED 
CORTICAL CELLULARITY
So far I have described two different approaches to investigate the role 
of Fbw7 in the nervous system. In the first approach Fbw7 was deleted in 
neuronal progenitor cells (fbw7***) while in the fbw7ACb mice the deletion was 
restricted to a specific area in the brain, the cerebellar vermis. The data obtained 
from these two lines demonstrated that Fbw7 is essential during neurogenesis 
and synapse formation. Furthermore it became apparent that the Fbw7 knockout 
phenotypes contain c-Jun dependent and c-Jun independent components. The 
deletion of Fbw7 occurred during developmental stages where precursor cells 
are affected and in both cases a reduced cellularity or smaller cerebellum was 
observed. These results lead to the hypothesis that Fbw7 deficient cells might 
die at early stages of neuronal differentiation in these mouse lines.
To investigate the role of Fbw7 in postmitotic neurons, I used a mouse 
line where the Cre-recombinase is expressed under the control of the 
Synapsin-1 promoter to generate animals that are Jbw7^:Synapsin-cre+ 
(fbw7ApN). In this mouse line the Cre mediated deletion is limited to postmitotic 
neurons in the brain and in the spinal cord (C. Hoesche et al., 1993; Y. Zhu et 
al., 2001). The histological analysis of Zhu et al. with NeuN as a neuronal 
marker in lacZ reporter mice demonstrated that Cre activity is mainly
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distributed in differentiated neurons outside the ventricular regions of the brain 
and spinal cord. Whilst neurons in the spinal cord, hippocampus and cerebral 
cortex where deleted efficiently, the lacZ immunoreactivity was low in the 
cerebellum and could only be observed in a few Purkinje cells but not in 
granule cells. Additionally the deletion does not affect glia (Y. Zhu et al.,
2001). Hoesche et al have demonstrated by placing a chloramphenicol acetyl 
transferase reporter under this promoter that the activity starts at E12 and peaks 
at P20 (C. Hoesche et al., 1993).
6.1 f b w 7 ApN mice are infertile and smaller than 
their wt littermates
In general fbw7ApN animals were smaller than their wt littermates and this 
size difference was more pronounced in animals from larger litters (Figure
6.1 A). However, fb w 7 ^N animals that have reached the weaning age did not 
loose weight, lived as long as their wt littermates, and did not develop tumours 
within 1 year of age (data not shown). To characterise the growth defect of 
fbw7ApN animals, the weight of the mice was taken once a week for the first 3 
month after birth. It became apparent that male and female fbw7ApN animals are 
smaller (Figure 6.IB). I also observed that pups disappeared during the weight- 
taking period, probably because they were eaten. Although their genotypes 
could not be confirmed, it is likely that these animals were mutants because 
additionally about 10% of fbw7ApN animals had to be culled within two month 
after birth due to severe growth retardation and a severe hindlimb tremor whilst 
heterozygous mice did not display any phenotype. As the analysis of embryos
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at different gestation levels between E15 and PO demonstrated that fb w 7 ^N 
embryos are present with mendelian frequency, I conclude that the observed 
submendelian frequency of fbw?*1*1* mutants at weaning age is caused by early 
postnatal deaths and animals that had to be culled (Figure 6.1C). Additionally 
neither male nor female fbw7*pN animals breed and therefore all further 
breedings were set up using a jb w f /f males or females with the respective 
fb w f /+:Synapsin-cre+ animal, which did not display any phenotype.
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Figure 6.1 fbw7ApN mice are present with submendelian frequency 
and are smaller than their wt littermates. A)Size comparison between 
a 1 year old fbw7APN animal and wt littermate showing that in some cases 
the weight difference persists through adulthood B) Weights from control 
and fbw7APN animals were recorded in 1 week intervals from birth onwards. 
fbw7ApN animals are significantly smaller than their littermates over the 
period measured, p-values females: p=0.0042, males p<0.001 C) Obtained 
genotypes at weaning age and embryonic stages between E15 and P0
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6.2 f b w 7 ApN  animais have a hindlimb defect and 
tremor
During the handling of the mice I noticed that Jbw7ApN animals have a 
hindlimb defect as they are unable to spread their hindpaws when suspended by 
their tail and instead keep them together or in some cases clasp them (Figure
6.2). Such defects are known to occur after treatment with neurotoxic drugs 
such as MPTP (W. Dauer and S. Przedborski, 2003) or in neurodegenerative 
diseases. For example, in a mouse model for HD, animals display a hindlimb 
defect (L. Mangiarini et al., 1996). Also, animals in which autophagy is 
impaired clasp their hindpaws (M. Komatsu et al., 2006). Additionally fb w 7 ^N 
animals have a tremor in their hindlimbs (see supplementary movie M l and 
M2) and this tremor was in general more pronounced in mutant animals that 
had to be culled. Since the tremor and hindlimb defect are indicative of 
neurodegeneration, I further analysed the fbw7ApN animals using different 
behavioural tests before proceeding with the immunohistochemical analysis of 
the brains.
To assess whether the fbw7ApN mice are ataxic, I performed a gait 
analysis using a U-shaped channel where the feet of mice were marked with ink 
and the footprints were recorded on filter paper. Whereas the front- and 
hindpaw- prints of control animals almost overlap, this was not the case in the 
mutant animals. However, fbw  7*pN animals are still able to walk straight (Figure 
6.3A), indicating that the fbw7ApN animals are only mildly ataxic and their
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hindlimb defect does not impair their gait severely. The reduced stride length of 
fbw7*pN animals is explained by the size difference between fb w 7 ^  mutants 
and controls (Figure 6.3B). While there was no difference in the width between 
the front paws of fbw 7^N and control animals (Figure 6.3C), I noticed that the 
hindpaw width is slightly bigger in fb w 7 ^N animals (Figure 6.3D). The wider 
hindlimb distance together with the hindlimb defect indicate that fbw 7ApN mice 
are either not strong enough to support their bodyweight and spread their 
hindlimbs or that they have alterations in the neuro-muscular connection.
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Figure 6.2 fbw7^p mice have a hindlimb defect. Wildtype adult animals 
of either 2 month of age (A) or 4 month of age (B) spread their hindlimbs 
when suspended by the tail whereas fbw7A*N animals are not able to do 
so.
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Figure 6.3 fbw7ApN animals are mildly ataxic. Gait analysis on fbw7ApN 
animals The front paws were painted in orange non-toxic ink and the 
back paws were painted in purple non-toxic ink. Animals were left to run 
towards housing at the end of the channel. A) Example of gait analysis. 
Distances were manually measured as indicated. B) Stride length 
measurement of control and fibw7ApA/animals C) Front paw width and D) 
Hind paw width measurements. Mean +/-SD values are shown. Control: 
n=16, fbw 7ApN:n=9.
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6.3 Reduced muscle strength and impaired pole 
test performance in f b w 7 A pN  mice
To investigate whether fl>w7‘v  animals are indeed weaker than their 
littermates, the hanging wire test was performed as described in 2.3.4.2. Mice 
are placed on top of a grid, which is subsequently turned over. At the end of the 
experiment the animals were scored “hold” if they were able to hold on or 
climbed on top of the turned grid 2 out of 3 times, and “fall” if they fell twice 
or more. As expected control mice were able to hold on or climb on top of the 
grid in 92% of cases while most of the fb w 7 ^N animals fell down into the 
nesting material and only 23% of the animals managed to hang onto the grid 
(Figure 6.4A). This demonstrates that Fbw7 deletion in postmitotic neurons 
causes a reduction in muscle strength that could also be the cause of the 
hindlimb defect.
To test mice for nigrostriatal dysfunction and degeneration, which can 
for instance be observed in Parkinson’s disease, the pole test is frequently used 
and has been proven helpful in the evaluation of striatal lesions after 
administration of the neurotoxic agents such as MPTP or 6-Hydroxydopamine 
(K. Matsuura et al., 1997). For the pole test the mice are placed on top of a 
vertical, rough surfaced pole and the latency time to climb down the pole is 
measured as described in 2.3.4.1. Control animals traverse the pole easily and 
quick (4.6 seconds on average) whereas fb w 7 ^  mutant animals are slower, 
needing 6.6 seconds on average to climb down (Figure 6.4B). Additionally the
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walking pattern of fbw 7***** animals is different. While control animals wind 
their tail around the pole and walk downwards with ease^v v /4^  animals move 
down the pole in a caterpillar like fashion (see supplementary movies M3 and 
M4).
Taken together the results from the behavioural analysis indicate that 
the motor performance of jbw 7^N mice is impaired and that fbw7ApN animals 
display a phenotype, the hindlimb defect, which is similar to a mouse model for 
HD (L. Mangiarini et al., 1996). Interestingly the hindlimb defect was also 
observed in mice where another protein degradation pathway, autophagy, is 
impaired (M. Komatsu et al., 2006). No cellular defects, apart from a smaller 
brain and the hindlimb defect, could be observed in the HD model whilst mice 
knockout for the autophagy-involved protein ATG7 under the Nestin-cre 
promoter displayed an atrophic cerebral cortex and loss of Purkinje cells (M. 
Komatsu et al., 2006). Based on these observations and because I had already 
observed a reduction in Purkinje cells in fbw7ACh animals, I wanted to 
investigate whether there are similar abnormalities in the brains of Jbw7ApN 
animals and they were analysed by immunohistochemical stainings as described 
below.
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Fig 6.4 Impaired hanging wire and pole test perfomance in fibw7ApA/ 
animals. A) Hanging wire test performed on 2-3 month old animals. 
Animals were placed on a grid, the grid was moved up and down to 
promote the animal to grip and turned over for 30 seconds. The time 
mice were able to hold on, climb on top of the lid, or fall off was measured. 
The experiment was repeated 3 times and the outcome quantified as 
Hold if the animal held on for at least 2 times, and fall if it fell of the grid 
2 or more times. p=0.0286 Mean +/- SD B) A pole test was performed 
on 1-3 month old animals. Animals were placed on a vertical pole and 
the time to transverse the pole downwards was measured for 3 consecutive 
runs. The slowest value, falls and stops were excluded form the 
measurements, two tailed t-test, p=0.0117. To illustrate the variance of 
the data a graph with the original datapoints and the 95% Cl were 
includedFor the impaired walking patters see supplementary movies M3 
and M4.
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6.4 No gross abnormalities of the brain in f b w 7 ApN  
animals
When comparing fb w 7 ^  brains with wt counterparts it became 
apparent that at 3 weeks of age the fbw7**N brains are slightly smaller than wt 
brains while the overall morphology is not altered. In the adult animal on the 
other hand there are no major size differences between the brains and again no 
gross morphological defects are observed (Figure 6.5A).
As described above, I have observed that the fbw7ApN animals are mildly 
ataxic (Figure 6.3). Furthermore fbw7ACh animals show a misorganisation of the 
cerebellum, which is an important integrator for motor coordination in the brain 
(Figure 5.1) Therefore I first examined the cerebellar morphology in fbw7ApN 
animals. In agreement with the size difference of the whole brain shown above, 
the cerebella of fbw7ApN mice are slightly smaller than the cerebella of control 
littermates. However, I could not observe any foliation defects or positioning 
defects of granule cells. Also the Purkinje cell density in fbw7ApN animals is 
comparable to control littermates (Figure 6.5), suggesting that the motor defects 
of the jbw7ApN mice do not originate in the cerebellum.
Analysis of the fbw7ApN brains by in situ hybridisation demonstrated a 
strong reduction of the fbw  7 signal in the cortex and dentate gyrus (Figure 3.9). 
To investigate whether there are any abnormalities in neuronal morphology in 
these or other brain regions, fbw 7^N brains sections were stained with a NeuN 
antibody to visualise neuronal nuclei. Sagittal sections of seven month-old
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control and f b w 7 mutant animals were then compared. Whilst the 
hypothalamus, pons and dentage gyrus of Jbw7ApN animals appear normal in 
NeuN stained sections and no major morphological differences could be found, 
the cellularity of the cerebral cortex appears slightly reduced in fbw7ApN animals 
(Figure 6.6). To investigate whether there are indeed alterations in the cortical 
cellularity in fbw7ApN animals, coronal NeuN stained sections were further 
analysed.
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Figure 6.5 No gross morphological changes and no loss of Purkinje 
cells in fb w 7 p^mouse brains A) Brains of 3 week old animals and 7 
month old fbw7 p animals do not display differences compared with wt 
brains apart from a reduced size.B) H&E, NeuN and Calbindin stained 
sections of sagittal cut cerebella of a control and fbw 7 p ^animal.No 
foliation defects or granule cells defects are present.C) Purkinje cell 
parameters were determined as previously described in two to six month 
old fbw7APN animals and littermate controls. A) The number of Purkinje 
cells is reduced in fbw7APN animals but so is the Purkinje cell layer lenght 
(B) in in fbw7ApN animals. The density obtained from the ration between 
Purkinje cell number and Purkinje cell layer lenght is not altered. Mean 
+/-SD shown, Control: n=4,fbw7APN: n=3
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Figure 6.6 Reduced cortical cellularity in fbw7ApN animals but normal 
pons, hippocampus and brain stem. Sagittal sections of control and 
fbw7ApN 7 month old animals were stained with NeuN. A) The cellularity 
of the cortical layer is reduced (arrow) The hippocampus (He) and dentage 
gyrus are formed normal as is the thalamus (Tm). The pons (Pn) and 
inferior olive (lo) are normal in fb w 7 ^ N animals and no gross morphological 
defect can be observed.
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6.5 Reduced cortical cellularity in f b w 7 ApN  animals
NeuN stainings in coronal sections confirmed that the cortical cellularity 
in fbw 7*N brains is reduced in the the cerbral cortex (Figure 6.7). Interestingly 
a variety of mouse strains with cortical lamination defects also display motor- 
coordination problem and some strains are named after their walking pattern 
phenotype such as staggerer, lurcher and reeler (reviewed in (A. Gupta et al.,
2002)). An impaired cortical lamination and cellularity are often the result of 
defects in neuronal migration during development, especially during the period 
of E ll  to El 7 when the cortical layers are formed (see also 1.4.1). Therefore I 
wanted to investigate whether the reduced cellularity is a consequence of an 
impaired neuronal migration and performed BrdU labelling experiments of 
neurons. Time mated pregnant females were injected with BrdU at E14.5 and 
pups were taken at E l7.5. Any cell that incorporated BrdU and became 
postmitotic at this time point retains the BrdU and will still be BrdU positive at 
E l7.5. Sagittal sections of E l7.5 fb w 7 ^  embryos that had received BrdU at 
E l4.5 show that the numbers of BrdU positive cells in the intermediate zone, 
ventricular zone and subventricular zone is strongly reduced. In addition the 
BrdU labelling of the ganglionic eminence is much weaker in fbw  7 ^  animals 
than in the control (Figure 6.8). This suggests that the fb w 7 ^  animals indeed 
display migration defects. Whilst the reduction in BrdU positive migrating cells 
can explain the reduced cellularity of the cerebral cortex in fb w 7 ^N animals, a 
further detailed analysis of neuronal subpopulations and migration patterns is
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required to fully elucidate the role of Fbw7 in the development of the strong 
behavioural phenotype and cortical migration (see also discussion).
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Figure 6.7 Reduced cortical cellularity in fbw7^pN animals
A) Coronal sections of 6 month old control and fbw 7ApNanimal. The 
cortical cellularity is reduced particularly in the lower part of the molecular 
layer which is likely to be layer V. B) Coronal more caudal section of 4 
month old control and fbw7*pN animals. Again the cellularity is reduced 
and appears not to be progressive as the loss has a similar extend as 
in 6 month old animals. C) NeuN positive cells in coronal cortical sections 
of the indicated area 2 in A were counted as described in Methods. The 
cell density per mm2 was calculated control: n=3, mutant n=3 
Layerll/lll: p= 0.0271, Layer V: p=0.0197, Layer VI: p=0.0357,Mean +/- 
SEM shown
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Figure 6.8 Reduced number of BrdU positive cells in the fbw7ApN 
cortex at E17. A time mated pregnant female was BrdU injected at E14.5. 
Sagittal sections of E17.5 embryos were taken and stained for BrdU A) 
H&E of the cerebral cortex and ganglionic eminence in a E17.5 control 
and fbw7ApN animal. Indicated areas are shown in B. B) H&E and BrdU 
stained sections from the cortex and the ganglionic eminence. The 
number of BrdU positive cells in the ventricular zone (VZ) subventricular 
zone (SVZ) as well as in the intermediate zone(IZ) and the ganglionic 
eminence (C) is strongly reduced while the number of BrdU positive cells 
in the cortical plate is similar.
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6.6 No loss of dopaminergic neurons in f b w 7 ApN  
animals
The behavioural phenotyping carried out in fbw7ApN mice indicated that 
these animals might have a defect in their nigrostriatal pathway. In humans the 
loss of dopaminergic neurons in the substantia nigra, which is part of the 
nigrostriatal pathway, is the cause for Parkinson’s disease (PD). Given that 
Fbw7 can interact with Parkin (see chapter 1.3.4) and that the fb w 7 ^ N mice 
display a tremor, it was imperative to investigate whether dopaminergic 
neurons die or degenerate in fbw7**N mice.
Dopamine belongs to the class of catecholaminergic neurotransmitters 
and it is synthesised from tyrosine by means of the enzyme Tyrosine 
Hydroxylase (TH). Therefore a staining with a TH antibody can give insights 
into whether dopaminergic neurons are affected in the fb w 7 ^N animals. I 
quantified the number of TH positive neurons in the substantia nigra and the 
VTA, regions that show a reduced number of dopaminergic neurons in PD. 
However, in neither of these areas a loss of TH positive neurons could be 
observed (Figures 6.9 and 6.10), indicating that the motor defects do not 
originate from loss of dopaminergic neurons. Neurons from the VTA and the 
substantia nigra project into the striatum in which the TH stain is present as a 
diffuse stain due to its axonal localisation (Figure 6.10 left panel). Although I 
did not quantify the staining intensities, there is no indication that there are 
major alterations in striatal TH expression or in the number of TH positive
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neurons in the locus coeruleus (Figure 6.1 OB right panel). Finally, a further step 
in investigating whether the Fbw7 knockout in postmitotic neurons has any 
effect on the nigrostriatal pathway was to analyse the GAD-67 
immunoreactivity in the striatum as degeneration of GABA-ergic neurons in 
this brain region occurs in HD (see chapter 1.4.4). The quantification of GAD- 
67 levels in the striatum of fbw7*pN animals shows, that the levels of GAD-67 
immunoreactivity in the striatum of fbw7ApN animals is comparable to that of 
controls (Figure 6.11) and no differences in striatal structure could be observed.
In parallel to the above analysis, I set up breedings with a mouse line in 
which the Cre-recombinase expression is driven by the rat tyrosine hydroxylase 
promoter, leading to the selective deletion of a floxed gene in 
catecholaminergic neurons (D. M. Gelman et al., 2003). The hypothesis was 
that, if the observed phenotype in fbw 7^N animals was caused by defects in 
catecholaminergic neurons, the behavioural defects o f fbw7ApN animals should 
be reproduced in these fbw ^,T h-cre+ (fbw7ACN) animals. However, fbw7ACN 
animals appear normal and do not display any of the behavioural defects such 
as hindlimb clasping or a tremor that were observed in the fbw7ApN animals 
(data not shown). Thus, taken together with the unaltered numbers of 
dopaminergic neurons in the VTA and substantia nigra of fbw 7ApN animals, I 
conclude that the phenotype in fbw7ApN animals is not caused by a loss of 
dopaminergic neurons in the nigrostriatal system. It remains to be established 
where the observed defect in fbw7ApN animals originates, (see also discussion).
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Figure 6.9 No loss of dopaminergic neurons in the VTA in fbw7ApN 
anim als. A) Example of 2 sections per genotype tha t were 
chosen for quantification of Tyrosine Hydroxylase positve neurons in the 
Ventral tegmetal area. B) Quantification of Tyrosine hydroxylase positive 
neurons in control and fbw7^pN animals. TH positive neurons in the VTA 
in both hemishperes were quantified and the obtained cell number 
averaged per animal. Data are shown as Mean+/- SD of indicated animals. 
No significant difference could be detected.
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Figure 6.10 No loss of dopaminergic neurons in the Substantia 
Nigra. A) Coronal section of 1 month old control and fbw 7ApN animals 
stained with Tyrosine Hydroxylase (TH) antibody.The arrangement of 
TH positive neurons is comparable and no difference could be detected 
when the number of TH positive neurons was quantified in B) Mean +/- 
SD are shown. C) Sagittal sections of control and fbw7ApN animal stained 
stained against TH. Additionally to the Substantia nigra (SN, middle 
panel) also the Striatum (St, left panel) and the Locus Coeruleus (LC, 
right panel) are immunoreactive for Tyrosine Hydroxylase. No apparent 
difference could be found in the Striatum and Locus Coeruleus.
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Figure 6.11 No alterations in GAD-67 levels in the striatum of fbw7ApN 
mice A) Sagittal sections from control and fbw7ApN animals were stained 
with a GAD-67 antibody. CPu: Caudate Putamen GP:Globus Pallidus 
No gross morphological differences or loss of striatal innervation can be 
observed B) GAD67 Intensities in the striatum were quantified as arbitrary 
units and no difference could be detected. Mean +/-SD values are shown
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6.7 The phenotype of f b w 7 ApN  animals is not c-Jun 
dependent
I also wanted to determine the c-Jun dependency of the fbw7**N 
phenotype. To do this f b w 7 animals were firstly crossed with cjurf^ mice to 
obtain fbw7ApN: c - ju n ^  animals. In parallel fbw7ApN animals were bred with 
junAA mice to obtain fbw7ApN:junAA/AA animals where c-Jun cannot be 
phosphorylated (A. Behrens et al., 1999). Both the fbw7ApN:c-jun/spN and 
fbw7ApN:junAA/AA animals are viable and fbw7ApN:c-junApN animals are also 
smaller that their wt littermates. A size comparison for fbw7ApN:junAA/AA was not 
possible as the junAA animals are larger and heavier than wt mice and 
subsequently the fbw7ApN:junAA/AA mice were heavier and larger as well. Neither 
the concomitant deletion of c-Jun, nor the knockout of Fbw7 in the junAA 
background, was able to rescue the observed hindlimb defect. This suggests 
that neither c-Jun nor c-Jun phosphorylation is not the main mediator for the 
behavioural phenotype (Figure 6.12).
Although no c-Jun dependency of the behavioural phenotype could be 
observed, the staining of coronal sections of fbw7ApN animals with the c-Jun 
(H79) antibody showed an increase of c-Jun in the dentate gyrus, a brain region 
where Fbw7 is efficiently deleted (Figure 6.13). Since c-Jun and particularly 
phospho-c-Jun have been connected to the induction of neuronal apoptosis, a 
TUNEL labelling was performed. In line with the observation that in NeuN 
stained sections the Dentate gyrus appears normal, no aberrant apoptosis or loss
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of cells could be observed in the Dentate gyrus or any other part of fb w 7 ^  
brains (Figure 6.13C and data not shown). Thus elevated c-Jun levels alone are 
not sufficient to cause neuronal apoptosis. Phospho-c-Jun levels, however, 
remain to be determined by immunohistocheminal stainings using phospho- 
specific antibodies.
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Figure6.12 The hindtim b defect is not c-Jun dependent
A) c-junApN animals do not display a hindlimb defect whilst concomitant 
deletion of Fbw7 and c-Jun in fbw7ApN:c-junApN animals does not rescue 
the phenotype. B) Deletion of Fbw7 in the jurtAA background also results 
in a hindlimb defect, demonstrating that c-Jun is not the main mediator 
of this phenotypic aspect
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Figure 6.13 Elevated c-jun levels but no apoptosis in the dentate 
gyrus of fbw7ApN animals All sections were stained with a c-Jun H79 
antibody. A) Control and fbw7ApN saggital sections of 1 month (top) and 
5 month old (bottom) animals.In fbw7Ap™ animals c-Jun levels are elevated 
in the dentate gyrus. B) The c-Jun stain in the dentate gyrus disappears 
upon concomitant deletion of Fbw7 and c-Jun, demonstrating that the 
staining is specific. C) No apoptosis in fbw 7ApN animals. Neither the 
Hippocampus nor the dentate gyrus display TUNEL positive cells.
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6.8 Discussion
To investigate the role of Fbw7 in postmitotic neurons, I have generated 
mice in which Fbw7 deletion is mediated by a Cre recombinase under the 
neuron specific SynapsinI promoter and I could confirm efficient deletion in the 
cerebral cortex, the pons and the dentate gyrus (Figure 3.9). I observed that 
these fbw 7 ^  mice display a variety of behavioural abnormalities such as a 
hindlimb defect, a tremor and reduced muscle strength and some of those 
phenotypes have been associated with mouse models and drug models for for 
PD or HD (R. J. Carter et al., 1999; M. J. Zuscik et al., 2000; P. O. Femagut et 
al., 2005). However, the fbw  7 ^N phenotype is not progressive and is not caused 
by a loss of dopaminergic neurons in the substantia nigra, ventral tegmental 
area, alterations in GAD67 levels or the cellularity in the striatum.
The histological analysis demonstrated that the gross morphological 
structure of the brain is not impaired and that fb w 7 ^  animals have a normal 
cerebellum. However, cellularity in the cerebral cortex, an area with high Fbw7 
message levels, is reduced and preliminary BrdU birthdating experiments 
suggest that in fb w 7 ^  animals less proliferating neurons are present at E l7 
after labelling them at E l4.
6.8.1 The reduced cortical cellularity could cause the phenotype
The histological analysis of the fb w 7 ^N animals demonstrated a reduced 
cellularity in the adult cortex throughout the cortical layers (Figures 6.6 and
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6.7). During development the cortical layering is established in an inside out 
pattern by radial migrating neurons between E14 and E l8 and migration defects 
at this stage lead to an altered cortical lamination (see also Fig. 1.7). 
Preliminary results from the BrdU birthdating of neurons at E14 demonstrated 
that the overall number of BrdU labelled cells, particularly in the intermediate 
and ventricular zone but also in the ganglionic eminence, is reduced at E l7 
(Figure 6.8). This could indicate that at the time of the BrdU injection fewer 
cells were in S phase and incorporated the BrdU in fb w 7 ^ .
If the switch from symmetric cell division, which generates more 
precursors, to asymmetric division occurred prematurely, or cells are not able to 
differentiate properly, this could also lead to a depletion of BrdU+ cells at E l7. 
The loss of cells due to premature differentiating divisions was for instance 
observed in the cerebellar Notch 1 knockout mice. There premature 
differentiating neurons die and this ultimately leads to a smaller cerebellum due 
to the lack of progenitor cells (S. Lutolf et al., 2002) (see also chapter 5.7.3).
It is also possible that the cells that were labelled at E l4, die during the 
three-day period before the brains were extracted. Based on the data obtained 
from the fbw  7 ^  neurospheres where differentiation defects were observed, one 
can envisage that also in fb w 7*^ brains the Fbw7 deletion interferes with the 
final differentiation. Therefore further BrdU labelling experiments over 
different times will be essential to identify the reason for the reduced cell 
number in the cerebral cortex. If cells were able to undergo the initial 
asymmetric division, one would expect a comparable BrdU labelling after a 
short time such as for instance 3hours. However, one would then expect the 
inappropriate expression of neuronal markers as cells migrate to their final
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position in the cortex, which should be accompanied by an increase in 
apoptosis. A subsequent loss of cells and fewer BrdU positive cells in the 
cerebral cortex at E l7 would be the final outcome. The above-described 
experiments are planned and setup, however I could not perform them yet due 
to the lack of females that could be used for time matings. Once these 
experiments are set up, one could aim to identify whether a specific subclass of 
neurons is affected by Fbw7 deletion. The neurons in layer V of the cortex are 
mainly pyramidal projection neurons that reach distant targets outside the 
cerebral cortex (Z. Molnar and A. F. Cheung, 2006). Among them are also 
corticospinal neurons. As the name suggests, they project towards the spinal 
cord and if these neurons were affected in fb w 7 ^  animals, this could also 
explain the behavioural phenotype. A number of genes that can be used as a 
marker for layer V neurons have been identified and are summarised in a recent 
review by Molyneaux (B. J. Molyneaux et al., 2007). Among them are also 
markers whose expression changes during development such as Ctip2 and 
therefore they could also be employed to characterise the cortical migration 
during development. Furthermore Chan et al have demonstrated that Emxl is a 
marker for pyramidal neurons in the adult cortex, which are projection neurons 
that connect the cortex with other brain regions (C. H. Chan et al., 2001). The 
use of such markers could help to identify whether only a subtype of neuron, 
eg. neurons that use a certain neurotransmitter, or target a specific area, are 
particularly sensitive to the loss of Fbw7. The analysis of corticalspinal neurons 
together with the analysis of the spinal cord itself would be crucial in 
elucidating the origin of the behavioural phenotype in fbw  7 ^N animals.
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Finally, similar to the fbw7ACh and fb w 7 ^  animals, it is also possible 
that different substrates mediate the phenotype. Notch 1 for instance is 
expressed in cortical neurons and is involved in the regulation of neurite 
outgrowth (O. Berezovska et al., 1999; L. Redmond et al., 2000). It would 
therefore be one possible target of Fbw7 in the cortex. Additionally there is 
emerging evidence that cell cycle regulators, including Cyclin E, are important 
in the nervous system and that a cell cycle re-entry in postmitotic neurons does 
mediate neuronal apoptosis (E. B. Becker and A. Bonni, 2004, 2005), (A. 
Lukaszewicz et al., 2005). It is therefore mandatory to investigate the different 
Fbw7 substrates in parallel with BrdU labelling experiments and apoptosis 
assays. Immunohistochemistry, western blotting and also FACS sorting of 
neuronal subpopulation (S. Sergent-Tanguy et al., 2003) could be employed to 
characterise the fate and differentiation of neurons in fbw7ApN animals.
6.8.2 Other possible reasons for the observed phenotype
6.8.2.1 Hypothesis I: Defects in axonal and/or dendritic development in 
f b w ? ^  neurons
E3 ligases have also been implicated in the regulation of neuronal 
differentiation, which includes extension of the growth cone and 
dendritogenesis. It has been demonstrated that in culture retinal xenopus 
neurons the ubiquitin-conjugate concentration increases dramatically if a 
growth cone encounters the guidance molecule netrin and that blocking the 
proteasome blocks the netrin dependent turning of the growth cone (D. S. 
Campbell and C. E. Holt, 2001). Additionally the ubiquitin proteasome system
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has been implicated in the establishment of neuronal polarity. It has for instance 
been shown that the proteasoma turnover of Akt in dendrites is essential for the 
establishment of dendrites and axons (D. Yan et al., 2006). Suppression of the 
proteasome in hippocampal cultures led to the symmetric distribution of Akt 
and resulted in the formation of multiple axons. Furthermore proteasomes can 
be sequestered to dendritic spines in an activity dependent manner, suggesting 
that they are involved in the activity dependent remodelling of the synapse (B. 
Bingol and E. M. Schuman, 2006) and an initial study that supports this model 
based on findings with the Fbw7 homologue in c.elegans, Sel-10, is described 
below.
6.8.2.2 Hypothesis 2: the motor defects are caused bv deficits in 
synapse elimination or svnaotic transmission
The c.elegans homologue of Fbw7, Sel-10, has recently been 
implicated in the elimination of synapses (M. Ding et al., 2007; D. M. Miller, 
2007). Ding et al. observed that an SCF complex containing Sel-10 is active at 
a primary neuromuscular synapse and that the complex is inhibited in its 
function by the inhibitory protein Syg-1. Syg-1 binding to Skr-1, the c.elegans 
homologue to Skp-1 and thereby blocks the ubiquitination and degradation of 
synaptic proteins at the primary synaptic site Interestingly, this interactions 
stimulates the ubiquitination of proteins and subsequent elimination of 
secondary synapses by a yet to be identified mechanism (M. Ding et al., 2007). 
Furthermore Ding et al. show that artificial elevation of SCF activity causes the 
elimination of primary and secondary synapses. Also in mammals neuron- 
muscular synapses are eliminated during development (reviewed in (H. Colman
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and J. W. Lichtman, 1993)). If one extrapolates the finding by Ding et al. to the 
mouse this would predict that deletion of Fbw7 and subsequent impairment of 
the SCFFbw7 complex should result in an impaired synapses elimination and 
subsequently alter the transmission from the nerve to the muscle, which is 
interesting with regards to the impaired motor function of the fb w 7 ^N animals. 
To investigate this, an analysis of the spinal cord and neuromuscular junctions 
in fbw7^ n animals should be performed. One could for instance repeat the in 
situ hybridisation to determine the expression levels of Fbw7 in the 
neuromuscular junction (NMJ), and analyse the NMJ in fb w 7 ^  animals. 
Established markers for the NMJ that could be used for such an analysis are 
antibodies against the acetylcholine-receptor and labelled bungarotoxin 
(reviewed in (J. Lu and J. W. Lichtman, 2007)). Studies in Drosophila have 
further implicated E3-ligase is the development of the neuromuscular junction. 
There the disruption of the locus of the RING-E3 ligase highwire results in 
defects at the neuromuscular junctions (C. Wu et al., 2005). If the observed 
motor defects in fb w 7 ^  animals are caused by defects in the spinal cord, an 
area where Synapsin-cre mediated deletion takes place, but the TH-cre 
recombinase is not active.
It has also been demonstrated that in addition to acute lesions, changes 
in neurotransmitter levels can cause an impaired pole test performance and this 
could also be the reason for the altered behaviour in fb w 7 ^N animals. The 
DAT'7' mice, where the dopamine transporter (DAT) is deleted, are also 
impaired in their pole test performance (P. O. Femagut et al., 2003). These 
mice display persistent elevated extracellular dopamine levels due to the lack of
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DAT, which is normally responsible for the re-uptake of dopamine as part of an 
auto-regulatory loop. To test whether deletion of Fbw7 impairs the synapse 
elimination in the brain one could stain or western blot with presynaptic 
(synaptophysin) or postsynaptic markers (eg. PSD-95) or synaptic vesicle 
proteins in a complementary approach with the use of electron microscopy to 
analyse the synapses at a high resolution level. The levels of neurotransmitters 
in the brain can be investigated by HPLC on dissected brain regions. This 
method has been used in the Parkin knockout mice, where altered 
neurotransmitter levels without a concurrent loss of dopaminergic neurons was 
observed (see chapter 1.4.4). A similar bioanalytical approach in fbw7***** 
animals could clarify whether the loss of Fbw7 causes alterations in 
neurotransmitter levels in the brain. Since the resulting changes in synaptic 
transmission would be permanent, this could also explain why there is no 
progression in the phenotype. If neurotransmitter levels were altered to a 
different degree in fbw7***N animals and fbw7AcN animals, this could explain the 
phenotypic differences between those two mouse lines.
6.8.3 The observed phenotype is not c-Jun dependent
To establish whether the observed behavioural and histological 
phenotype is c-Jun dependent, crosses with either c-jun ^  or junAA mice were 
set up. By using the hindlimb defect as a first indicator of the fbw7ApN 
phenotype, I established that the hindlimb defect is not rescued in the 
fbw7ApN:c-junApN or the fbw 7 ^ :junAA/AA mice, indicating that this part of the 
phenotype is not c-Jun dependent (Figure 6.12). Furthermore I observed that 
the elevated c-Jun levels in the dentate gyrus were not sufficient to cause
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apoptosis. Interestingly, this is similar to the effect observed in c-jun transgenic 
Purkinje cells where high c-Jun levels alone also did not cause apoptosis (see 
chapter 5). However, if neurons in the dentate gyrus of fbw7ApN animals were 
more sensitive to stress, as are c-Jun transgenic Purkinje cells, one would 
predict that administration of the excitotoxic agent kainate should aggravate the 
seizures compared to wt animals as the excitotoxicity of kainate is mediated via 
the JNK signalling pathway (see also chapter 1.1.1 and references therein).
The hippocampus is implicated in learning and memory formation and it 
will be interesting to see how fbw  7^N animals perform in behavioural tests for 
learning and memory formation and whether elevated c-Jun levels play a role in 
these processes. To further investigate the effect of Fbw7 in the hippocampus I 
set up crosses where Fbw7 is deleted using CamK2-cre transgenic mice 
(fbw7AHc) (L. Minichiello et al., 1999). Preliminary data suggest that fbw7AHc 
mice do not display a hindlimb defect or tremor such as the fbw7ApN animals 
(data not shown), which further supports the notion that the hippocampal 
alterations in fbw7&pN animals are not responsible for the observed behavioural 
phenotype. However, a detailed behavioural analysis of the fbw7AHc animals has 
yet to be performed. One would predict that like in fbw7ApN animals, c-Jun 
levels in the dentate gyrus should be elevated. Although ablation of c-Jun in the 
nervous system (c - j u n was shown not to alter the performance in the Morris 
water maze test (G. Raivich et al., 2004), the presence of elevated c-Jun levels 
in either the fbw7ApN (Figure 6.13) or fbw7AHc mice, will allow to test whether 
the presence of c-Jun alone modulates the hippocampal function and to what 
extent it is involved in learning and memory formation.
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7 CONCLUDING REMARKS AND OUTLOOK
The aim of this thesis was to test the hypothesis that the E3-ligase Fbw7 
is a key regulator of phospho-c-Jun levels in the nervous system. For this 
reason I generated various brain specific conditional knockout lines for Fbw7 
(summarised in Table 7.1). Based on the finding that Fbw7 is mutated in 
cancers and that it has many substrates, an important role of Fbw7 in the 
organism was predicted and confirmed in early publications demonstrating that 
the lethal effect of a germline knockout of Fbw7 are caused by elevated Notch 
and cyclin E levels during vascular development (M. T. Tetzlaff et al., 2004; R. 
Tsunematsu et al., 2004). By means of the combinatorial use of different 
conditional Fbw7 knockout lines I could demonstrate that Fbw7 is important 
during brain development and that a nervous system specific deletion in the 
neural lineage also causes lethality whilst the regional or temporal restricted 
Fbw7 deletion in the brain does not impair viability. I obtained data that suggest 
that in addition to c-Jun Fbw7 has other substrates in the brain as some of the 
observed phenotypes are not c-Jun dependent.
7.1 Fbw7 deletion causes distinct phenotypes in 
different mouse lines
Using the Nestin-cre line I investigated the role of Fbw7 during early 
neuronal development and observed that deletion in the neural lineage results in 
a reduced cellularity and perinatal lethality (chapter 4). However, compared to 
the severe defects of the germline knockout animals, which display an
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impairment of the neural tube closure, the gross brain morphology was 
preserved in Jbw7AN animals. This demonstrates that apart from being essential 
during neurulation, Fbw7 continues to play an important role in the brain after 
E l0.5. Interestingly Nestin-cre mediated Fbw7 deletion in neurons and glia is 
lethal whilst deletion in exclusively postmitotic neurons by the Synapsin-driven 
Cre-recombinase does not. The initial studies on these mouse lines demonstated 
that the expression pattern of these different promoter elements is almost 
complementary. Whilst it was shown in Nestin-GFP mice that Nestin-promoter 
driven expression is high in the ventricular zone, no synapsin-cre mediated 
deletion can be detected within this brain region in lacZ: Synapsin-cre reporter 
mice (J. L. Mignone et al., 2004) (Y. Zhu et al., 2001). A loss of cells during 
the initial differentiation could explain why the cellularity is more strongly 
reduced in the fb w 7 ^  cortex than in the fbw7ApN cortex, where deletion takes 
place after this lineage decision has been initiated and where a major population 
of the brain cells, namely glia, are not affected. Experiments performed by Jorg 
Hoeck showed that fbw7AN neurospheres display differentiation defects (J. 
Hoeck personal communication). Taken together with the reduced cellularity in 
fbw7AN animals it is possible that Fbw7 is involved in the regulation of 
progenitor- differentiation during brain development. The fact that the fbw7ApN 
mice display also a reduced cellularity suggests however, that Fbw7 is also 
involved in additional later occurring processes. These possibilities are 
discussed below.
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7.2 Fbw7 in the cortex
Fbw7 is highly expressed in the cerebral cortex as shown by in situ 
hybridisation on E l8 fb w 7 ^  and adult fbw 7***** animals. I observed that Fbw7 
deletion in the cortex causes a reduced cortical cellularity in two different 
mouse lines (fbw7ApN and fbw7AN). Defects in cortical development can occur at 
different stages in development, early during the initial asymmetric division, 
during cell migration and when cells finish migration and assume their cortical 
position in the respective cortical layers. Although the gross structure of the 
cortical layering appears preserved infbw7ApN animals, the cellularity is reduced 
(Fig 6.7). This suggests that cells die during migration or early development. It 
will be interesting to analyse whether as part of the reduced cellularity certain 
neuronal subpopulations are more affected by the Fbw7 deletion than others. To 
do this, established markers that label distinct neuronal subpopulations such as 
for instance Ctip for layer V, which also contains corticospinal neurons, will be 
employed (B. J. Molyneaux et al., 2007).
To monitor the migration and differentiation of neurons in fbw7ACb or 
fbw7ApN animals a GFP-Fbw7 reporter line where GFP expression is induced by 
Cre-recombinase mediated deletion could be used. However, I would anticipate 
a lower number of GFP positive cells in the fbw7ApN cortex due to cell death as 
a result of Fbw7 deletion. Although TUNEL assays were not performed on the 
mouse lines described here, it is feasible to hypothesise that the analysis of 
earlier developmental stages in the fbw7ACh animals and a closer monitoring of 
migrating neurons in fbw7ApN animals will show an increase in neuronal 
apoptosis that precedes the loss of cells.
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7.3 Fbw7 in the cerebellum
Deletion of Fbw7 in the cerebellar vermis, fbw7  , caused a reduction 
in vermis size, a reduced Purkinje cell density and an additional fissure. In 
contrast mice harbouring the Fbw7 deletion in postmitotic neurons did not 
show any cerebellar phenotype. At a first glance this indicates that the observed 
cerebellar defect is due to deletion in progenitor cells as postmitotic cells 
appear unaffected. However, there exists some ambiguity regarding 
Synapsin-cre mediated deletion in the cerebellum. The initial characterisation 
of the Synapsin-cre transgenic line showed that Cre expression in the 
cerebellum is only detectable in some Purkinje cells and not the granule cell 
layer (Y. Zhu et al., 2001). Thus the absence of a cerebellar phenotype could be 
explained by the absence of cre-mediated recombination. Nonetheless, the in 
situ hybridisation in the cerebellum of /b w /^ m ic e  showed some reduction of 
signal with the generic and the exon 5 specific probe and furthermore the 
deletion PCR for Fbw7 displayed efficient deletion in the cerebellum (Figure 
3.10 and data not shown). Another study has also observed an efficient 
cerebellar deletion of their protein of interest using the synapsin-cre mouse line 
to knockout the (33-subunit of the y-aminobutyric acid type A receptor (C. 
Ferguson et al., 2007). Thus based on the in situ hybridisation data, the deletion 
PCR and the report by Ferguson et al. one can speculate that deletion of Fbw7 
in cerebellar progenitors that will form the cerebellar vermis has a more 
dramatic effect on the overall cerebellar structure than deletion in postmitotic 
cerebellar neurons. Purkinje cells become postmitotic between E l l  and E l3 
and Synapsin-cre mediated deletion can be detected from E l2.5 onwards as
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observed in some Purkinje cells by Zhu et al. in the initial characterisation of 
the synapsin-cre mouse line (J. Altman and S. A. Bayer, 1978; Y. Zhu et al., 
2001). Therefore if Purkinje cells expressed Fbw7 and the observed cerebellar 
knockout phenotype were Purkinje cell autonomous, the fb w 7 ^N cerebella 
should display the same morphological defects in arborisation as fbw7ACb 
Purkinje cells. Based on the performed quantification and macroscopic 
analysis, this is not the case. This argues in favour of hypothesis-1 that was 
proposed in chapter 5.7 and suggests that the observed Purkinje cell defect is 
due to defects in granule cells, which provide essential afferent input to 
Purkinje cells (chapter 5.7). Since there is a loss of signal in the granule cell 
layer in fb w 7 ^  animals without any cerebellar foliation defects when the 
deletion occurs at the postmitotic stage, this furthermore suggests, that Fbw7 
deletion in granule cell precursors is responsible for the observed foliation
A C 'hdefects in fbw7  animals (see also Chapter 5.7.4). However, the analysis of 
synapsin-cre reporter mice by analogous p-galactosidase staining as performed 
for the Engrailed-2 ere line (see appendix) could help to clarify this issue and 
asses the onset and the extent of deletion in the cerebellum offbw7ApNmict.
Additionally, the previously mentioned cross of different knockout 
animals with mice where Cre-expression also induces the expression of a GFP 
reporter could provide a tool to investigate the fate of Fbw7 deleted cells in the 
cerebellum as well. Based on the data that deletion of Fbw7 leads to a reduced 
cellularity and a smaller cerebellum, I would anticipate that the number of GFP 
positive granule cells is strongly reduced in fbw7ACb granule cells whilst in the 
fbw7ApN GFP-positive granule cells would be present. The analysis of the
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Purkinje cell maturation and synapse formation in cerebellar slices of 
fbw7ACh-GFP reporter mice could also give insights into how Fbw7 influences 
the differentiation and arborisation of Purkinje cells. Whilst I could 
demonstrate that in the fbw7ACb the loss of Purkinje cells is phospho-c-Jun 
dependent, an analogous analysis of fbw7ApN mice has still to be carried out. 
Although the behavioural phenotype was not rescued in fbw7ApN:c-junApN 
animals, this does not exclude a rescue of the cortical phenotype as the 
phenotype of conditional Fbw7 knockout animals is composed of c-Jun 
dependent and independent components. If the cortical cellularity were rescued 
in fbw7ACb :c-junACb animals, one could conclude that the behavioural phenotype 
is not caused by loss of these neurons. If it were not rescued, this could 
indicate, that the phenotype is caused by the cortical defects and that other 
substrates are responsible for the observed phenotype.
7.4 Fbw7 and neuronal connectivity
Deletion of Fbw7 in the cerebellum impaired the arborisation in 
Purkinje cells. Analysis of the parallel and climbing fibres indicated that the 
number of Vglutl and Vglut2 positive synapses is reduced, although this has 
still to be quantified. Furthermore, given the behavioural phenotype of the 
fbw7ApN animals together with the lack of loss of dopaminergic neurons, it is 
possible that the loss of Fbw7 in postmitotic neurons impairs the synaptic 
transmission. Interestingly, preliminary data from electron microscopy 
experiments demonstrate a pre- and post synaptic as well as cytoplasmic 
localisation of Fbw7 in wt brains (Gennadij Raivich, personal communication).
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Furthermore, a number of reports have demonstrated various roles for E3 
ligases in the regulation of synapse formation, transmission and signalling. In 
Drosophila, the disruption of the locus of the RING-E3-ligase highwire results 
in defects at the neuromuscular junctions (C. Wu et al., 2005). Presynaptic 
proteins that are components of synaptic vesicles such as syntaxin and 
synaptophysin are targeted for degradation by the E3 ligases Siahl and Siah2 
(T. C. Wheeler et al., 2002) and it has been shown that the 
post-synaptic-density protein PSD-95 is ubiquitinated by Mdm2 and thereby 
efficiently removed after synapse activation (M. Colledge et al., 2003). As, the 
above studies show that E3 ligases fulfil diverse regulatory roles at the synapse; 
Fbw7 might also participate in such processes. It remains to be established, to 
what extent a putative synaptic function would relate to already known Fbw7 
substrates such as c-Jun, c-Myc, N-myc or cyclin E. So far I could demonstrate 
that Fbw7 mediated c-Jun regulation is important for the arborisation of 
Purkinje cells by a mechanism which remains to be fully elucidated. Many of 
the known Fbw7 substrates are normally localised to the nucleus, however, it 
cannot be excluded that Fbw7 shuttles to the nucleus upon a still unknown 
stimulus, and thus exerts its E3 ligase function in a signal dependent manner.
Further investigation into the identified Fbw7 substrates and also 
possible upstream regulators is therefore mandatory for understanding the role 
of Fbw7 in the nervous system. One could for instance screen for Fbw7 
interacting proteins with a yeast-two- hybrid system using a brain library, or by 
using GST-pulldowns or Tap-tagging. These experiments could potentially 
identify novel substrates and upstream regulators of Fbw7 itself. In parallel a 
bioinformatics approach could be employed to identify putative neuronal or
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even synaptic substrates by applying criteria that appear to be common in many 
Fbw7 substrates such as the phospho-degron, interaction with GSK-3 and Pinl, 
or ERK.
In summary this thesis clearly demonstrates that Fbw7 has an important, 
non-redundant function in the nervous system. The observation that the deletion 
of Fbw7 in postmitotic neurons causes a hindlimb defect and tremor similar to 
other neurodegenerative pathologies indicates that Fbw7 could also play a role 
in diseases of the nervous system. While some o f the phenotypes were c-Jun 
dependent, others were not, indicating that on a molecular level Fbw7 is an 
important regulator of the function of potentially many substrates.
Finally, but importantly the generation of fb w /^  mice provides a 
valuable tool to extend the characterisation of Fbw7 functions to other parts of 
the organisms in addition to the brain by crossing theses fbw  /^anim als to other 
tissue specific Cre expression lines.
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Table 7.1 Summary of generated mouse lines
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Appendix : Engrailed2-mediated deletion in the cerebellar vermis
A
B
Appendix 1: Deletion under the Engrailed promoter is limited to the 
cerebellar verm is. A coronal cryosection  obta ined  from  a 
En2cre:ptenflox'+:p53flox/+:R O SA 26lacZflox/+ mouse was stained for |3- 
galactosidase to visualise areas affected by Engrailed-2 mediated deletion. 
A) Deletion is restricted to the cerebellar vermis and affects the cells in 
the vermis as demonstrated in high magnification in B: granule cells (GC), 
Purkinje cells (PC) and Molecular layer (ML)
